id	sid	tid	token	lemma	pos
dpc-4075	1	1	dermatology	dermatology	NOUN
dpc-4075	1	2	:	:	PUNCT
dpc-4075	1	3	practical	practical	ADJ
dpc-4075	1	4	and	and	CCONJ
dpc-4075	1	5	conceptual	conceptual	ADJ
dpc-4075	1	6	review	review	NOUN
dpc-4075	1	7	|	|	ADV
dpc-4075	1	8	dermatol	dermatol	ADJ
dpc-4075	1	9	pract	pract	NOUN
dpc-4075	1	10	concept	concept	NOUN
dpc-4075	1	11	.	.	PUNCT
dpc-4075	2	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	2	2	:	:	PUNCT
dpc-4075	2	3	e2023315s	e2023315s	PROPN
dpc-4075	2	4	1	1	NUM
dpc-4075	2	5	vitiligo	vitiligo	VERB
dpc-4075	2	6	:	:	PUNCT
dpc-4075	2	7	epidemiology	epidemiology	NOUN
dpc-4075	2	8	and	and	CCONJ
dpc-4075	2	9	economic	economic	ADJ
dpc-4075	2	10	impact	impact	NOUN
dpc-4075	2	11	luigi	luigi	PROPN
dpc-4075	2	12	naldi1	naldi1	PROPN
dpc-4075	2	13	,	,	PUNCT
dpc-4075	2	14	adriano	adriano	PROPN
dpc-4075	2	15	pagani2	pagani2	PROPN
dpc-4075	2	16	,	,	PUNCT
dpc-4075	2	17	chiara	chiara	X
dpc-4075	2	18	alduini2	alduini2	NOUN
dpc-4075	2	19	1	1	NUM
dpc-4075	2	20	uoc	uoc	NOUN
dpc-4075	2	21	dermatologia	dermatologia	NOUN
dpc-4075	2	22	,	,	PUNCT
dpc-4075	2	23	ospedale	ospedale	PROPN
dpc-4075	2	24	san	san	PROPN
dpc-4075	2	25	bortolo	bortolo	PROPN
dpc-4075	2	26	,	,	PUNCT
dpc-4075	2	27	vicenza	vicenza	PROPN
dpc-4075	2	28	,	,	PUNCT
dpc-4075	2	29	centro	centro	PROPN
dpc-4075	2	30	studi	studi	PROPN
dpc-4075	2	31	gised	gise	VERB
dpc-4075	2	32	,	,	PUNCT
dpc-4075	2	33	bergamo	bergamo	X
dpc-4075	2	34	2	2	NUM
dpc-4075	2	35	kearney	kearney	PROPN
dpc-4075	2	36	,	,	PUNCT
dpc-4075	2	37	milan	milan	PROPN
dpc-4075	2	38	key	key	ADJ
dpc-4075	2	39	words	word	NOUN
dpc-4075	2	40	:	:	PUNCT
dpc-4075	2	41	vitiligo	vitiligo	NOUN
dpc-4075	2	42	,	,	PUNCT
dpc-4075	2	43	epidemiology	epidemiology	NOUN
dpc-4075	2	44	,	,	PUNCT
dpc-4075	2	45	mental	mental	ADJ
dpc-4075	2	46	health	health	NOUN
dpc-4075	2	47	,	,	PUNCT
dpc-4075	2	48	social	social	ADJ
dpc-4075	2	49	cost	cost	NOUN
dpc-4075	2	50	citation	citation	NOUN
dpc-4075	2	51	:	:	PUNCT
dpc-4075	2	52	naldi	naldi	PROPN
dpc-4075	2	53	l	l	PROPN
dpc-4075	2	54	,	,	PUNCT
dpc-4075	2	55	pagani	pagani	PROPN
dpc-4075	2	56	a	a	X
dpc-4075	2	57	,	,	PUNCT
dpc-4075	2	58	alduini	alduini	PROPN
dpc-4075	2	59	c.	c.	PROPN
dpc-4075	2	60	vitiligo	vitiligo	NOUN
dpc-4075	2	61	:	:	PUNCT
dpc-4075	2	62	epidemiology	epidemiology	NOUN
dpc-4075	2	63	and	and	CCONJ
dpc-4075	2	64	economic	economic	ADJ
dpc-4075	2	65	impact	impact	NOUN
dpc-4075	2	66	.	.	PUNCT
dpc-4075	3	1	dermatol	dermatol	NOUN
dpc-4075	3	2	pract	pract	PROPN
dpc-4075	3	3	concept.2023;13(4)s2	concept.2023;13(4)s2	PROPN
dpc-4075	3	4	:	:	PUNCT
dpc-4075	3	5	e2023315s	e2023315s	PROPN
dpc-4075	3	6	.	.	PROPN
dpc-4075	3	7	doi	doi	PROPN
dpc-4075	3	8	:	:	PUNCT
dpc-4075	3	9	https://doi.org/10.5826/dpc.1304s2a315s	https://doi.org/10.5826/dpc.1304s2a315s	PROPN
dpc-4075	3	10	accepted	accept	VERB
dpc-4075	3	11	:	:	PUNCT
dpc-4075	3	12	december	december	PROPN
dpc-4075	3	13	11	11	NUM
dpc-4075	3	14	,	,	PUNCT
dpc-4075	3	15	2023	2023	NUM
dpc-4075	3	16	;	;	PUNCT
dpc-4075	3	17	published	publish	VERB
dpc-4075	3	18	:	:	PUNCT
dpc-4075	4	1	december	december	PROPN
dpc-4075	4	2	2023	2023	NUM
dpc-4075	4	3	copyright	copyright	NOUN
dpc-4075	4	4	:	:	PUNCT
dpc-4075	4	5	©	©	PROPN
dpc-4075	4	6	2023	2023	NUM
dpc-4075	4	7	naldi	naldi	NOUN
dpc-4075	4	8	et	et	PROPN
dpc-4075	4	9	al	al	PROPN
dpc-4075	4	10	.	.	PUNCT
dpc-4075	5	1	this	this	PRON
dpc-4075	5	2	is	be	AUX
dpc-4075	5	3	an	an	DET
dpc-4075	5	4	open	open	ADJ
dpc-4075	5	5	-	-	PUNCT
dpc-4075	5	6	access	access	NOUN
dpc-4075	5	7	article	article	NOUN
dpc-4075	5	8	distributed	distribute	VERB
dpc-4075	5	9	under	under	ADP
dpc-4075	5	10	the	the	DET
dpc-4075	5	11	terms	term	NOUN
dpc-4075	5	12	of	of	ADP
dpc-4075	5	13	the	the	DET
dpc-4075	5	14	creative	creative	ADJ
dpc-4075	5	15	commons	common	NOUN
dpc-4075	5	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4075	5	17	license	license	NOUN
dpc-4075	5	18	(	(	PUNCT
dpc-4075	5	19	by	by	ADP
dpc-4075	5	20	-	-	PUNCT
dpc-4075	5	21	nc-4.0	nc-4.0	NOUN
dpc-4075	5	22	)	)	PUNCT
dpc-4075	5	23	,	,	PUNCT
dpc-4075	5	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4075	5	25	,	,	PUNCT
dpc-4075	5	26	which	which	PRON
dpc-4075	5	27	permits	permit	VERB
dpc-4075	5	28	unrestricted	unrestricted	ADJ
dpc-4075	5	29	noncommercial	noncommercial	ADJ
dpc-4075	5	30	use	use	NOUN
dpc-4075	5	31	,	,	PUNCT
dpc-4075	5	32	distribution	distribution	NOUN
dpc-4075	5	33	,	,	PUNCT
dpc-4075	5	34	and	and	CCONJ
dpc-4075	5	35	reproduction	reproduction	NOUN
dpc-4075	5	36	in	in	ADP
dpc-4075	5	37	any	any	DET
dpc-4075	5	38	medium	medium	NOUN
dpc-4075	5	39	,	,	PUNCT
dpc-4075	5	40	provided	provide	VERB
dpc-4075	5	41	the	the	DET
dpc-4075	5	42	original	original	ADJ
dpc-4075	5	43	authors	author	NOUN
dpc-4075	5	44	and	and	CCONJ
dpc-4075	5	45	source	source	NOUN
dpc-4075	5	46	are	be	AUX
dpc-4075	5	47	credited	credit	VERB
dpc-4075	5	48	.	.	PUNCT
dpc-4075	6	1	funding	funding	NOUN
dpc-4075	6	2	:	:	PUNCT
dpc-4075	6	3	none	none	NOUN
dpc-4075	6	4	.	.	PUNCT
dpc-4075	7	1	competing	compete	VERB
dpc-4075	7	2	interests	interest	NOUN
dpc-4075	7	3	:	:	PUNCT
dpc-4075	7	4	none	none	NOUN
dpc-4075	7	5	.	.	PUNCT
dpc-4075	8	1	authorship	authorship	NOUN
dpc-4075	8	2	:	:	PUNCT
dpc-4075	8	3	all	all	DET
dpc-4075	8	4	authors	author	NOUN
dpc-4075	8	5	have	have	AUX
dpc-4075	8	6	contributed	contribute	VERB
dpc-4075	8	7	significantly	significantly	ADV
dpc-4075	8	8	to	to	ADP
dpc-4075	8	9	this	this	DET
dpc-4075	8	10	publication	publication	NOUN
dpc-4075	8	11	.	.	PUNCT
dpc-4075	9	1	corresponding	correspond	VERB
dpc-4075	9	2	author	author	NOUN
dpc-4075	9	3	:	:	PUNCT
dpc-4075	9	4	chiara	chiara	PROPN
dpc-4075	9	5	alduini	alduini	PROPN
dpc-4075	9	6	,	,	PUNCT
dpc-4075	9	7	kearney	kearney	PROPN
dpc-4075	9	8	,	,	PUNCT
dpc-4075	9	9	milan	milan	PROPN
dpc-4075	9	10	,	,	PUNCT
dpc-4075	9	11	italy	italy	PROPN
dpc-4075	9	12	.	.	PUNCT
dpc-4075	10	1	email	email	NOUN
dpc-4075	10	2	:	:	PUNCT
dpc-4075	10	3	chiara.alduini@kearney.com	chiara.alduini@kearney.com	X
dpc-4075	10	4	introduction	introduction	NOUN
dpc-4075	10	5	:	:	PUNCT
dpc-4075	10	6	vitiligo	vitiligo	NOUN
dpc-4075	10	7	is	be	AUX
dpc-4075	10	8	an	an	DET
dpc-4075	10	9	acquired	acquire	VERB
dpc-4075	10	10	disorder	disorder	NOUN
dpc-4075	10	11	of	of	ADP
dpc-4075	10	12	pigmentation	pigmentation	NOUN
dpc-4075	10	13	,	,	PUNCT
dpc-4075	10	14	characterized	characterize	VERB
dpc-4075	10	15	by	by	ADP
dpc-4075	10	16	the	the	DET
dpc-4075	10	17	development	development	NOUN
dpc-4075	10	18	of	of	ADP
dpc-4075	10	19	white	white	ADJ
dpc-4075	10	20	patches	patch	NOUN
dpc-4075	10	21	on	on	ADP
dpc-4075	10	22	the	the	DET
dpc-4075	10	23	skin	skin	NOUN
dpc-4075	10	24	,	,	PUNCT
dpc-4075	10	25	often	often	ADV
dpc-4075	10	26	with	with	ADP
dpc-4075	10	27	a	a	DET
dpc-4075	10	28	typical	typical	ADJ
dpc-4075	10	29	symmetrical	symmetrical	ADJ
dpc-4075	10	30	distribution	distribution	NOUN
dpc-4075	10	31	and	and	CCONJ
dpc-4075	10	32	progressive	progressive	ADJ
dpc-4075	10	33	extension	extension	NOUN
dpc-4075	10	34	[	[	X
dpc-4075	10	35	1,2	1,2	NUM
dpc-4075	10	36	]	]	PUNCT
dpc-4075	10	37	.	.	PUNCT
dpc-4075	11	1	although	although	SCONJ
dpc-4075	11	2	vitiligo	vitiligo	NOUN
dpc-4075	11	3	does	do	AUX
dpc-4075	11	4	not	not	PART
dpc-4075	11	5	cause	cause	VERB
dpc-4075	11	6	direct	direct	ADJ
dpc-4075	11	7	physical	physical	ADJ
dpc-4075	11	8	impairment	impairment	NOUN
dpc-4075	11	9	,	,	PUNCT
dpc-4075	11	10	it	it	PRON
dpc-4075	11	11	can	can	AUX
dpc-4075	11	12	produce	produce	VERB
dpc-4075	11	13	a	a	DET
dpc-4075	11	14	relevant	relevant	ADJ
dpc-4075	11	15	psychosocial	psychosocial	ADJ
dpc-4075	11	16	burden	burden	NOUN
dpc-4075	11	17	.	.	PUNCT
dpc-4075	12	1	despite	despite	SCONJ
dpc-4075	12	2	this	this	DET
dpc-4075	12	3	burden	burden	NOUN
dpc-4075	12	4	,	,	PUNCT
dpc-4075	12	5	effective	effective	ADJ
dpc-4075	12	6	treatments	treatment	NOUN
dpc-4075	12	7	are	be	AUX
dpc-4075	12	8	lacking	lack	VERB
dpc-4075	12	9	,	,	PUNCT
dpc-4075	12	10	emphasizing	emphasize	VERB
dpc-4075	12	11	the	the	DET
dpc-4075	12	12	need	need	NOUN
dpc-4075	12	13	for	for	ADP
dpc-4075	12	14	new	new	ADJ
dpc-4075	12	15	therapeutic	therapeutic	ADJ
dpc-4075	12	16	options	option	NOUN
dpc-4075	12	17	.	.	PUNCT
dpc-4075	13	1	objectives	objective	NOUN
dpc-4075	13	2	:	:	PUNCT
dpc-4075	13	3	the	the	DET
dpc-4075	13	4	aim	aim	NOUN
dpc-4075	13	5	of	of	ADP
dpc-4075	13	6	this	this	DET
dpc-4075	13	7	study	study	NOUN
dpc-4075	13	8	was	be	AUX
dpc-4075	13	9	to	to	PART
dpc-4075	13	10	systematically	systematically	ADV
dpc-4075	13	11	scan	scan	VERB
dpc-4075	13	12	the	the	DET
dpc-4075	13	13	scientific	scientific	ADJ
dpc-4075	13	14	literature	literature	NOUN
dpc-4075	13	15	for	for	ADP
dpc-4075	13	16	studies	study	NOUN
dpc-4075	13	17	dealing	deal	VERB
dpc-4075	13	18	with	with	ADP
dpc-4075	13	19	vitiligo	vitiligo	NOUN
dpc-4075	13	20	epidemiology	epidemiology	NOUN
dpc-4075	13	21	.	.	PUNCT
dpc-4075	14	1	additionally	additionally	ADV
dpc-4075	14	2	,	,	PUNCT
dpc-4075	14	3	the	the	DET
dpc-4075	14	4	study	study	NOUN
dpc-4075	14	5	aimed	aim	VERB
dpc-4075	14	6	to	to	PART
dpc-4075	14	7	assess	assess	VERB
dpc-4075	14	8	the	the	DET
dpc-4075	14	9	social	social	ADJ
dpc-4075	14	10	costs	cost	NOUN
dpc-4075	14	11	of	of	ADP
dpc-4075	14	12	vitiligo	vitiligo	NOUN
dpc-4075	14	13	,	,	PUNCT
dpc-4075	14	14	ultimately	ultimately	ADV
dpc-4075	14	15	raising	raise	VERB
dpc-4075	14	16	awareness	awareness	NOUN
dpc-4075	14	17	about	about	ADP
dpc-4075	14	18	the	the	DET
dpc-4075	14	19	societal	societal	ADJ
dpc-4075	14	20	impact	impact	NOUN
dpc-4075	14	21	of	of	ADP
dpc-4075	14	22	the	the	DET
dpc-4075	14	23	condition	condition	NOUN
dpc-4075	14	24	.	.	PUNCT
dpc-4075	15	1	the	the	DET
dpc-4075	15	2	focus	focus	NOUN
dpc-4075	15	3	was	be	AUX
dpc-4075	15	4	on	on	ADP
dpc-4075	15	5	italian	italian	ADJ
dpc-4075	15	6	data	datum	NOUN
dpc-4075	15	7	.	.	PUNCT
dpc-4075	16	1	methods	method	NOUN
dpc-4075	16	2	:	:	PUNCT
dpc-4075	16	3	our	our	PRON
dpc-4075	16	4	research	research	NOUN
dpc-4075	16	5	employed	employ	VERB
dpc-4075	16	6	a	a	DET
dpc-4075	16	7	comprehensive	comprehensive	ADJ
dpc-4075	16	8	methodology	methodology	NOUN
dpc-4075	16	9	.	.	PUNCT
dpc-4075	17	1	for	for	ADP
dpc-4075	17	2	the	the	DET
dpc-4075	17	3	epidemiology	epidemiology	NOUN
dpc-4075	17	4	,	,	PUNCT
dpc-4075	17	5	we	we	PRON
dpc-4075	17	6	systematically	systematically	ADV
dpc-4075	17	7	searched	search	VERB
dpc-4075	17	8	pubmed	pubmed	PROPN
dpc-4075	17	9	database	database	PROPN
dpc-4075	17	10	up	up	ADP
dpc-4075	17	11	to	to	ADP
dpc-4075	17	12	october	october	PROPN
dpc-4075	17	13	2023	2023	NUM
dpc-4075	17	14	and	and	CCONJ
dpc-4075	17	15	complemented	complement	VERB
dpc-4075	17	16	the	the	DET
dpc-4075	17	17	analysis	analysis	NOUN
dpc-4075	17	18	with	with	ADP
dpc-4075	17	19	real	real	ADJ
dpc-4075	17	20	world	world	NOUN
dpc-4075	17	21	evidence	evidence	NOUN
dpc-4075	17	22	.	.	PUNCT
dpc-4075	18	1	for	for	ADP
dpc-4075	18	2	social	social	ADJ
dpc-4075	18	3	costs	cost	NOUN
dpc-4075	18	4	,	,	PUNCT
dpc-4075	18	5	we	we	PRON
dpc-4075	18	6	conducted	conduct	VERB
dpc-4075	18	7	an	an	DET
dpc-4075	18	8	in	in	ADP
dpc-4075	18	9	-	-	PUNCT
dpc-4075	18	10	depth	depth	NOUN
dpc-4075	18	11	literature	literature	NOUN
dpc-4075	18	12	review	review	NOUN
dpc-4075	18	13	,	,	PUNCT
dpc-4075	18	14	administered	administer	VERB
dpc-4075	18	15	a	a	DET
dpc-4075	18	16	web	web	NOUN
dpc-4075	18	17	-	-	NOUN
dpc-4075	18	18	survey	survey	NOUN
dpc-4075	18	19	to	to	ADP
dpc-4075	18	20	20	20	NUM
dpc-4075	18	21	italian	italian	ADJ
dpc-4075	18	22	dermatologists	dermatologist	NOUN
dpc-4075	18	23	and	and	CCONJ
dpc-4075	18	24	conducted	conduct	VERB
dpc-4075	18	25	an	an	DET
dpc-4075	18	26	equivalent	equivalent	ADJ
dpc-4075	18	27	number	number	NOUN
dpc-4075	18	28	of	of	ADP
dpc-4075	18	29	interviews	interview	NOUN
dpc-4075	18	30	during	during	ADP
dpc-4075	18	31	the	the	DET
dpc-4075	18	32	same	same	ADJ
dpc-4075	18	33	period	period	NOUN
dpc-4075	18	34	in	in	ADP
dpc-4075	18	35	march	march	PROPN
dpc-4075	18	36	2022	2022	NUM
dpc-4075	18	37	.	.	PUNCT
dpc-4075	19	1	results	result	NOUN
dpc-4075	19	2	:	:	PUNCT
dpc-4075	19	3	the	the	DET
dpc-4075	19	4	data	datum	NOUN
dpc-4075	19	5	suggest	suggest	VERB
dpc-4075	19	6	that	that	SCONJ
dpc-4075	19	7	in	in	ADP
dpc-4075	19	8	italy	italy	PROPN
dpc-4075	19	9	the	the	DET
dpc-4075	19	10	prevalence	prevalence	NOUN
dpc-4075	19	11	of	of	ADP
dpc-4075	19	12	vitiligo	vitiligo	NOUN
dpc-4075	19	13	increases	increase	NOUN
dpc-4075	19	14	with	with	ADP
dpc-4075	19	15	age	age	NOUN
dpc-4075	19	16	,	,	PUNCT
dpc-4075	19	17	and	and	CCONJ
dpc-4075	19	18	it	it	PRON
dpc-4075	19	19	varies	vary	VERB
dpc-4075	19	20	from	from	ADP
dpc-4075	19	21	0.19	0.19	NUM
dpc-4075	19	22	%	%	NOUN
dpc-4075	19	23	(	(	PUNCT
dpc-4075	19	24	age	age	NOUN
dpc-4075	19	25	18	18	NUM
dpc-4075	19	26	-	-	SYM
dpc-4075	19	27	21	21	NUM
dpc-4075	19	28	)	)	PUNCT
dpc-4075	19	29	to	to	ADP
dpc-4075	19	30	0.6	0.6	NUM
dpc-4075	19	31	%	%	NOUN
dpc-4075	19	32	(	(	PUNCT
dpc-4075	19	33	age	age	NOUN
dpc-4075	19	34	>	>	X
dpc-4075	19	35	45	45	NUM
dpc-4075	19	36	)	)	PUNCT
dpc-4075	20	1	[	[	X
dpc-4075	20	2	3,4	3,4	NUM
dpc-4075	20	3	]	]	PUNCT
dpc-4075	20	4	.	.	PUNCT
dpc-4075	21	1	we	we	PRON
dpc-4075	21	2	estimated	estimate	VERB
dpc-4075	21	3	152,000	152,000	NUM
dpc-4075	21	4	patients	patient	NOUN
dpc-4075	21	5	diagnosed	diagnose	VERB
dpc-4075	21	6	with	with	ADP
dpc-4075	21	7	non	non	ADJ
dpc-4075	21	8	segmental	segmental	ADJ
dpc-4075	21	9	vitiligo	vitiligo	NOUN
dpc-4075	21	10	(	(	PUNCT
dpc-4075	21	11	nsv	nsv	PROPN
dpc-4075	21	12	)	)	PUNCT
dpc-4075	21	13	in	in	ADP
dpc-4075	21	14	italy	italy	PROPN
dpc-4075	21	15	;	;	PUNCT
dpc-4075	21	16	based	base	VERB
dpc-4075	21	17	on	on	ADP
dpc-4075	21	18	body	body	NOUN
dpc-4075	21	19	surface	surface	NOUN
dpc-4075	21	20	area	area	NOUN
dpc-4075	21	21	(	(	PUNCT
dpc-4075	21	22	bsa	bsa	PROPN
dpc-4075	21	23	)	)	PUNCT
dpc-4075	21	24	,	,	PUNCT
dpc-4075	21	25	33	33	NUM
dpc-4075	21	26	%	%	NOUN
dpc-4075	21	27	are	be	AUX
dpc-4075	21	28	not	not	PART
dpc-4075	21	29	severe	severe	ADJ
dpc-4075	21	30	,	,	PUNCT
dpc-4075	21	31	31	31	NUM
dpc-4075	21	32	%	%	NOUN
dpc-4075	21	33	mild	mild	ADJ
dpc-4075	21	34	,	,	PUNCT
dpc-4075	21	35	27	27	NUM
dpc-4075	21	36	%	%	NOUN
dpc-4075	21	37	moderate	moderate	ADJ
dpc-4075	21	38	/	/	SYM
dpc-4075	21	39	severe	severe	ADJ
dpc-4075	21	40	,	,	PUNCT
dpc-4075	21	41	9	9	NUM
dpc-4075	21	42	%	%	NOUN
dpc-4075	21	43	very	very	ADV
dpc-4075	21	44	severe	severe	ADJ
dpc-4075	21	45	.	.	PUNCT
dpc-4075	22	1	the	the	DET
dpc-4075	22	2	yearly	yearly	ADJ
dpc-4075	22	3	social	social	ADJ
dpc-4075	22	4	costs	cost	NOUN
dpc-4075	22	5	of	of	ADP
dpc-4075	22	6	vitiligo	vitiligo	NOUN
dpc-4075	22	7	amount	amount	NOUN
dpc-4075	22	8	to	to	ADP
dpc-4075	22	9	€	€	SYM
dpc-4075	22	10	0.5bln	0.5bln	NUM
dpc-4075	22	11	.	.	PUNCT
dpc-4075	23	1	conclusions	conclusion	NOUN
dpc-4075	23	2	:	:	PUNCT
dpc-4075	23	3	there	there	PRON
dpc-4075	23	4	is	be	VERB
dpc-4075	23	5	a	a	DET
dpc-4075	23	6	remarkable	remarkable	ADJ
dpc-4075	23	7	association	association	NOUN
dpc-4075	23	8	of	of	ADP
dpc-4075	23	9	vitiligo	vitiligo	NOUN
dpc-4075	23	10	with	with	ADP
dpc-4075	23	11	anxiety	anxiety	NOUN
dpc-4075	23	12	and	and	CCONJ
dpc-4075	23	13	depression	depression	NOUN
dpc-4075	24	1	[	[	X
dpc-4075	24	2	5,6,7,8,9	5,6,7,8,9	NUM
dpc-4075	24	3	]	]	PUNCT
dpc-4075	24	4	,	,	PUNCT
dpc-4075	24	5	and	and	CCONJ
dpc-4075	24	6	mental	mental	ADJ
dpc-4075	24	7	health	health	NOUN
dpc-4075	24	8	is	be	AUX
dpc-4075	24	9	associated	associate	VERB
dpc-4075	24	10	with	with	ADP
dpc-4075	24	11	30	30	NUM
dpc-4075	24	12	%	%	NOUN
dpc-4075	24	13	of	of	ADP
dpc-4075	24	14	social	social	ADJ
dpc-4075	24	15	costs	cost	NOUN
dpc-4075	24	16	.	.	PUNCT
dpc-4075	25	1	moreover	moreover	ADV
dpc-4075	25	2	,	,	PUNCT
dpc-4075	25	3	vitiligo	vitiligo	VERB
dpc-4075	25	4	social	social	ADJ
dpc-4075	25	5	costs	cost	NOUN
dpc-4075	25	6	distribution	distribution	NOUN
dpc-4075	25	7	highlights	highlight	NOUN
dpc-4075	25	8	inequity	inequity	NOUN
dpc-4075	25	9	,	,	PUNCT
dpc-4075	25	10	with	with	ADP
dpc-4075	25	11	patients	patient	NOUN
dpc-4075	25	12	bearing	bear	VERB
dpc-4075	25	13	55	55	NUM
dpc-4075	25	14	%	%	NOUN
dpc-4075	25	15	of	of	ADP
dpc-4075	25	16	them	they	PRON
dpc-4075	25	17	.	.	PUNCT
dpc-4075	26	1	abstract	abstract	ADJ
dpc-4075	26	2	2	2	NUM
dpc-4075	26	3	review	review	NOUN
dpc-4075	26	4	|	|	ADV
dpc-4075	26	5	dermatol	dermatol	ADJ
dpc-4075	26	6	pract	pract	NOUN
dpc-4075	26	7	concept	concept	NOUN
dpc-4075	26	8	.	.	PUNCT
dpc-4075	27	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	27	2	:	:	PUNCT
dpc-4075	27	3	e2023315s	e2023315s	PROPN
dpc-4075	27	4	introduction	introduction	NOUN
dpc-4075	27	5	vitiligo	vitiligo	NOUN
dpc-4075	27	6	is	be	AUX
dpc-4075	27	7	a	a	DET
dpc-4075	27	8	chronic	chronic	ADJ
dpc-4075	27	9	autoimmune	autoimmune	NOUN
dpc-4075	27	10	depigmenting	depigmente	VERB
dpc-4075	27	11	skin	skin	NOUN
dpc-4075	27	12	disease	disease	NOUN
dpc-4075	27	13	that	that	PRON
dpc-4075	27	14	results	result	VERB
dpc-4075	27	15	in	in	ADP
dpc-4075	27	16	patchy	patchy	ADJ
dpc-4075	27	17	loss	loss	NOUN
dpc-4075	27	18	of	of	ADP
dpc-4075	27	19	skin	skin	NOUN
dpc-4075	27	20	color	color	NOUN
dpc-4075	27	21	due	due	ADP
dpc-4075	27	22	to	to	ADP
dpc-4075	27	23	the	the	DET
dpc-4075	27	24	progressive	progressive	ADJ
dpc-4075	27	25	destruction	destruction	NOUN
dpc-4075	27	26	of	of	ADP
dpc-4075	27	27	melanocytes	melanocyte	NOUN
dpc-4075	27	28	[	[	X
dpc-4075	27	29	1,10	1,10	NUM
dpc-4075	27	30	]	]	PUNCT
dpc-4075	27	31	;	;	PUNCT
dpc-4075	27	32	it	it	PRON
dpc-4075	27	33	is	be	AUX
dpc-4075	27	34	now	now	ADV
dpc-4075	27	35	widely	widely	ADV
dpc-4075	27	36	accepted	accept	VERB
dpc-4075	27	37	that	that	SCONJ
dpc-4075	27	38	vitiligo	vitiligo	NOUN
dpc-4075	27	39	has	have	VERB
dpc-4075	27	40	an	an	DET
dpc-4075	27	41	autoimmune	autoimmune	ADJ
dpc-4075	27	42	nature	nature	NOUN
dpc-4075	27	43	.	.	PUNCT
dpc-4075	28	1	this	this	DET
dpc-4075	28	2	condition	condition	NOUN
dpc-4075	28	3	is	be	AUX
dpc-4075	28	4	characterized	characterize	VERB
dpc-4075	28	5	by	by	ADP
dpc-4075	28	6	extended	extended	ADJ
dpc-4075	28	7	periods	period	NOUN
dpc-4075	28	8	of	of	ADP
dpc-4075	28	9	stability	stability	NOUN
dpc-4075	28	10	interspersed	intersperse	VERB
dpc-4075	28	11	with	with	ADP
dpc-4075	28	12	shorter	short	ADJ
dpc-4075	28	13	periods	period	NOUN
dpc-4075	28	14	of	of	ADP
dpc-4075	28	15	accelerated	accelerate	VERB
dpc-4075	28	16	depigmentation	depigmentation	NOUN
dpc-4075	29	1	[	[	X
dpc-4075	29	2	11	11	NUM
dpc-4075	29	3	]	]	PUNCT
dpc-4075	29	4	.	.	PUNCT
dpc-4075	30	1	treatment	treatment	NOUN
dpc-4075	30	2	remains	remain	VERB
dpc-4075	30	3	a	a	DET
dpc-4075	30	4	challenge	challenge	NOUN
dpc-4075	30	5	in	in	ADP
dpc-4075	30	6	dermatology	dermatology	NOUN
dpc-4075	30	7	,	,	PUNCT
dpc-4075	30	8	as	as	SCONJ
dpc-4075	30	9	available	available	ADJ
dpc-4075	30	10	options	option	NOUN
dpc-4075	30	11	produce	produce	VERB
dpc-4075	30	12	limited	limited	ADJ
dpc-4075	30	13	results	result	NOUN
dpc-4075	30	14	[	[	X
dpc-4075	30	15	12,13	12,13	NUM
dpc-4075	30	16	]	]	PUNCT
dpc-4075	30	17	.	.	PUNCT
dpc-4075	31	1	vitiligo	vitiligo	PROPN
dpc-4075	31	2	is	be	AUX
dpc-4075	31	3	a	a	DET
dpc-4075	31	4	prevalent	prevalent	ADJ
dpc-4075	31	5	global	global	ADJ
dpc-4075	31	6	skin	skin	NOUN
dpc-4075	31	7	condition	condition	NOUN
dpc-4075	31	8	which	which	PRON
dpc-4075	31	9	affects	affect	VERB
dpc-4075	31	10	equally	equally	ADV
dpc-4075	31	11	both	both	DET
dpc-4075	31	12	genders	gender	NOUN
dpc-4075	31	13	,	,	PUNCT
dpc-4075	31	14	though	though	SCONJ
dpc-4075	31	15	slightly	slightly	ADV
dpc-4075	31	16	more	more	ADV
dpc-4075	31	17	prevalent	prevalent	ADJ
dpc-4075	31	18	in	in	ADP
dpc-4075	31	19	females	female	NOUN
dpc-4075	31	20	,	,	PUNCT
dpc-4075	31	21	and	and	CCONJ
dpc-4075	31	22	more	more	ADJ
dpc-4075	31	23	than	than	ADP
dpc-4075	31	24	60	60	NUM
dpc-4075	31	25	%	%	NOUN
dpc-4075	31	26	of	of	ADP
dpc-4075	31	27	patients	patient	NOUN
dpc-4075	31	28	experienced	experience	VERB
dpc-4075	31	29	disease	disease	NOUN
dpc-4075	31	30	onset	onset	VERB
dpc-4075	31	31	before	before	ADP
dpc-4075	31	32	the	the	DET
dpc-4075	31	33	age	age	NOUN
dpc-4075	31	34	of	of	ADP
dpc-4075	31	35	30	30	NUM
dpc-4075	31	36	[	[	X
dpc-4075	31	37	14,15	14,15	NUM
dpc-4075	31	38	]	]	PUNCT
dpc-4075	31	39	.	.	PUNCT
dpc-4075	32	1	there	there	PRON
dpc-4075	32	2	are	be	VERB
dpc-4075	32	3	two	two	NUM
dpc-4075	32	4	main	main	ADJ
dpc-4075	32	5	clinical	clinical	ADJ
dpc-4075	32	6	phenotypes	phenotype	NOUN
dpc-4075	32	7	[	[	X
dpc-4075	32	8	16	16	NUM
dpc-4075	32	9	]	]	X
dpc-4075	32	10	:	:	PUNCT
dpc-4075	32	11	non	non	X
dpc-4075	32	12	segmental	segmental	ADJ
dpc-4075	32	13	vitiligo	vitiligo	PROPN
dpc-4075	32	14	(	(	PUNCT
dpc-4075	32	15	nsv	nsv	PROPN
dpc-4075	32	16	)	)	PUNCT
dpc-4075	32	17	and	and	CCONJ
dpc-4075	32	18	segmental	segmental	ADJ
dpc-4075	32	19	vitiligo	vitiligo	NOUN
dpc-4075	32	20	(	(	PUNCT
dpc-4075	32	21	sv	sv	NOUN
dpc-4075	32	22	)	)	PUNCT
dpc-4075	32	23	.	.	PUNCT
dpc-4075	33	1	nsv	nsv	PROPN
dpc-4075	33	2	is	be	AUX
dpc-4075	33	3	the	the	DET
dpc-4075	33	4	most	most	ADV
dpc-4075	33	5	common	common	ADJ
dpc-4075	33	6	form	form	NOUN
dpc-4075	33	7	,	,	PUNCT
dpc-4075	33	8	characterized	characterize	VERB
dpc-4075	33	9	by	by	ADP
dpc-4075	33	10	symmetrical	symmetrical	ADJ
dpc-4075	33	11	lesions	lesion	NOUN
dpc-4075	33	12	on	on	ADP
dpc-4075	33	13	both	both	DET
dpc-4075	33	14	sides	side	NOUN
dpc-4075	33	15	of	of	ADP
dpc-4075	33	16	the	the	DET
dpc-4075	33	17	body	body	NOUN
dpc-4075	33	18	,	,	PUNCT
dpc-4075	33	19	progressing	progress	VERB
dpc-4075	33	20	slowly	slowly	ADV
dpc-4075	33	21	and	and	CCONJ
dpc-4075	33	22	unpredictably	unpredictably	ADV
dpc-4075	33	23	.	.	PUNCT
dpc-4075	34	1	vitiligo	vitiligo	PROPN
dpc-4075	34	2	is	be	AUX
dpc-4075	34	3	frequently	frequently	ADV
dpc-4075	34	4	associated	associate	VERB
dpc-4075	34	5	with	with	ADP
dpc-4075	34	6	various	various	ADJ
dpc-4075	34	7	autoimmune	autoimmune	ADJ
dpc-4075	34	8	comorbidities	comorbiditie	NOUN
dpc-4075	34	9	such	such	ADJ
dpc-4075	34	10	as	as	ADP
dpc-4075	34	11	hypothyroidism	hypothyroidism	NOUN
dpc-4075	34	12	and	and	CCONJ
dpc-4075	34	13	rheumatoid	rheumatoid	VERB
dpc-4075	34	14	arthritis	arthritis	NOUN
dpc-4075	34	15	[	[	X
dpc-4075	34	16	17	17	NUM
dpc-4075	34	17	]	]	PUNCT
dpc-4075	34	18	.	.	PUNCT
dpc-4075	35	1	the	the	DET
dpc-4075	35	2	psychological	psychological	ADJ
dpc-4075	35	3	impact	impact	NOUN
dpc-4075	35	4	is	be	AUX
dpc-4075	35	5	substantial	substantial	ADJ
dpc-4075	35	6	,	,	PUNCT
dpc-4075	35	7	negatively	negatively	ADV
dpc-4075	35	8	affecting	affect	VERB
dpc-4075	35	9	patients	patient	NOUN
dpc-4075	35	10	’	'	PUNCT
dpc-4075	35	11	quality	quality	NOUN
dpc-4075	35	12	of	of	ADP
dpc-4075	35	13	life	life	NOUN
dpc-4075	35	14	(	(	PUNCT
dpc-4075	35	15	qol	qol	NOUN
dpc-4075	35	16	)	)	PUNCT
dpc-4075	35	17	and	and	CCONJ
dpc-4075	35	18	mental	mental	ADJ
dpc-4075	35	19	health	health	NOUN
dpc-4075	36	1	[	[	X
dpc-4075	36	2	5,6,7,8,9,18,19	5,6,7,8,9,18,19	NUM
dpc-4075	36	3	]	]	PUNCT
dpc-4075	36	4	.	.	PUNCT
dpc-4075	37	1	indeed	indeed	ADV
dpc-4075	37	2	,	,	PUNCT
dpc-4075	37	3	the	the	DET
dpc-4075	37	4	stigma	stigma	NOUN
dpc-4075	37	5	associated	associate	VERB
dpc-4075	37	6	with	with	ADP
dpc-4075	37	7	vitiligo	vitiligo	NOUN
dpc-4075	37	8	impacts	impact	NOUN
dpc-4075	37	9	personal	personal	ADJ
dpc-4075	37	10	lives	life	NOUN
dpc-4075	37	11	and	and	CCONJ
dpc-4075	37	12	productivity	productivity	NOUN
dpc-4075	37	13	,	,	PUNCT
dpc-4075	37	14	leading	lead	VERB
dpc-4075	37	15	to	to	ADP
dpc-4075	37	16	poor	poor	ADJ
dpc-4075	37	17	self	self	NOUN
dpc-4075	37	18	-	-	PUNCT
dpc-4075	37	19	acceptance	acceptance	NOUN
dpc-4075	37	20	and	and	CCONJ
dpc-4075	37	21	psychological	psychological	ADJ
dpc-4075	37	22	distress	distress	NOUN
dpc-4075	37	23	[	[	X
dpc-4075	37	24	20	20	NUM
dpc-4075	37	25	]	]	PUNCT
dpc-4075	37	26	.	.	PUNCT
dpc-4075	38	1	everyday	everyday	ADJ
dpc-4075	38	2	activities	activity	NOUN
dpc-4075	38	3	are	be	AUX
dpc-4075	38	4	disrupted	disrupt	VERB
dpc-4075	38	5	,	,	PUNCT
dpc-4075	38	6	causing	cause	VERB
dpc-4075	38	7	considerable	considerable	ADJ
dpc-4075	38	8	time	time	NOUN
dpc-4075	38	9	and	and	CCONJ
dpc-4075	38	10	energy	energy	NOUN
dpc-4075	38	11	waste	waste	NOUN
dpc-4075	38	12	for	for	ADP
dpc-4075	38	13	patients	patient	NOUN
dpc-4075	38	14	and	and	CCONJ
dpc-4075	38	15	their	their	PRON
dpc-4075	38	16	caregivers	caregiver	NOUN
dpc-4075	38	17	.	.	PUNCT
dpc-4075	39	1	patients	patient	NOUN
dpc-4075	39	2	commonly	commonly	ADV
dpc-4075	39	3	experience	experience	VERB
dpc-4075	39	4	depression	depression	NOUN
dpc-4075	39	5	,	,	PUNCT
dpc-4075	39	6	anxiety	anxiety	NOUN
dpc-4075	39	7	,	,	PUNCT
dpc-4075	39	8	stigmatization	stigmatization	NOUN
dpc-4075	39	9	,	,	PUNCT
dpc-4075	39	10	hopelessness	hopelessness	NOUN
dpc-4075	39	11	,	,	PUNCT
dpc-4075	39	12	and	and	CCONJ
dpc-4075	39	13	loss	loss	NOUN
dpc-4075	39	14	of	of	ADP
dpc-4075	39	15	self	self	NOUN
dpc-4075	39	16	-	-	PUNCT
dpc-4075	39	17	esteem	esteem	NOUN
dpc-4075	39	18	[	[	X
dpc-4075	39	19	20,21	20,21	NUM
dpc-4075	39	20	]	]	PUNCT
dpc-4075	39	21	.	.	PUNCT
dpc-4075	40	1	despite	despite	SCONJ
dpc-4075	40	2	the	the	DET
dpc-4075	40	3	substantial	substantial	ADJ
dpc-4075	40	4	burden	burden	NOUN
dpc-4075	40	5	it	it	PRON
dpc-4075	40	6	places	place	VERB
dpc-4075	40	7	on	on	ADP
dpc-4075	40	8	individuals	individual	NOUN
dpc-4075	40	9	,	,	PUNCT
dpc-4075	40	10	there	there	PRON
dpc-4075	40	11	is	be	VERB
dpc-4075	40	12	still	still	ADV
dpc-4075	40	13	a	a	DET
dpc-4075	40	14	notable	notable	ADJ
dpc-4075	40	15	unmet	unmet	NOUN
dpc-4075	40	16	need	need	VERB
dpc-4075	40	17	for	for	ADP
dpc-4075	40	18	effective	effective	ADJ
dpc-4075	40	19	treatments	treatment	NOUN
dpc-4075	40	20	,	,	PUNCT
dpc-4075	40	21	leaving	leave	VERB
dpc-4075	40	22	patients	patient	NOUN
dpc-4075	40	23	frustrated	frustrate	VERB
dpc-4075	40	24	and	and	CCONJ
dpc-4075	40	25	hopeful	hopeful	ADJ
dpc-4075	40	26	for	for	ADP
dpc-4075	40	27	the	the	DET
dpc-4075	40	28	development	development	NOUN
dpc-4075	40	29	of	of	ADP
dpc-4075	40	30	efficacious	efficacious	ADJ
dpc-4075	40	31	options	option	NOUN
dpc-4075	40	32	.	.	PUNCT
dpc-4075	41	1	objectives	objective	VERB
dpc-4075	41	2	the	the	DET
dpc-4075	41	3	goals	goal	NOUN
dpc-4075	41	4	of	of	ADP
dpc-4075	41	5	the	the	DET
dpc-4075	41	6	study	study	NOUN
dpc-4075	41	7	were	be	AUX
dpc-4075	41	8	to	to	PART
dpc-4075	41	9	determine	determine	VERB
dpc-4075	41	10	the	the	DET
dpc-4075	41	11	prevalence	prevalence	NOUN
dpc-4075	41	12	of	of	ADP
dpc-4075	41	13	vitiligo	vitiligo	PROPN
dpc-4075	41	14	in	in	ADP
dpc-4075	41	15	italy	italy	PROPN
dpc-4075	41	16	,	,	PUNCT
dpc-4075	41	17	segment	segment	NOUN
dpc-4075	41	18	patients	patient	NOUN
dpc-4075	41	19	to	to	PART
dpc-4075	41	20	understand	understand	VERB
dpc-4075	41	21	treatment	treatment	NOUN
dpc-4075	41	22	adoption	adoption	NOUN
dpc-4075	41	23	and	and	CCONJ
dpc-4075	41	24	behavior	behavior	NOUN
dpc-4075	41	25	,	,	PUNCT
dpc-4075	41	26	and	and	CCONJ
dpc-4075	41	27	assess	assess	VERB
dpc-4075	41	28	the	the	DET
dpc-4075	41	29	social	social	ADJ
dpc-4075	41	30	costs	cost	NOUN
dpc-4075	41	31	associated	associate	VERB
dpc-4075	41	32	with	with	ADP
dpc-4075	41	33	the	the	DET
dpc-4075	41	34	condition	condition	NOUN
dpc-4075	41	35	.	.	PUNCT
dpc-4075	42	1	moreover	moreover	ADV
dpc-4075	42	2	,	,	PUNCT
dpc-4075	42	3	the	the	DET
dpc-4075	42	4	aim	aim	NOUN
dpc-4075	42	5	was	be	AUX
dpc-4075	42	6	to	to	PART
dpc-4075	42	7	shed	shed	VERB
dpc-4075	42	8	light	light	NOUN
dpc-4075	42	9	on	on	ADP
dpc-4075	42	10	the	the	DET
dpc-4075	42	11	economic	economic	ADJ
dpc-4075	42	12	and	and	CCONJ
dpc-4075	42	13	societal	societal	ADJ
dpc-4075	42	14	burdens	burden	NOUN
dpc-4075	42	15	of	of	ADP
dpc-4075	42	16	vitiligo	vitiligo	PROPN
dpc-4075	42	17	in	in	ADP
dpc-4075	42	18	italy	italy	PROPN
dpc-4075	42	19	.	.	PUNCT
dpc-4075	43	1	methods	method	NOUN
dpc-4075	43	2	our	our	PRON
dpc-4075	43	3	research	research	NOUN
dpc-4075	43	4	utilized	utilize	VERB
dpc-4075	43	5	a	a	DET
dpc-4075	43	6	comprehensive	comprehensive	ADJ
dpc-4075	43	7	methodology	methodology	NOUN
dpc-4075	43	8	,	,	PUNCT
dpc-4075	43	9	encompassing	encompass	VERB
dpc-4075	43	10	web	web	NOUN
dpc-4075	43	11	-	-	NOUN
dpc-4075	43	12	surveys	survey	NOUN
dpc-4075	43	13	involving	involve	VERB
dpc-4075	43	14	20	20	NUM
dpc-4075	43	15	italian	italian	ADJ
dpc-4075	43	16	dermatologists	dermatologist	NOUN
dpc-4075	43	17	(	(	PUNCT
dpc-4075	43	18	i.e.	i.e.	X
dpc-4075	43	19	,	,	PUNCT
dpc-4075	43	20	“	"	PUNCT
dpc-4075	43	21	medical	medical	ADJ
dpc-4075	43	22	survey	survey	NOUN
dpc-4075	43	23	”	"	PUNCT
dpc-4075	43	24	)	)	PUNCT
dpc-4075	43	25	in	in	ADP
dpc-4075	43	26	march	march	PROPN
dpc-4075	43	27	2022	2022	NUM
dpc-4075	43	28	,	,	PUNCT
dpc-4075	43	29	interviews	interview	NOUN
dpc-4075	43	30	with	with	ADP
dpc-4075	43	31	an	an	DET
dpc-4075	43	32	additional	additional	ADJ
dpc-4075	43	33	20	20	NUM
dpc-4075	43	34	dermatologists	dermatologist	NOUN
dpc-4075	43	35	during	during	ADP
dpc-4075	43	36	the	the	DET
dpc-4075	43	37	same	same	ADJ
dpc-4075	43	38	period	period	NOUN
dpc-4075	43	39	,	,	PUNCT
dpc-4075	43	40	and	and	CCONJ
dpc-4075	43	41	an	an	DET
dpc-4075	43	42	extensive	extensive	ADJ
dpc-4075	43	43	desk	desk	NOUN
dpc-4075	43	44	research	research	NOUN
dpc-4075	43	45	that	that	PRON
dpc-4075	43	46	scrutinized	scrutinize	VERB
dpc-4075	43	47	over	over	ADP
dpc-4075	43	48	100	100	NUM
dpc-4075	43	49	publications	publication	NOUN
dpc-4075	43	50	,	,	PUNCT
dpc-4075	43	51	articles	article	NOUN
dpc-4075	43	52	,	,	PUNCT
dpc-4075	43	53	and	and	CCONJ
dpc-4075	43	54	industry	industry	NOUN
dpc-4075	43	55	reports	report	NOUN
dpc-4075	43	56	.	.	PUNCT
dpc-4075	44	1	in	in	ADP
dpc-4075	44	2	particular	particular	ADJ
dpc-4075	44	3	,	,	PUNCT
dpc-4075	44	4	data	datum	NOUN
dpc-4075	44	5	collection	collection	NOUN
dpc-4075	44	6	included	include	VERB
dpc-4075	44	7	a	a	DET
dpc-4075	44	8	broad	broad	ADJ
dpc-4075	44	9	range	range	NOUN
dpc-4075	44	10	of	of	ADP
dpc-4075	44	11	sources	source	NOUN
dpc-4075	44	12	,	,	PUNCT
dpc-4075	44	13	including	include	VERB
dpc-4075	44	14	real	real	ADJ
dpc-4075	44	15	-	-	PUNCT
dpc-4075	44	16	world	world	NOUN
dpc-4075	44	17	evidence	evidence	NOUN
dpc-4075	44	18	,	,	PUNCT
dpc-4075	44	19	scientific	scientific	ADJ
dpc-4075	44	20	publications	publication	NOUN
dpc-4075	44	21	,	,	PUNCT
dpc-4075	44	22	public	public	ADJ
dpc-4075	44	23	entities	entity	NOUN
dpc-4075	44	24	’	'	PUNCT
dpc-4075	44	25	websites	website	NOUN
dpc-4075	44	26	(	(	PUNCT
dpc-4075	44	27	e.g.	e.g.	ADV
dpc-4075	44	28	,	,	PUNCT
dpc-4075	44	29	inps	inps	ADJ
dpc-4075	44	30	,	,	PUNCT
dpc-4075	44	31	gu	gu	PROPN
dpc-4075	44	32	(	(	PUNCT
dpc-4075	44	33	gazzetta	gazzetta	PROPN
dpc-4075	44	34	ufficiale	ufficiale	PROPN
dpc-4075	44	35	)	)	PUNCT
dpc-4075	44	36	)	)	PUNCT
dpc-4075	44	37	,	,	PUNCT
dpc-4075	44	38	scientific	scientific	ADJ
dpc-4075	44	39	guidelines	guideline	NOUN
dpc-4075	44	40	,	,	PUNCT
dpc-4075	44	41	national	national	ADJ
dpc-4075	44	42	and	and	CCONJ
dpc-4075	44	43	regional	regional	ADJ
dpc-4075	44	44	nhs	nhs	NOUN
dpc-4075	44	45	tariffs	tariff	NOUN
dpc-4075	44	46	,	,	PUNCT
dpc-4075	44	47	statistics	statistic	NOUN
dpc-4075	44	48	institutes	institutes	PROPN
dpc-4075	44	49	(	(	PUNCT
dpc-4075	44	50	e.g.	e.g.	ADV
dpc-4075	44	51	,	,	PUNCT
dpc-4075	44	52	istat	istat	PROPN
dpc-4075	44	53	,	,	PUNCT
dpc-4075	44	54	eurostat	eurostat	PROPN
dpc-4075	44	55	)	)	PUNCT
dpc-4075	44	56	,	,	PUNCT
dpc-4075	44	57	surveys	survey	NOUN
dpc-4075	44	58	,	,	PUNCT
dpc-4075	44	59	interviews	interview	NOUN
dpc-4075	44	60	,	,	PUNCT
dpc-4075	44	61	as	as	ADV
dpc-4075	44	62	well	well	ADV
dpc-4075	44	63	as	as	ADP
dpc-4075	44	64	information	information	NOUN
dpc-4075	44	65	from	from	ADP
dpc-4075	44	66	company	company	NOUN
dpc-4075	44	67	websites	website	NOUN
dpc-4075	44	68	and	and	CCONJ
dpc-4075	44	69	the	the	DET
dpc-4075	44	70	medical	medical	ADJ
dpc-4075	44	71	press	press	NOUN
dpc-4075	44	72	.	.	PUNCT
dpc-4075	45	1	epidemiology	epidemiology	NOUN
dpc-4075	45	2	we	we	PRON
dpc-4075	45	3	systematically	systematically	ADV
dpc-4075	45	4	searched	search	VERB
dpc-4075	45	5	pubmed	pubmed	PROPN
dpc-4075	45	6	database	database	PROPN
dpc-4075	45	7	up	up	ADP
dpc-4075	45	8	to	to	ADP
dpc-4075	45	9	october	october	PROPN
dpc-4075	45	10	4	4	NUM
dpc-4075	45	11	,	,	PUNCT
dpc-4075	45	12	2023	2023	NUM
dpc-4075	45	13	,	,	PUNCT
dpc-4075	45	14	with	with	ADP
dpc-4075	45	15	the	the	DET
dpc-4075	45	16	following	follow	VERB
dpc-4075	45	17	key	key	ADJ
dpc-4075	45	18	words	word	NOUN
dpc-4075	45	19	:	:	PUNCT
dpc-4075	45	20	epidemiology	epidemiology	NOUN
dpc-4075	45	21	,	,	PUNCT
dpc-4075	45	22	prevalence	prevalence	NOUN
dpc-4075	45	23	,	,	PUNCT
dpc-4075	45	24	incidence	incidence	NOUN
dpc-4075	45	25	,	,	PUNCT
dpc-4075	45	26	co	co	NOUN
dpc-4075	45	27	-	-	NOUN
dpc-4075	45	28	morbidities	morbidity	NOUN
dpc-4075	45	29	,	,	PUNCT
dpc-4075	45	30	risk	risk	NOUN
dpc-4075	45	31	factors	factor	NOUN
dpc-4075	45	32	.	.	PUNCT
dpc-4075	46	1	a	a	DET
dpc-4075	46	2	total	total	NOUN
dpc-4075	46	3	of	of	ADP
dpc-4075	46	4	761	761	NUM
dpc-4075	46	5	papers	paper	NOUN
dpc-4075	46	6	were	be	AUX
dpc-4075	46	7	retrieved	retrieve	VERB
dpc-4075	46	8	and	and	CCONJ
dpc-4075	46	9	,	,	PUNCT
dpc-4075	46	10	after	after	ADP
dpc-4075	46	11	an	an	DET
dpc-4075	46	12	eligibility	eligibility	NOUN
dpc-4075	46	13	assessment	assessment	NOUN
dpc-4075	46	14	,	,	PUNCT
dpc-4075	46	15	only	only	ADV
dpc-4075	46	16	82	82	NUM
dpc-4075	46	17	were	be	AUX
dpc-4075	46	18	maintained	maintain	VERB
dpc-4075	46	19	.	.	PUNCT
dpc-4075	47	1	out	out	ADP
dpc-4075	47	2	of	of	ADP
dpc-4075	47	3	these	these	DET
dpc-4075	47	4	papers	paper	NOUN
dpc-4075	47	5	,	,	PUNCT
dpc-4075	47	6	12	12	NUM
dpc-4075	47	7	were	be	AUX
dpc-4075	47	8	systematic	systematic	ADJ
dpc-4075	47	9	reviews	review	NOUN
dpc-4075	47	10	summarising	summarise	VERB
dpc-4075	47	11	various	various	ADJ
dpc-4075	47	12	aspects	aspect	NOUN
dpc-4075	47	13	of	of	ADP
dpc-4075	47	14	the	the	DET
dpc-4075	47	15	vitiligo	vitiligo	ADJ
dpc-4075	47	16	epidemiology	epidemiology	NOUN
dpc-4075	48	1	[	[	X
dpc-4075	48	2	5	5	NUM
dpc-4075	48	3	-	-	PUNCT
dpc-4075	48	4	9,25	9,25	NUM
dpc-4075	48	5	-	-	PUNCT
dpc-4075	48	6	28	28	NUM
dpc-4075	48	7	]	]	PUNCT
dpc-4075	48	8	,	,	PUNCT
dpc-4075	48	9	and	and	CCONJ
dpc-4075	48	10	another	another	DET
dpc-4075	48	11	8	8	NUM
dpc-4075	48	12	studies	study	NOUN
dpc-4075	48	13	presented	present	VERB
dpc-4075	48	14	data	datum	NOUN
dpc-4075	48	15	on	on	ADP
dpc-4075	48	16	the	the	DET
dpc-4075	48	17	epidemiology	epidemiology	NOUN
dpc-4075	48	18	of	of	ADP
dpc-4075	48	19	vitiligo	vitiligo	PROPN
dpc-4075	48	20	in	in	ADP
dpc-4075	48	21	italy	italy	PROPN
dpc-4075	49	1	[	[	X
dpc-4075	49	2	3,4,29	3,4,29	NUM
dpc-4075	49	3	-	-	SYM
dpc-4075	49	4	35	35	NUM
dpc-4075	49	5	]	]	PUNCT
dpc-4075	49	6	.	.	PUNCT
dpc-4075	50	1	to	to	PART
dpc-4075	50	2	avoid	avoid	VERB
dpc-4075	50	3	repetition	repetition	NOUN
dpc-4075	50	4	and	and	CCONJ
dpc-4075	50	5	redundancy	redundancy	NOUN
dpc-4075	50	6	,	,	PUNCT
dpc-4075	50	7	we	we	PRON
dpc-4075	50	8	decided	decide	VERB
dpc-4075	50	9	to	to	PART
dpc-4075	50	10	focus	focus	VERB
dpc-4075	50	11	on	on	ADP
dpc-4075	50	12	the	the	DET
dpc-4075	50	13	above	above	ADV
dpc-4075	50	14	-	-	PUNCT
dpc-4075	50	15	mentioned	mention	VERB
dpc-4075	50	16	studies	study	NOUN
dpc-4075	50	17	only	only	ADV
dpc-4075	50	18	,	,	PUNCT
dpc-4075	50	19	i.e.	i.e.	X
dpc-4075	50	20	,	,	PUNCT
dpc-4075	50	21	systematic	systematic	ADJ
dpc-4075	50	22	reviews	review	NOUN
dpc-4075	50	23	and	and	CCONJ
dpc-4075	50	24	italian	italian	ADJ
dpc-4075	50	25	data	datum	NOUN
dpc-4075	50	26	.	.	PUNCT
dpc-4075	51	1	we	we	PRON
dpc-4075	51	2	then	then	ADV
dpc-4075	51	3	complemented	complement	VERB
dpc-4075	51	4	the	the	DET
dpc-4075	51	5	analysis	analysis	NOUN
dpc-4075	51	6	through	through	ADP
dpc-4075	51	7	a	a	DET
dpc-4075	51	8	bottom	bottom	ADJ
dpc-4075	51	9	-	-	PUNCT
dpc-4075	51	10	up	up	ADP
dpc-4075	51	11	approach	approach	NOUN
dpc-4075	51	12	,	,	PUNCT
dpc-4075	51	13	using	use	VERB
dpc-4075	51	14	real	real	ADJ
dpc-4075	51	15	-	-	PUNCT
dpc-4075	51	16	world	world	NOUN
dpc-4075	51	17	evidence	evidence	NOUN
dpc-4075	51	18	[	[	X
dpc-4075	51	19	36	36	NUM
dpc-4075	51	20	]	]	PUNCT
dpc-4075	51	21	.	.	PUNCT
dpc-4075	52	1	lastly	lastly	ADV
dpc-4075	52	2	,	,	PUNCT
dpc-4075	52	3	we	we	PRON
dpc-4075	52	4	established	establish	VERB
dpc-4075	52	5	patient	patient	ADJ
dpc-4075	52	6	classes	class	NOUN
dpc-4075	52	7	for	for	ADP
dpc-4075	52	8	non	non	ADJ
dpc-4075	52	9	-	-	ADJ
dpc-4075	52	10	segmental	segmental	ADJ
dpc-4075	52	11	vitiligo	vitiligo	NOUN
dpc-4075	52	12	(	(	PUNCT
dpc-4075	52	13	nsv	nsv	PROPN
dpc-4075	52	14	)	)	PUNCT
dpc-4075	52	15	based	base	VERB
dpc-4075	52	16	on	on	ADP
dpc-4075	52	17	clinical	clinical	ADJ
dpc-4075	52	18	and	and	CCONJ
dpc-4075	52	19	demographic	demographic	ADJ
dpc-4075	52	20	characteristics	characteristic	NOUN
dpc-4075	52	21	and	and	CCONJ
dpc-4075	52	22	validated	validate	VERB
dpc-4075	52	23	these	these	DET
dpc-4075	52	24	classifications	classification	NOUN
dpc-4075	52	25	through	through	ADP
dpc-4075	52	26	expert	expert	NOUN
dpc-4075	52	27	interviews	interview	NOUN
dpc-4075	52	28	.	.	PUNCT
dpc-4075	53	1	social	social	ADJ
dpc-4075	53	2	cost	cost	NOUN
dpc-4075	53	3	we	we	PRON
dpc-4075	53	4	assessed	assess	VERB
dpc-4075	53	5	both	both	CCONJ
dpc-4075	53	6	healthcare	healthcare	NOUN
dpc-4075	53	7	and	and	CCONJ
dpc-4075	53	8	non	non	ADJ
dpc-4075	53	9	-	-	ADJ
dpc-4075	53	10	healthcare	healthcare	ADJ
dpc-4075	53	11	costs	cost	NOUN
dpc-4075	53	12	associated	associate	VERB
dpc-4075	53	13	with	with	ADP
dpc-4075	53	14	vitiligo	vitiligo	NOUN
dpc-4075	53	15	.	.	PUNCT
dpc-4075	54	1	among	among	ADP
dpc-4075	54	2	healthcare	healthcare	NOUN
dpc-4075	54	3	costs	cost	NOUN
dpc-4075	54	4	,	,	PUNCT
dpc-4075	54	5	we	we	PRON
dpc-4075	54	6	examined	examine	VERB
dpc-4075	54	7	three	three	NUM
dpc-4075	54	8	components	component	NOUN
dpc-4075	54	9	:	:	PUNCT
dpc-4075	54	10	•	•	NUM
dpc-4075	54	11	vitiligo	vitiligo	NOUN
dpc-4075	54	12	treatment	treatment	NOUN
dpc-4075	54	13	:	:	PUNCT
dpc-4075	54	14	through	through	ADP
dpc-4075	54	15	the	the	DET
dpc-4075	54	16	medical	medical	ADJ
dpc-4075	54	17	survey	survey	NOUN
dpc-4075	54	18	,	,	PUNCT
dpc-4075	54	19	we	we	PRON
dpc-4075	54	20	investigated	investigate	VERB
dpc-4075	54	21	the	the	DET
dpc-4075	54	22	treatment	treatment	NOUN
dpc-4075	54	23	behavior	behavior	NOUN
dpc-4075	54	24	within	within	ADP
dpc-4075	54	25	distinct	distinct	ADJ
dpc-4075	54	26	patient	patient	ADJ
dpc-4075	54	27	classes	class	NOUN
dpc-4075	54	28	,	,	PUNCT
dpc-4075	54	29	specifically	specifically	ADV
dpc-4075	54	30	focusing	focus	VERB
dpc-4075	54	31	on	on	ADP
dpc-4075	54	32	topical	topical	ADJ
dpc-4075	54	33	treatments	treatment	NOUN
dpc-4075	54	34	,	,	PUNCT
dpc-4075	54	35	phototherapy	phototherapy	NOUN
dpc-4075	54	36	,	,	PUNCT
dpc-4075	54	37	depigmentation	depigmentation	NOUN
dpc-4075	54	38	,	,	PUNCT
dpc-4075	54	39	and	and	CCONJ
dpc-4075	54	40	surgery	surgery	NOUN
dpc-4075	54	41	.	.	PUNCT
dpc-4075	55	1	we	we	PRON
dpc-4075	55	2	further	far	ADV
dpc-4075	55	3	quantified	quantify	VERB
dpc-4075	55	4	the	the	DET
dpc-4075	55	5	costs	cost	NOUN
dpc-4075	55	6	associated	associate	VERB
dpc-4075	55	7	with	with	ADP
dpc-4075	55	8	each	each	DET
dpc-4075	55	9	treatment	treatment	NOUN
dpc-4075	55	10	,	,	PUNCT
dpc-4075	55	11	using	use	VERB
dpc-4075	55	12	publicly	publicly	ADV
dpc-4075	55	13	available	available	ADJ
dpc-4075	55	14	sources	source	NOUN
dpc-4075	55	15	.	.	PUNCT
dpc-4075	56	1	both	both	CCONJ
dpc-4075	56	2	nhs	nhs	NOUN
dpc-4075	56	3	and	and	CCONJ
dpc-4075	56	4	patient	patient	ADJ
dpc-4075	56	5	costs	cost	NOUN
dpc-4075	56	6	were	be	AUX
dpc-4075	56	7	considered	consider	VERB
dpc-4075	56	8	.	.	PUNCT
dpc-4075	57	1	•	•	ADJ
dpc-4075	57	2	autoimmune	autoimmune	ADJ
dpc-4075	57	3	comorbidities	comorbiditie	NOUN
dpc-4075	57	4	:	:	PUNCT
dpc-4075	57	5	our	our	PRON
dpc-4075	57	6	study	study	NOUN
dpc-4075	57	7	delved	delve	VERB
dpc-4075	57	8	into	into	ADP
dpc-4075	57	9	the	the	DET
dpc-4075	57	10	prevalence	prevalence	NOUN
dpc-4075	57	11	of	of	ADP
dpc-4075	57	12	autoimmune	autoimmune	ADJ
dpc-4075	57	13	comorbidities	comorbiditie	NOUN
dpc-4075	57	14	among	among	ADP
dpc-4075	57	15	vitiligo	vitiligo	ADJ
dpc-4075	57	16	patients	patient	NOUN
dpc-4075	57	17	,	,	PUNCT
dpc-4075	57	18	including	include	VERB
dpc-4075	57	19	conditions	condition	NOUN
dpc-4075	57	20	such	such	ADJ
dpc-4075	57	21	as	as	ADP
dpc-4075	57	22	hypothyroidism	hypothyroidism	NOUN
dpc-4075	57	23	,	,	PUNCT
dpc-4075	57	24	rheumatoid	rheumatoid	NOUN
dpc-4075	57	25	arthritis	arthritis	NOUN
dpc-4075	57	26	,	,	PUNCT
dpc-4075	57	27	and	and	CCONJ
dpc-4075	57	28	inflammatory	inflammatory	ADJ
dpc-4075	57	29	bowel	bowel	NOUN
dpc-4075	57	30	disease	disease	NOUN
dpc-4075	57	31	.	.	PUNCT
dpc-4075	58	1	for	for	ADP
dpc-4075	58	2	each	each	PRON
dpc-4075	58	3	of	of	ADP
dpc-4075	58	4	these	these	DET
dpc-4075	58	5	comorbidities	comorbiditie	NOUN
dpc-4075	58	6	,	,	PUNCT
dpc-4075	58	7	we	we	PRON
dpc-4075	58	8	examined	examine	VERB
dpc-4075	58	9	literature	literature	NOUN
dpc-4075	58	10	on	on	ADP
dpc-4075	58	11	both	both	CCONJ
dpc-4075	58	12	direct	direct	ADJ
dpc-4075	58	13	and	and	CCONJ
dpc-4075	58	14	indirect	indirect	ADJ
dpc-4075	58	15	associated	associated	ADJ
dpc-4075	58	16	costs	cost	NOUN
dpc-4075	58	17	.	.	PUNCT
dpc-4075	59	1	•	•	NUM
dpc-4075	59	2	mental	mental	ADJ
dpc-4075	59	3	health	health	NOUN
dpc-4075	59	4	conditions	condition	NOUN
dpc-4075	59	5	assessment	assessment	NOUN
dpc-4075	59	6	:	:	PUNCT
dpc-4075	59	7	we	we	PRON
dpc-4075	59	8	explored	explore	VERB
dpc-4075	59	9	the	the	DET
dpc-4075	59	10	prevalence	prevalence	NOUN
dpc-4075	59	11	of	of	ADP
dpc-4075	59	12	mental	mental	ADJ
dpc-4075	59	13	health	health	NOUN
dpc-4075	59	14	comorbidities	comorbiditie	NOUN
dpc-4075	59	15	,	,	PUNCT
dpc-4075	59	16	such	such	ADJ
dpc-4075	59	17	as	as	ADP
dpc-4075	59	18	depression	depression	NOUN
dpc-4075	59	19	and	and	CCONJ
dpc-4075	59	20	anxiety	anxiety	NOUN
dpc-4075	59	21	,	,	PUNCT
dpc-4075	59	22	in	in	ADP
dpc-4075	59	23	vitiligo	vitiligo	NOUN
dpc-4075	59	24	patients	patient	NOUN
dpc-4075	59	25	and	and	CCONJ
dpc-4075	59	26	their	their	PRON
dpc-4075	59	27	caregivers	caregiver	NOUN
dpc-4075	59	28	,	,	PUNCT
dpc-4075	59	29	as	as	SCONJ
dpc-4075	59	30	reported	report	VERB
dpc-4075	59	31	in	in	ADP
dpc-4075	59	32	the	the	DET
dpc-4075	59	33	literature	literature	NOUN
dpc-4075	59	34	.	.	PUNCT
dpc-4075	60	1	on	on	ADP
dpc-4075	60	2	the	the	DET
dpc-4075	60	3	non	non	ADJ
dpc-4075	60	4	-	-	ADJ
dpc-4075	60	5	healthcare	healthcare	ADJ
dpc-4075	60	6	cost	cost	NOUN
dpc-4075	60	7	front	front	NOUN
dpc-4075	60	8	,	,	PUNCT
dpc-4075	60	9	we	we	PRON
dpc-4075	60	10	assessed	assess	VERB
dpc-4075	60	11	two	two	NUM
dpc-4075	60	12	components	component	NOUN
dpc-4075	60	13	:	:	PUNCT
dpc-4075	60	14	•	•	NUM
dpc-4075	60	15	non	non	ADJ
dpc-4075	60	16	-	-	ADJ
dpc-4075	60	17	drug	drug	ADJ
dpc-4075	60	18	products	product	NOUN
dpc-4075	60	19	:	:	PUNCT
dpc-4075	60	20	through	through	ADP
dpc-4075	60	21	medical	medical	ADJ
dpc-4075	60	22	survey	survey	NOUN
dpc-4075	60	23	,	,	PUNCT
dpc-4075	60	24	we	we	PRON
dpc-4075	60	25	examined	examine	VERB
dpc-4075	60	26	the	the	DET
dpc-4075	60	27	usage	usage	NOUN
dpc-4075	60	28	of	of	ADP
dpc-4075	60	29	non	non	ADJ
dpc-4075	60	30	-	-	ADJ
dpc-4075	60	31	drug	drug	ADJ
dpc-4075	60	32	products	product	NOUN
dpc-4075	60	33	(	(	PUNCT
dpc-4075	60	34	e.g.	e.g.	ADV
dpc-4075	60	35	,	,	PUNCT
dpc-4075	60	36	make	make	VERB
dpc-4075	60	37	-	-	PUNCT
dpc-4075	60	38	up/	up/	NOUN
dpc-4075	60	39	concealer	concealer	NOUN
dpc-4075	60	40	,	,	PUNCT
dpc-4075	60	41	self	self	NOUN
dpc-4075	60	42	-	-	PUNCT
dpc-4075	60	43	tanners	tanner	NOUN
dpc-4075	60	44	,	,	PUNCT
dpc-4075	60	45	sunscreen	sunscreen	NOUN
dpc-4075	60	46	)	)	PUNCT
dpc-4075	60	47	within	within	ADP
dpc-4075	60	48	different	different	ADJ
dpc-4075	60	49	patient	patient	NOUN
dpc-4075	60	50	review	review	NOUN
dpc-4075	60	51	|	|	ADV
dpc-4075	60	52	dermatol	dermatol	ADJ
dpc-4075	60	53	pract	pract	NOUN
dpc-4075	60	54	concept	concept	NOUN
dpc-4075	60	55	.	.	PUNCT
dpc-4075	61	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	61	2	:	:	PUNCT
dpc-4075	61	3	e2023315s	e2023315s	PROPN
dpc-4075	61	4	3	3	NUM
dpc-4075	61	5	classes	class	NOUN
dpc-4075	61	6	.	.	PUNCT
dpc-4075	62	1	other	other	ADJ
dpc-4075	62	2	direct	direct	ADJ
dpc-4075	62	3	costs	cost	NOUN
dpc-4075	62	4	were	be	AUX
dpc-4075	62	5	also	also	ADV
dpc-4075	62	6	considered	consider	VERB
dpc-4075	62	7	(	(	PUNCT
dpc-4075	62	8	e.g.	e.g.	ADV
dpc-4075	62	9	,	,	PUNCT
dpc-4075	62	10	transportation	transportation	NOUN
dpc-4075	62	11	expenses	expense	NOUN
dpc-4075	62	12	)	)	PUNCT
dpc-4075	62	13	.	.	PUNCT
dpc-4075	63	1	•	•	NUM
dpc-4075	63	2	indirect	indirect	ADJ
dpc-4075	63	3	social	social	ADJ
dpc-4075	63	4	costs	cost	NOUN
dpc-4075	63	5	:	:	PUNCT
dpc-4075	63	6	our	our	PRON
dpc-4075	63	7	study	study	NOUN
dpc-4075	63	8	included	include	VERB
dpc-4075	63	9	an	an	DET
dpc-4075	63	10	estimation	estimation	NOUN
dpc-4075	63	11	of	of	ADP
dpc-4075	63	12	the	the	DET
dpc-4075	63	13	time	time	NOUN
dpc-4075	63	14	allocated	allocate	VERB
dpc-4075	63	15	for	for	ADP
dpc-4075	63	16	treating	treat	VERB
dpc-4075	63	17	vitiligo	vitiligo	NOUN
dpc-4075	63	18	and	and	CCONJ
dpc-4075	63	19	mental	mental	ADJ
dpc-4075	63	20	health	health	NOUN
dpc-4075	63	21	comorbidities	comorbiditie	NOUN
dpc-4075	63	22	within	within	ADP
dpc-4075	63	23	each	each	DET
dpc-4075	63	24	patient	patient	ADJ
dpc-4075	63	25	class	class	NOUN
dpc-4075	63	26	.	.	PUNCT
dpc-4075	64	1	we	we	PRON
dpc-4075	64	2	also	also	ADV
dpc-4075	64	3	evaluated	evaluate	VERB
dpc-4075	64	4	the	the	DET
dpc-4075	64	5	influence	influence	NOUN
dpc-4075	64	6	of	of	ADP
dpc-4075	64	7	mental	mental	ADJ
dpc-4075	64	8	health	health	NOUN
dpc-4075	64	9	comorbidities	comorbiditie	NOUN
dpc-4075	64	10	on	on	ADP
dpc-4075	64	11	employment	employment	NOUN
dpc-4075	64	12	status	status	NOUN
dpc-4075	64	13	.	.	PUNCT
dpc-4075	65	1	results	result	VERB
dpc-4075	65	2	epidemiology	epidemiology	NOUN
dpc-4075	65	3	here	here	ADV
dpc-4075	65	4	we	we	PRON
dpc-4075	65	5	present	present	VERB
dpc-4075	65	6	eight	eight	NUM
dpc-4075	65	7	italian	italian	ADJ
dpc-4075	65	8	studies	study	NOUN
dpc-4075	65	9	with	with	ADP
dpc-4075	65	10	a	a	DET
dpc-4075	65	11	clear	clear	ADJ
dpc-4075	65	12	epidemiologic	epidemiologic	ADJ
dpc-4075	65	13	design	design	NOUN
dpc-4075	65	14	[	[	X
dpc-4075	65	15	3,4,29	3,4,29	NUM
dpc-4075	65	16	-	-	SYM
dpc-4075	65	17	35	35	NUM
dpc-4075	65	18	]	]	PUNCT
dpc-4075	65	19	.	.	PUNCT
dpc-4075	66	1	in	in	ADP
dpc-4075	66	2	the	the	DET
dpc-4075	66	3	praktis	praktis	NOUN
dpc-4075	66	4	study	study	NOUN
dpc-4075	66	5	,	,	PUNCT
dpc-4075	66	6	conducted	conduct	VERB
dpc-4075	66	7	between	between	ADP
dpc-4075	66	8	march	march	PROPN
dpc-4075	66	9	1	1	NUM
dpc-4075	66	10	,	,	PUNCT
dpc-4075	66	11	2003	2003	NUM
dpc-4075	66	12	,	,	PUNCT
dpc-4075	66	13	and	and	CCONJ
dpc-4075	66	14	april	april	PROPN
dpc-4075	66	15	30	30	NUM
dpc-4075	66	16	,	,	PUNCT
dpc-4075	66	17	2004	2004	NUM
dpc-4075	66	18	,	,	PUNCT
dpc-4075	66	19	a	a	DET
dpc-4075	66	20	random	random	ADJ
dpc-4075	66	21	sample	sample	NOUN
dpc-4075	66	22	of	of	ADP
dpc-4075	66	23	12,483	12,483	NUM
dpc-4075	66	24	italian	italian	ADJ
dpc-4075	66	25	subjects	subject	NOUN
dpc-4075	66	26	aged	age	VERB
dpc-4075	66	27	45	45	NUM
dpc-4075	66	28	or	or	CCONJ
dpc-4075	66	29	older	old	ADJ
dpc-4075	66	30	was	be	AUX
dpc-4075	66	31	collected	collect	VERB
dpc-4075	66	32	and	and	CCONJ
dpc-4075	66	33	interviewed	interview	VERB
dpc-4075	66	34	,	,	PUNCT
dpc-4075	66	35	showing	show	VERB
dpc-4075	66	36	a	a	DET
dpc-4075	66	37	0.6	0.6	NUM
dpc-4075	66	38	%	%	NOUN
dpc-4075	66	39	lifetime	lifetime	NOUN
dpc-4075	66	40	prevalence	prevalence	NOUN
dpc-4075	66	41	of	of	ADP
dpc-4075	66	42	physician	physician	NOUN
dpc-4075	66	43	-	-	PUNCT
dpc-4075	66	44	diagnosed	diagnose	VERB
dpc-4075	66	45	vitiligo	vitiligo	NOUN
dpc-4075	66	46	,	,	PUNCT
dpc-4075	66	47	with	with	ADP
dpc-4075	66	48	no	no	DET
dpc-4075	66	49	difference	difference	NOUN
dpc-4075	66	50	according	accord	VERB
dpc-4075	66	51	to	to	ADP
dpc-4075	66	52	gender	gender	NOUN
dpc-4075	66	53	and	and	CCONJ
dpc-4075	66	54	an	an	DET
dpc-4075	66	55	increasing	increase	VERB
dpc-4075	66	56	prevalence	prevalence	NOUN
dpc-4075	66	57	with	with	ADP
dpc-4075	66	58	age	age	NOUN
dpc-4075	66	59	[	[	X
dpc-4075	66	60	29	29	NUM
dpc-4075	66	61	]	]	PUNCT
dpc-4075	66	62	.	.	PUNCT
dpc-4075	67	1	the	the	DET
dpc-4075	67	2	epienlist	epienlist	PROPN
dpc-4075	67	3	project	project	NOUN
dpc-4075	67	4	,	,	PUNCT
dpc-4075	67	5	carried	carry	VERB
dpc-4075	67	6	out	out	ADP
dpc-4075	67	7	by	by	ADP
dpc-4075	67	8	the	the	DET
dpc-4075	67	9	department	department	NOUN
dpc-4075	67	10	of	of	ADP
dpc-4075	67	11	dermatology	dermatology	NOUN
dpc-4075	67	12	at	at	ADP
dpc-4075	67	13	the	the	DET
dpc-4075	67	14	italian	italian	ADJ
dpc-4075	67	15	navy	navy	PROPN
dpc-4075	67	16	hospital	hospital	NOUN
dpc-4075	67	17	in	in	ADP
dpc-4075	67	18	taranto	taranto	PROPN
dpc-4075	67	19	,	,	PUNCT
dpc-4075	67	20	examined	examine	VERB
dpc-4075	67	21	23,468	23,468	NUM
dpc-4075	67	22	potential	potential	ADJ
dpc-4075	67	23	conscripts	conscript	NOUN
dpc-4075	67	24	in	in	ADP
dpc-4075	67	25	southern	southern	PROPN
dpc-4075	67	26	italy	italy	PROPN
dpc-4075	67	27	,	,	PUNCT
dpc-4075	67	28	aged	age	VERB
dpc-4075	67	29	18	18	NUM
dpc-4075	67	30	-	-	SYM
dpc-4075	67	31	21	21	NUM
dpc-4075	67	32	.	.	PUNCT
dpc-4075	68	1	those	those	PRON
dpc-4075	68	2	with	with	ADP
dpc-4075	68	3	skin	skin	NOUN
dpc-4075	68	4	lesions	lesion	NOUN
dpc-4075	68	5	were	be	AUX
dpc-4075	68	6	referred	refer	VERB
dpc-4075	68	7	to	to	ADP
dpc-4075	68	8	the	the	DET
dpc-4075	68	9	hospital	hospital	NOUN
dpc-4075	68	10	for	for	ADP
dpc-4075	68	11	diagnosis	diagnosis	NOUN
dpc-4075	68	12	.	.	PUNCT
dpc-4075	69	1	the	the	DET
dpc-4075	69	2	point	point	NOUN
dpc-4075	69	3	prevalence	prevalence	NOUN
dpc-4075	69	4	of	of	ADP
dpc-4075	69	5	vitiligo	vitiligo	NOUN
dpc-4075	69	6	was	be	AUX
dpc-4075	69	7	0.19	0.19	NUM
dpc-4075	69	8	%	%	NOUN
dpc-4075	69	9	[	[	X
dpc-4075	69	10	3	3	NUM
dpc-4075	69	11	]	]	PUNCT
dpc-4075	69	12	.	.	PUNCT
dpc-4075	70	1	quality	quality	NOUN
dpc-4075	70	2	of	of	ADP
dpc-4075	70	3	life	life	NOUN
dpc-4075	70	4	was	be	AUX
dpc-4075	70	5	assessed	assess	VERB
dpc-4075	70	6	for	for	ADP
dpc-4075	70	7	40	40	NUM
dpc-4075	70	8	vitiligo	vitiligo	NOUN
dpc-4075	70	9	patients	patient	NOUN
dpc-4075	70	10	,	,	PUNCT
dpc-4075	70	11	with	with	ADP
dpc-4075	70	12	a	a	DET
dpc-4075	70	13	mean	mean	ADJ
dpc-4075	70	14	dermatology	dermatology	NOUN
dpc-4075	70	15	life	life	NOUN
dpc-4075	70	16	quality	quality	NOUN
dpc-4075	70	17	index	index	NOUN
dpc-4075	70	18	(	(	PUNCT
dpc-4075	70	19	dlqi	dlqi	ADJ
dpc-4075	70	20	)	)	PUNCT
dpc-4075	70	21	score	score	NOUN
dpc-4075	70	22	of	of	ADP
dpc-4075	70	23	1.82	1.82	NUM
dpc-4075	70	24	[	[	SYM
dpc-4075	70	25	33	33	NUM
dpc-4075	70	26	]	]	PUNCT
dpc-4075	70	27	.	.	PUNCT
dpc-4075	71	1	analysis	analysis	NOUN
dpc-4075	71	2	revealed	reveal	VERB
dpc-4075	71	3	that	that	SCONJ
dpc-4075	71	4	only	only	ADJ
dpc-4075	71	5	lesions	lesion	NOUN
dpc-4075	71	6	on	on	ADP
dpc-4075	71	7	the	the	DET
dpc-4075	71	8	hands	hand	NOUN
dpc-4075	71	9	(	(	PUNCT
dpc-4075	71	10	or:6.32	or:6.32	NUM
dpc-4075	71	11	)	)	PUNCT
dpc-4075	71	12	and	and	CCONJ
dpc-4075	71	13	face	face	NOUN
dpc-4075	71	14	(	(	PUNCT
dpc-4075	71	15	or:5.03	or:5.03	NOUN
dpc-4075	71	16	)	)	PUNCT
dpc-4075	71	17	significantly	significantly	ADV
dpc-4075	71	18	influenced	influence	VERB
dpc-4075	71	19	the	the	DET
dpc-4075	71	20	mean	mean	NOUN
dpc-4075	71	21	dlqi	dlqi	VERB
dpc-4075	71	22	.	.	PUNCT
dpc-4075	72	1	a	a	DET
dpc-4075	72	2	survey	survey	NOUN
dpc-4075	72	3	of	of	ADP
dpc-4075	72	4	quality	quality	NOUN
dpc-4075	72	5	of	of	ADP
dpc-4075	72	6	life	life	NOUN
dpc-4075	72	7	was	be	AUX
dpc-4075	72	8	conducted	conduct	VERB
dpc-4075	72	9	on	on	ADP
dpc-4075	72	10	181	181	NUM
dpc-4075	72	11	consecutive	consecutive	ADJ
dpc-4075	72	12	vitiligo	vitiligo	NOUN
dpc-4075	72	13	patients	patient	NOUN
dpc-4075	72	14	at	at	ADP
dpc-4075	72	15	a	a	DET
dpc-4075	72	16	single	single	ADJ
dpc-4075	72	17	institution	institution	NOUN
dpc-4075	72	18	in	in	ADP
dpc-4075	72	19	rome	rome	PROPN
dpc-4075	72	20	,	,	PUNCT
dpc-4075	72	21	using	use	VERB
dpc-4075	72	22	the	the	DET
dpc-4075	72	23	skindex-29	skindex-29	PROPN
dpc-4075	72	24	tool	tool	NOUN
dpc-4075	72	25	[	[	X
dpc-4075	72	26	30	30	NUM
dpc-4075	72	27	]	]	PUNCT
dpc-4075	72	28	.	.	PUNCT
dpc-4075	73	1	the	the	DET
dpc-4075	73	2	problems	problem	NOUN
dpc-4075	73	3	more	more	ADV
dpc-4075	73	4	frequently	frequently	ADV
dpc-4075	73	5	experienced	experience	VERB
dpc-4075	73	6	were	be	AUX
dpc-4075	73	7	worry	worry	NOUN
dpc-4075	73	8	of	of	ADP
dpc-4075	73	9	the	the	DET
dpc-4075	73	10	disease	disease	NOUN
dpc-4075	73	11	getting	get	VERB
dpc-4075	73	12	worse	bad	ADJ
dpc-4075	73	13	(	(	PUNCT
dpc-4075	73	14	60	60	NUM
dpc-4075	73	15	%	%	NOUN
dpc-4075	73	16	)	)	PUNCT
dpc-4075	73	17	,	,	PUNCT
dpc-4075	73	18	anger	anger	NOUN
dpc-4075	73	19	(	(	PUNCT
dpc-4075	73	20	37	37	NUM
dpc-4075	73	21	%	%	NOUN
dpc-4075	73	22	)	)	PUNCT
dpc-4075	73	23	,	,	PUNCT
dpc-4075	73	24	embarrassment	embarrassment	NOUN
dpc-4075	73	25	(	(	PUNCT
dpc-4075	73	26	34	34	NUM
dpc-4075	73	27	%	%	NOUN
dpc-4075	73	28	)	)	PUNCT
dpc-4075	73	29	,	,	PUNCT
dpc-4075	73	30	depression	depression	NOUN
dpc-4075	73	31	(	(	PUNCT
dpc-4075	73	32	31	31	NUM
dpc-4075	73	33	%	%	NOUN
dpc-4075	73	34	)	)	PUNCT
dpc-4075	73	35	.	.	PUNCT
dpc-4075	74	1	another	another	DET
dpc-4075	74	2	survey	survey	NOUN
dpc-4075	74	3	of	of	ADP
dpc-4075	74	4	quality	quality	NOUN
dpc-4075	74	5	of	of	ADP
dpc-4075	74	6	life	life	NOUN
dpc-4075	74	7	using	use	VERB
dpc-4075	74	8	dlqi	dlqi	PROPN
dpc-4075	74	9	was	be	AUX
dpc-4075	74	10	conducted	conduct	VERB
dpc-4075	74	11	on	on	ADP
dpc-4075	74	12	a	a	DET
dpc-4075	74	13	sample	sample	NOUN
dpc-4075	74	14	of	of	ADP
dpc-4075	74	15	161	161	NUM
dpc-4075	74	16	vitiligo	vitiligo	NOUN
dpc-4075	74	17	patients	patient	NOUN
dpc-4075	74	18	referred	refer	VERB
dpc-4075	74	19	to	to	ADP
dpc-4075	74	20	9	9	NUM
dpc-4075	74	21	dermatological	dermatological	ADJ
dpc-4075	74	22	departments	department	NOUN
dpc-4075	74	23	in	in	ADP
dpc-4075	74	24	italian	italian	ADJ
dpc-4075	74	25	hospitals	hospital	NOUN
dpc-4075	74	26	[	[	X
dpc-4075	74	27	34	34	NUM
dpc-4075	74	28	]	]	PUNCT
dpc-4075	74	29	.	.	PUNCT
dpc-4075	75	1	the	the	DET
dpc-4075	75	2	mean	mean	ADJ
dpc-4075	75	3	total	total	ADJ
dpc-4075	75	4	dlqi	dlqi	ADJ
dpc-4075	75	5	score	score	NOUN
dpc-4075	75	6	was	be	AUX
dpc-4075	75	7	4.3	4.3	NUM
dpc-4075	75	8	(	(	PUNCT
dpc-4075	75	9	sd±4.9	sd±4.9	NOUN
dpc-4075	75	10	;	;	PUNCT
dpc-4075	75	11	range	range	NOUN
dpc-4075	75	12	:	:	PUNCT
dpc-4075	75	13	0	0	NUM
dpc-4075	75	14	-	-	SYM
dpc-4075	75	15	22	22	NUM
dpc-4075	75	16	)	)	PUNCT
dpc-4075	75	17	.	.	PUNCT
dpc-4075	76	1	in	in	ADP
dpc-4075	76	2	multivariate	multivariate	NOUN
dpc-4075	76	3	analysis	analysis	NOUN
dpc-4075	76	4	,	,	PUNCT
dpc-4075	76	5	dlqi	dlqi	VERB
dpc-4075	76	6	>	>	SYM
dpc-4075	76	7	5	5	NUM
dpc-4075	76	8	was	be	AUX
dpc-4075	76	9	associated	associate	VERB
dpc-4075	76	10	with	with	ADP
dpc-4075	76	11	female	female	ADJ
dpc-4075	76	12	gender	gender	NOUN
dpc-4075	76	13	,	,	PUNCT
dpc-4075	76	14	stability	stability	NOUN
dpc-4075	76	15	of	of	ADP
dpc-4075	76	16	the	the	DET
dpc-4075	76	17	disease	disease	NOUN
dpc-4075	76	18	and	and	CCONJ
dpc-4075	76	19	involvement	involvement	NOUN
dpc-4075	76	20	of	of	ADP
dpc-4075	76	21	the	the	DET
dpc-4075	76	22	face	face	NOUN
dpc-4075	76	23	at	at	ADP
dpc-4075	76	24	disease	disease	NOUN
dpc-4075	76	25	onset	onset	VERB
dpc-4075	76	26	.	.	PUNCT
dpc-4075	77	1	in	in	ADP
dpc-4075	77	2	a	a	DET
dpc-4075	77	3	survey	survey	NOUN
dpc-4075	77	4	conducted	conduct	VERB
dpc-4075	77	5	during	during	ADP
dpc-4075	77	6	spring	spring	NOUN
dpc-4075	77	7	1997	1997	NUM
dpc-4075	77	8	,	,	PUNCT
dpc-4075	77	9	a	a	DET
dpc-4075	77	10	total	total	NOUN
dpc-4075	77	11	of	of	ADP
dpc-4075	77	12	3,179	3,179	NUM
dpc-4075	77	13	schoolchildren	schoolchildren	NOUN
dpc-4075	77	14	attending	attend	VERB
dpc-4075	77	15	secondary	secondary	ADJ
dpc-4075	77	16	schools	school	NOUN
dpc-4075	77	17	in	in	ADP
dpc-4075	77	18	italy	italy	PROPN
dpc-4075	77	19	were	be	AUX
dpc-4075	77	20	assessed	assess	VERB
dpc-4075	77	21	through	through	ADP
dpc-4075	77	22	a	a	DET
dpc-4075	77	23	questionnaire	questionnaire	NOUN
dpc-4075	77	24	filled	fill	VERB
dpc-4075	77	25	in	in	ADP
dpc-4075	77	26	by	by	ADP
dpc-4075	77	27	their	their	PRON
dpc-4075	77	28	parents	parent	NOUN
dpc-4075	77	29	[	[	X
dpc-4075	77	30	31	31	NUM
dpc-4075	77	31	]	]	PUNCT
dpc-4075	77	32	.	.	PUNCT
dpc-4075	78	1	the	the	DET
dpc-4075	78	2	reported	report	VERB
dpc-4075	78	3	prevalence	prevalence	NOUN
dpc-4075	78	4	of	of	ADP
dpc-4075	78	5	vitiligo	vitiligo	NOUN
dpc-4075	78	6	was	be	AUX
dpc-4075	78	7	0.06	0.06	NUM
dpc-4075	78	8	%	%	NOUN
dpc-4075	78	9	.	.	PUNCT
dpc-4075	79	1	the	the	DET
dpc-4075	79	2	eden	eden	PROPN
dpc-4075	79	3	fragrance	fragrance	NOUN
dpc-4075	79	4	study	study	NOUN
dpc-4075	79	5	enrolled	enrol	VERB
dpc-4075	79	6	2,035	2,035	NUM
dpc-4075	79	7	randomly	randomly	ADV
dpc-4075	79	8	sampled	sample	VERB
dpc-4075	79	9	individuals	individual	NOUN
dpc-4075	79	10	aged	age	VERB
dpc-4075	79	11	18	18	NUM
dpc-4075	79	12	or	or	CCONJ
dpc-4075	79	13	older	old	ADJ
dpc-4075	79	14	in	in	ADP
dpc-4075	79	15	italy	italy	PROPN
dpc-4075	79	16	.	.	PUNCT
dpc-4075	80	1	clinical	clinical	ADJ
dpc-4075	80	2	examinations	examination	NOUN
dpc-4075	80	3	and	and	CCONJ
dpc-4075	80	4	patch	patch	NOUN
dpc-4075	80	5	tests	test	NOUN
dpc-4075	80	6	were	be	AUX
dpc-4075	80	7	conducted	conduct	VERB
dpc-4075	80	8	.	.	PUNCT
dpc-4075	81	1	the	the	DET
dpc-4075	81	2	lifetime	lifetime	NOUN
dpc-4075	81	3	prevalence	prevalence	NOUN
dpc-4075	81	4	of	of	ADP
dpc-4075	81	5	vitiligo	vitiligo	NOUN
dpc-4075	81	6	was	be	AUX
dpc-4075	81	7	0.4	0.4	NUM
dpc-4075	81	8	%	%	NOUN
dpc-4075	81	9	,	,	PUNCT
dpc-4075	81	10	with	with	ADP
dpc-4075	81	11	no	no	DET
dpc-4075	81	12	significant	significant	ADJ
dpc-4075	81	13	gender	gender	NOUN
dpc-4075	81	14	difference	difference	NOUN
dpc-4075	81	15	[	[	X
dpc-4075	81	16	35	35	NUM
dpc-4075	81	17	]	]	PUNCT
dpc-4075	81	18	.	.	PUNCT
dpc-4075	82	1	the	the	DET
dpc-4075	82	2	prevalence	prevalence	NOUN
dpc-4075	82	3	of	of	ADP
dpc-4075	82	4	vitiligo	vitiligo	PROPN
dpc-4075	82	5	in	in	ADP
dpc-4075	82	6	italy	italy	PROPN
dpc-4075	82	7	,	,	PUNCT
dpc-4075	82	8	as	as	SCONJ
dpc-4075	82	9	determined	determine	VERB
dpc-4075	82	10	by	by	ADP
dpc-4075	82	11	the	the	DET
dpc-4075	82	12	studies	study	NOUN
dpc-4075	82	13	,	,	PUNCT
dpc-4075	82	14	falls	fall	VERB
dpc-4075	82	15	within	within	ADP
dpc-4075	82	16	the	the	DET
dpc-4075	82	17	range	range	NOUN
dpc-4075	82	18	of	of	ADP
dpc-4075	82	19	0.19%-0.6	0.19%-0.6	NOUN
dpc-4075	82	20	%	%	NOUN
dpc-4075	82	21	,	,	PUNCT
dpc-4075	82	22	increasing	increase	VERB
dpc-4075	82	23	with	with	ADP
dpc-4075	82	24	age	age	NOUN
dpc-4075	82	25	.	.	PUNCT
dpc-4075	83	1	in	in	ADP
dpc-4075	83	2	addition	addition	NOUN
dpc-4075	83	3	,	,	PUNCT
dpc-4075	83	4	an	an	DET
dpc-4075	83	5	italian	italian	ADJ
dpc-4075	83	6	res	re	NOUN
dpc-4075	83	7	real	real	ADJ
dpc-4075	83	8	-	-	PUNCT
dpc-4075	83	9	world	world	NOUN
dpc-4075	83	10	evidence	evidence	NOUN
dpc-4075	83	11	study	study	NOUN
dpc-4075	83	12	[	[	X
dpc-4075	83	13	36	36	NUM
dpc-4075	83	14	]	]	PUNCT
dpc-4075	83	15	was	be	AUX
dpc-4075	83	16	considered	consider	VERB
dpc-4075	83	17	.	.	PUNCT
dpc-4075	84	1	this	this	DET
dpc-4075	84	2	study	study	NOUN
dpc-4075	84	3	examined	examine	VERB
dpc-4075	84	4	the	the	DET
dpc-4075	84	5	number	number	NOUN
dpc-4075	84	6	of	of	ADP
dpc-4075	84	7	patients	patient	NOUN
dpc-4075	84	8	undergoing	undergo	VERB
dpc-4075	84	9	phototherapy	phototherapy	NOUN
dpc-4075	84	10	treatment	treatment	NOUN
dpc-4075	84	11	for	for	ADP
dpc-4075	84	12	vitiligo	vitiligo	NOUN
dpc-4075	84	13	from	from	ADP
dpc-4075	84	14	2013	2013	NUM
dpc-4075	84	15	to	to	ADP
dpc-4075	84	16	2018	2018	NUM
dpc-4075	84	17	and	and	CCONJ
dpc-4075	84	18	revealed	reveal	VERB
dpc-4075	84	19	that	that	SCONJ
dpc-4075	84	20	0.06	0.06	NUM
dpc-4075	84	21	%	%	NOUN
dpc-4075	84	22	of	of	ADP
dpc-4075	84	23	the	the	DET
dpc-4075	84	24	patient	patient	ADJ
dpc-4075	84	25	population	population	NOUN
dpc-4075	84	26	received	receive	VERB
dpc-4075	84	27	such	such	ADJ
dpc-4075	84	28	treatment	treatment	NOUN
dpc-4075	84	29	during	during	ADP
dpc-4075	84	30	that	that	DET
dpc-4075	84	31	period	period	NOUN
dpc-4075	84	32	.	.	PUNCT
dpc-4075	85	1	employing	employ	VERB
dpc-4075	85	2	a	a	DET
dpc-4075	85	3	bottom	bottom	ADJ
dpc-4075	85	4	-	-	PUNCT
dpc-4075	85	5	up	up	ADP
dpc-4075	85	6	methodology	methodology	NOUN
dpc-4075	85	7	,	,	PUNCT
dpc-4075	85	8	we	we	PRON
dpc-4075	85	9	expanded	expand	VERB
dpc-4075	85	10	the	the	DET
dpc-4075	85	11	study	study	NOUN
dpc-4075	85	12	’s	’s	PART
dpc-4075	85	13	scope	scope	NOUN
dpc-4075	85	14	to	to	PART
dpc-4075	85	15	incorporate	incorporate	VERB
dpc-4075	85	16	patients	patient	NOUN
dpc-4075	85	17	who	who	PRON
dpc-4075	85	18	underwent	undergo	VERB
dpc-4075	85	19	phototherapy	phototherapy	NOUN
dpc-4075	85	20	prior	prior	ADV
dpc-4075	85	21	to	to	ADP
dpc-4075	85	22	2013	2013	NUM
dpc-4075	85	23	or	or	CCONJ
dpc-4075	85	24	received	receive	VERB
dpc-4075	85	25	alternative	alternative	ADJ
dpc-4075	85	26	treatments	treatment	NOUN
dpc-4075	85	27	,	,	PUNCT
dpc-4075	85	28	to	to	PART
dpc-4075	85	29	ensure	ensure	VERB
dpc-4075	85	30	a	a	DET
dpc-4075	85	31	complete	complete	ADJ
dpc-4075	85	32	understanding	understanding	NOUN
dpc-4075	85	33	of	of	ADP
dpc-4075	85	34	the	the	DET
dpc-4075	85	35	vitiligo	vitiligo	NOUN
dpc-4075	85	36	-	-	PUNCT
dpc-4075	85	37	diagnosed	diagnose	VERB
dpc-4075	85	38	population	population	NOUN
dpc-4075	85	39	.	.	PUNCT
dpc-4075	86	1	we	we	PRON
dpc-4075	86	2	then	then	ADV
dpc-4075	86	3	added	add	VERB
dpc-4075	86	4	undiagnosed	undiagnosed	ADJ
dpc-4075	86	5	cases	case	NOUN
dpc-4075	86	6	(	(	PUNCT
dpc-4075	86	7	41	41	NUM
dpc-4075	86	8	%	%	NOUN
dpc-4075	86	9	)	)	PUNCT
dpc-4075	87	1	[	[	X
dpc-4075	87	2	35	35	NUM
dpc-4075	87	3	]	]	PUNCT
dpc-4075	87	4	to	to	PART
dpc-4075	87	5	derive	derive	VERB
dpc-4075	87	6	a	a	DET
dpc-4075	87	7	lifetime	lifetime	NOUN
dpc-4075	87	8	vitiligo	vitiligo	NOUN
dpc-4075	87	9	prevalence	prevalence	NOUN
dpc-4075	87	10	rate	rate	NOUN
dpc-4075	87	11	of	of	ADP
dpc-4075	87	12	0.55	0.55	NUM
dpc-4075	87	13	%	%	NOUN
dpc-4075	87	14	,	,	PUNCT
dpc-4075	87	15	which	which	PRON
dpc-4075	87	16	is	be	AUX
dpc-4075	87	17	in	in	ADP
dpc-4075	87	18	line	line	NOUN
dpc-4075	87	19	with	with	ADP
dpc-4075	87	20	that	that	PRON
dpc-4075	87	21	reported	report	VERB
dpc-4075	87	22	by	by	ADP
dpc-4075	87	23	literature	literature	NOUN
dpc-4075	87	24	.	.	PUNCT
dpc-4075	88	1	considering	consider	VERB
dpc-4075	88	2	that	that	SCONJ
dpc-4075	88	3	only	only	ADV
dpc-4075	88	4	15	15	NUM
dpc-4075	88	5	%	%	NOUN
dpc-4075	88	6	of	of	ADP
dpc-4075	88	7	vitiligo	vitiligo	NOUN
dpc-4075	88	8	cases	case	NOUN
dpc-4075	88	9	are	be	AUX
dpc-4075	88	10	non	non	ADJ
dpc-4075	88	11	-	-	ADJ
dpc-4075	88	12	segmental	segmental	ADJ
dpc-4075	88	13	vitiligo	vitiligo	NOUN
dpc-4075	88	14	(	(	PUNCT
dpc-4075	88	15	nsv	nsv	PROPN
dpc-4075	88	16	)	)	PUNCT
dpc-4075	89	1	[	[	X
dpc-4075	89	2	37	37	NUM
dpc-4075	89	3	-	-	SYM
dpc-4075	89	4	40	40	NUM
dpc-4075	89	5	]	]	PUNCT
dpc-4075	89	6	,	,	PUNCT
dpc-4075	89	7	we	we	PRON
dpc-4075	89	8	estimated	estimate	VERB
dpc-4075	89	9	a	a	DET
dpc-4075	89	10	total	total	NOUN
dpc-4075	89	11	of	of	ADP
dpc-4075	89	12	279,000	279,000	NUM
dpc-4075	89	13	nsv	nsv	PROPN
dpc-4075	89	14	patients	patient	NOUN
dpc-4075	89	15	in	in	ADP
dpc-4075	89	16	italy	italy	PROPN
dpc-4075	89	17	in	in	ADP
dpc-4075	89	18	2022	2022	NUM
dpc-4075	89	19	.	.	PUNCT
dpc-4075	90	1	among	among	ADP
dpc-4075	90	2	these	these	PRON
dpc-4075	90	3	,	,	PUNCT
dpc-4075	90	4	152,000	152,000	NUM
dpc-4075	90	5	received	receive	VERB
dpc-4075	90	6	a	a	DET
dpc-4075	90	7	diagnosis	diagnosis	NOUN
dpc-4075	90	8	,	,	PUNCT
dpc-4075	90	9	with	with	ADP
dpc-4075	90	10	33	33	NUM
dpc-4075	90	11	%	%	NOUN
dpc-4075	90	12	classified	classify	VERB
dpc-4075	90	13	as	as	ADP
dpc-4075	90	14	having	have	VERB
dpc-4075	90	15	bsa	bsa	PROPN
dpc-4075	90	16	<	<	X
dpc-4075	90	17	0.5	0.5	NUM
dpc-4075	90	18	%	%	NOUN
dpc-4075	90	19	(	(	PUNCT
dpc-4075	90	20	not	not	PART
dpc-4075	90	21	severe	severe	ADJ
dpc-4075	90	22	at	at	ADV
dpc-4075	90	23	all	all	ADV
dpc-4075	90	24	)	)	PUNCT
dpc-4075	90	25	,	,	PUNCT
dpc-4075	90	26	31	31	NUM
dpc-4075	90	27	%	%	NOUN
dpc-4075	90	28	with	with	ADP
dpc-4075	90	29	bsa	bsa	PROPN
dpc-4075	90	30	0.5%-3.5	0.5%-3.5	ADP
dpc-4075	90	31	%	%	NOUN
dpc-4075	90	32	(	(	PUNCT
dpc-4075	90	33	mild	mild	ADJ
dpc-4075	90	34	)	)	PUNCT
dpc-4075	90	35	,	,	PUNCT
dpc-4075	90	36	27	27	NUM
dpc-4075	90	37	%	%	NOUN
dpc-4075	90	38	with	with	ADP
dpc-4075	90	39	bsa	bsa	PROPN
dpc-4075	90	40	3.5%-10	3.5%-10	NUM
dpc-4075	90	41	%	%	NOUN
dpc-4075	90	42	(	(	PUNCT
dpc-4075	90	43	moderate	moderate	ADJ
dpc-4075	90	44	/	/	SYM
dpc-4075	90	45	severe	severe	ADJ
dpc-4075	90	46	)	)	PUNCT
dpc-4075	90	47	,	,	PUNCT
dpc-4075	90	48	and	and	CCONJ
dpc-4075	90	49	9	9	NUM
dpc-4075	90	50	%	%	NOUN
dpc-4075	90	51	with	with	ADP
dpc-4075	90	52	bsa	bsa	PROPN
dpc-4075	90	53	>	>	X
dpc-4075	90	54	10	10	NUM
dpc-4075	90	55	%	%	NOUN
dpc-4075	90	56	(	(	PUNCT
dpc-4075	90	57	very	very	ADV
dpc-4075	90	58	severe	severe	ADJ
dpc-4075	90	59	)	)	PUNCT
dpc-4075	91	1	[	[	X
dpc-4075	91	2	41	41	NUM
dpc-4075	91	3	]	]	PUNCT
dpc-4075	91	4	.	.	PUNCT
dpc-4075	92	1	vitiligo	vitiligo	PROPN
dpc-4075	92	2	treatment	treatment	NOUN
dpc-4075	92	3	cost	cost	VERB
dpc-4075	92	4	the	the	DET
dpc-4075	92	5	costs	cost	NOUN
dpc-4075	92	6	of	of	ADP
dpc-4075	92	7	vitiligo	vitiligo	ADJ
dpc-4075	92	8	treatment	treatment	NOUN
dpc-4075	92	9	include	include	VERB
dpc-4075	92	10	all	all	DET
dpc-4075	92	11	direct	direct	ADJ
dpc-4075	92	12	medical	medical	ADJ
dpc-4075	92	13	expenses	expense	NOUN
dpc-4075	92	14	,	,	PUNCT
dpc-4075	92	15	including	include	VERB
dpc-4075	92	16	therapies	therapy	NOUN
dpc-4075	92	17	,	,	PUNCT
dpc-4075	92	18	examinations	examination	NOUN
dpc-4075	92	19	,	,	PUNCT
dpc-4075	92	20	laboratory	laboratory	NOUN
dpc-4075	92	21	tests	test	NOUN
dpc-4075	92	22	,	,	PUNCT
dpc-4075	92	23	and	and	CCONJ
dpc-4075	92	24	supplements	supplement	NOUN
dpc-4075	92	25	.	.	PUNCT
dpc-4075	93	1	nsv	nsv	PROPN
dpc-4075	93	2	treatment	treatment	NOUN
dpc-4075	93	3	rate	rate	NOUN
dpc-4075	93	4	varies	vary	VERB
dpc-4075	93	5	among	among	ADP
dpc-4075	93	6	patient	patient	ADJ
dpc-4075	93	7	segments	segment	NOUN
dpc-4075	93	8	.	.	PUNCT
dpc-4075	94	1	treatment	treatment	NOUN
dpc-4075	94	2	rate	rate	NOUN
dpc-4075	94	3	tends	tend	VERB
dpc-4075	94	4	to	to	PART
dpc-4075	94	5	be	be	AUX
dpc-4075	94	6	higher	high	ADJ
dpc-4075	94	7	in	in	ADP
dpc-4075	94	8	more	more	ADV
dpc-4075	94	9	severe	severe	ADJ
dpc-4075	94	10	forms	form	NOUN
dpc-4075	94	11	of	of	ADP
dpc-4075	94	12	nsv	nsv	PROPN
dpc-4075	94	13	:	:	PUNCT
dpc-4075	94	14	only	only	ADV
dpc-4075	94	15	35	35	NUM
dpc-4075	94	16	%	%	NOUN
dpc-4075	94	17	of	of	ADP
dpc-4075	94	18	not	not	PART
dpc-4075	94	19	severe	severe	ADJ
dpc-4075	94	20	nsv	nsv	PROPN
dpc-4075	94	21	patients	patient	NOUN
dpc-4075	94	22	receive	receive	VERB
dpc-4075	94	23	treatment	treatment	NOUN
dpc-4075	94	24	compared	compare	VERB
dpc-4075	94	25	to	to	ADP
dpc-4075	94	26	84	84	NUM
dpc-4075	94	27	%	%	NOUN
dpc-4075	94	28	of	of	ADP
dpc-4075	94	29	very	very	ADV
dpc-4075	94	30	severe	severe	ADJ
dpc-4075	94	31	nsv	nsv	PROPN
dpc-4075	94	32	patients	patient	NOUN
dpc-4075	94	33	.	.	PUNCT
dpc-4075	95	1	within	within	ADP
dpc-4075	95	2	the	the	DET
dpc-4075	95	3	same	same	ADJ
dpc-4075	95	4	moderate	moderate	ADJ
dpc-4075	95	5	-	-	PUNCT
dpc-4075	95	6	severe	severe	ADJ
dpc-4075	95	7	segment	segment	NOUN
dpc-4075	95	8	,	,	PUNCT
dpc-4075	95	9	adolescents	adolescent	NOUN
dpc-4075	95	10	and	and	CCONJ
dpc-4075	95	11	females	female	NOUN
dpc-4075	95	12	exhibit	exhibit	VERB
dpc-4075	95	13	a	a	DET
dpc-4075	95	14	relatively	relatively	ADV
dpc-4075	95	15	higher	high	ADJ
dpc-4075	95	16	treatment	treatment	NOUN
dpc-4075	95	17	rate	rate	NOUN
dpc-4075	95	18	(	(	PUNCT
dpc-4075	95	19	81	81	NUM
dpc-4075	95	20	%	%	NOUN
dpc-4075	95	21	and	and	CCONJ
dpc-4075	95	22	80	80	NUM
dpc-4075	95	23	%	%	NOUN
dpc-4075	95	24	respectively	respectively	ADV
dpc-4075	95	25	)	)	PUNCT
dpc-4075	95	26	compared	compare	VERB
dpc-4075	95	27	adult	adult	NOUN
dpc-4075	95	28	males	male	NOUN
dpc-4075	95	29	(	(	PUNCT
dpc-4075	95	30	70	70	NUM
dpc-4075	95	31	%	%	NOUN
dpc-4075	95	32	)	)	PUNCT
dpc-4075	95	33	.	.	PUNCT
dpc-4075	96	1	for	for	ADP
dpc-4075	96	2	each	each	DET
dpc-4075	96	3	patient	patient	ADJ
dpc-4075	96	4	class	class	NOUN
dpc-4075	96	5	,	,	PUNCT
dpc-4075	96	6	treatment	treatment	NOUN
dpc-4075	96	7	preferences	preference	NOUN
dpc-4075	96	8	were	be	AUX
dpc-4075	96	9	examined	examine	VERB
dpc-4075	96	10	through	through	ADP
dpc-4075	96	11	the	the	DET
dpc-4075	96	12	medical	medical	ADJ
dpc-4075	96	13	survey	survey	NOUN
dpc-4075	96	14	:	:	PUNCT
dpc-4075	96	15	preferred	preferred	ADJ
dpc-4075	96	16	options	option	NOUN
dpc-4075	96	17	for	for	ADP
dpc-4075	96	18	cases	case	NOUN
dpc-4075	96	19	of	of	ADP
dpc-4075	96	20	lower	low	ADJ
dpc-4075	96	21	severity	severity	NOUN
dpc-4075	96	22	included	include	VERB
dpc-4075	96	23	topical	topical	ADJ
dpc-4075	96	24	corticosteroids	corticosteroid	NOUN
dpc-4075	96	25	and	and	CCONJ
dpc-4075	96	26	calcineurin	calcineurin	ADJ
dpc-4075	96	27	inhibitors	inhibitor	NOUN
dpc-4075	96	28	,	,	PUNCT
dpc-4075	96	29	while	while	SCONJ
dpc-4075	96	30	in	in	ADP
dpc-4075	96	31	moderate	moderate	ADJ
dpc-4075	96	32	-	-	PUNCT
dpc-4075	96	33	severe	severe	ADJ
dpc-4075	96	34	cases	case	NOUN
dpc-4075	96	35	,	,	PUNCT
dpc-4075	96	36	phototherapy	phototherapy	NOUN
dpc-4075	96	37	and	and	CCONJ
dpc-4075	96	38	systemic	systemic	ADJ
dpc-4075	96	39	corticosteroids	corticosteroid	NOUN
dpc-4075	96	40	were	be	AUX
dpc-4075	96	41	preferred	prefer	VERB
dpc-4075	96	42	(	(	PUNCT
dpc-4075	96	43	figure	figure	NOUN
dpc-4075	96	44	1	1	NUM
dpc-4075	96	45	)	)	PUNCT
dpc-4075	96	46	.	.	PUNCT
dpc-4075	97	1	to	to	PART
dpc-4075	97	2	compute	compute	VERB
dpc-4075	97	3	costs	cost	NOUN
dpc-4075	97	4	,	,	PUNCT
dpc-4075	97	5	we	we	PRON
dpc-4075	97	6	identified	identify	VERB
dpc-4075	97	7	the	the	DET
dpc-4075	97	8	most	most	ADV
dpc-4075	97	9	used	use	VERB
dpc-4075	97	10	molecules	molecule	NOUN
dpc-4075	97	11	and	and	CCONJ
dpc-4075	97	12	their	their	PRON
dpc-4075	97	13	average	average	ADJ
dpc-4075	97	14	therapeutic	therapeutic	ADJ
dpc-4075	97	15	regimens	regimen	NOUN
dpc-4075	97	16	,	,	PUNCT
dpc-4075	97	17	and	and	CCONJ
dpc-4075	97	18	we	we	PRON
dpc-4075	97	19	distinguished	distinguish	VERB
dpc-4075	97	20	between	between	ADP
dpc-4075	97	21	costs	cost	NOUN
dpc-4075	97	22	in	in	ADP
dpc-4075	97	23	private	private	ADJ
dpc-4075	97	24	and	and	CCONJ
dpc-4075	97	25	public	public	ADJ
dpc-4075	97	26	settings	setting	NOUN
dpc-4075	97	27	(	(	PUNCT
dpc-4075	97	28	table	table	NOUN
dpc-4075	97	29	2	2	NUM
dpc-4075	97	30	)	)	PUNCT
dpc-4075	97	31	.	.	PUNCT
dpc-4075	98	1	according	accord	VERB
dpc-4075	98	2	to	to	ADP
dpc-4075	98	3	the	the	DET
dpc-4075	98	4	medical	medical	ADJ
dpc-4075	98	5	survey	survey	NOUN
dpc-4075	98	6	,	,	PUNCT
dpc-4075	98	7	49.5	49.5	NUM
dpc-4075	98	8	%	%	NOUN
dpc-4075	98	9	of	of	ADP
dpc-4075	98	10	patients	patient	NOUN
dpc-4075	98	11	are	be	AUX
dpc-4075	98	12	treated	treat	VERB
dpc-4075	98	13	in	in	ADP
dpc-4075	98	14	public	public	NOUN
dpc-4075	98	15	,	,	PUNCT
dpc-4075	98	16	and	and	CCONJ
dpc-4075	98	17	50.5	50.5	NUM
dpc-4075	98	18	%	%	NOUN
dpc-4075	98	19	in	in	ADP
dpc-4075	98	20	private	private	ADJ
dpc-4075	98	21	settings	setting	NOUN
dpc-4075	98	22	.	.	PUNCT
dpc-4075	99	1	then	then	ADV
dpc-4075	99	2	,	,	PUNCT
dpc-4075	99	3	considering	consider	VERB
dpc-4075	99	4	the	the	DET
dpc-4075	99	5	specific	specific	ADJ
dpc-4075	99	6	needs	need	NOUN
dpc-4075	99	7	of	of	ADP
dpc-4075	99	8	each	each	DET
dpc-4075	99	9	class	class	NOUN
dpc-4075	99	10	of	of	ADP
dpc-4075	99	11	nsv	nsv	PROPN
dpc-4075	99	12	patients	patient	NOUN
dpc-4075	99	13	,	,	PUNCT
dpc-4075	99	14	we	we	PRON
dpc-4075	99	15	added	add	VERB
dpc-4075	99	16	costs	cost	NOUN
dpc-4075	99	17	for	for	ADP
dpc-4075	99	18	dermatologist	dermatologist	NOUN
dpc-4075	99	19	and	and	CCONJ
dpc-4075	99	20	nutritionist	nutritionist	PROPN
dpc-4075	99	21	examinations	examination	NOUN
dpc-4075	99	22	,	,	PUNCT
dpc-4075	99	23	blood/	blood/	NUM
dpc-4075	99	24	urine	urine	NOUN
dpc-4075	99	25	tests	test	NOUN
dpc-4075	99	26	,	,	PUNCT
dpc-4075	99	27	and	and	CCONJ
dpc-4075	99	28	supplements	supplement	NOUN
dpc-4075	99	29	.	.	PUNCT
dpc-4075	100	1	total	total	ADJ
dpc-4075	100	2	medical	medical	ADJ
dpc-4075	100	3	costs	cost	NOUN
dpc-4075	100	4	for	for	ADP
dpc-4075	100	5	nsv	nsv	PROPN
dpc-4075	100	6	patients	patient	NOUN
dpc-4075	100	7	amount	amount	VERB
dpc-4075	100	8	to	to	ADP
dpc-4075	100	9	€	€	SYM
dpc-4075	100	10	80mln	80mln	NOUN
dpc-4075	100	11	and	and	CCONJ
dpc-4075	100	12	the	the	DET
dpc-4075	100	13	large	large	ADJ
dpc-4075	100	14	majority	majority	NOUN
dpc-4075	100	15	(	(	PUNCT
dpc-4075	100	16	95	95	NUM
dpc-4075	100	17	%	%	NOUN
dpc-4075	100	18	)	)	PUNCT
dpc-4075	100	19	is	be	AUX
dpc-4075	100	20	covered	cover	VERB
dpc-4075	100	21	by	by	ADP
dpc-4075	100	22	the	the	DET
dpc-4075	100	23	patient	patient	NOUN
dpc-4075	100	24	.	.	PUNCT
dpc-4075	101	1	costs	cost	NOUN
dpc-4075	101	2	consist	consist	VERB
dpc-4075	101	3	of	of	ADP
dpc-4075	101	4	treatments	treatment	NOUN
dpc-4075	101	5	(	(	PUNCT
dpc-4075	101	6	35	35	NUM
dpc-4075	101	7	%	%	NOUN
dpc-4075	101	8	)	)	PUNCT
dpc-4075	101	9	and	and	CCONJ
dpc-4075	101	10	supplements	supplement	NOUN
dpc-4075	101	11	(	(	PUNCT
dpc-4075	101	12	38	38	NUM
dpc-4075	101	13	%	%	NOUN
dpc-4075	101	14	)	)	PUNCT
dpc-4075	101	15	,	,	PUNCT
dpc-4075	101	16	followed	follow	VERB
dpc-4075	101	17	by	by	ADP
dpc-4075	101	18	medical	medical	ADJ
dpc-4075	101	19	examinations	examination	NOUN
dpc-4075	101	20	(	(	PUNCT
dpc-4075	101	21	23	23	NUM
dpc-4075	101	22	%	%	NOUN
dpc-4075	101	23	)	)	PUNCT
dpc-4075	101	24	and	and	CCONJ
dpc-4075	101	25	lab	lab	NOUN
dpc-4075	101	26	tests	test	NOUN
dpc-4075	101	27	(	(	PUNCT
dpc-4075	101	28	4	4	NUM
dpc-4075	101	29	%	%	NOUN
dpc-4075	101	30	)	)	PUNCT
dpc-4075	101	31	.	.	PUNCT
dpc-4075	102	1	the	the	DET
dpc-4075	102	2	annual	annual	ADJ
dpc-4075	102	3	treatment	treatment	NOUN
dpc-4075	102	4	cost	cost	NOUN
dpc-4075	102	5	per	per	ADP
dpc-4075	102	6	patient	patient	NOUN
dpc-4075	102	7	ranges	range	NOUN
dpc-4075	102	8	from	from	ADP
dpc-4075	102	9	€	€	SYM
dpc-4075	102	10	208	208	NUM
dpc-4075	102	11	for	for	ADP
dpc-4075	102	12	not	not	PART
dpc-4075	102	13	severe	severe	ADJ
dpc-4075	102	14	cases	case	NOUN
dpc-4075	102	15	to	to	ADP
dpc-4075	102	16	€	€	SYM
dpc-4075	102	17	906	906	NUM
dpc-4075	102	18	for	for	ADP
dpc-4075	102	19	moderate	moderate	ADJ
dpc-4075	102	20	/	/	SYM
dpc-4075	102	21	severe	severe	ADJ
dpc-4075	102	22	adolescents	adolescent	NOUN
dpc-4075	102	23	.	.	PUNCT
dpc-4075	103	1	autoimmune	autoimmune	ADJ
dpc-4075	103	2	comorbidities	comorbiditie	NOUN
dpc-4075	103	3	in	in	ADP
dpc-4075	103	4	a	a	DET
dpc-4075	103	5	retrospective	retrospective	ADJ
dpc-4075	103	6	study	study	NOUN
dpc-4075	103	7	,	,	PUNCT
dpc-4075	103	8	15.3	15.3	NUM
dpc-4075	103	9	%	%	NOUN
dpc-4075	103	10	of	of	ADP
dpc-4075	103	11	patients	patient	NOUN
dpc-4075	103	12	with	with	ADP
dpc-4075	103	13	vitiligo	vitiligo	PROPN
dpc-4075	103	14	had	have	VERB
dpc-4075	103	15	one	one	NUM
dpc-4075	103	16	or	or	CCONJ
dpc-4075	103	17	more	more	ADV
dpc-4075	103	18	significant	significant	ADJ
dpc-4075	103	19	comorbid	comorbid	NOUN
dpc-4075	103	20	autoimmune	autoimmune	ADJ
dpc-4075	103	21	condition	condition	NOUN
dpc-4075	103	22	,	,	PUNCT
dpc-4075	103	23	4	4	NUM
dpc-4075	103	24	review	review	NOUN
dpc-4075	103	25	|	|	ADV
dpc-4075	103	26	dermatol	dermatol	ADJ
dpc-4075	103	27	pract	pract	NOUN
dpc-4075	103	28	concept	concept	NOUN
dpc-4075	103	29	.	.	PUNCT
dpc-4075	104	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	104	2	:	:	PUNCT
dpc-4075	104	3	e2023315s	e2023315s	PROPN
dpc-4075	104	4	table	table	NOUN
dpc-4075	104	5	1	1	NUM
dpc-4075	104	6	.	.	PUNCT
dpc-4075	104	7	summarization	summarization	NOUN
dpc-4075	104	8	of	of	ADP
dpc-4075	104	9	data	datum	NOUN
dpc-4075	104	10	from	from	ADP
dpc-4075	104	11	relevant	relevant	ADJ
dpc-4075	104	12	italian	italian	ADJ
dpc-4075	104	13	studies	study	NOUN
dpc-4075	104	14	.	.	PUNCT
dpc-4075	105	1	first	first	ADJ
dpc-4075	105	2	author	author	NOUN
dpc-4075	105	3	publication	publication	NOUN
dpc-4075	105	4	focus	focus	NOUN
dpc-4075	105	5	study	study	NOUN
dpc-4075	105	6	size	size	NOUN
dpc-4075	105	7	results	result	VERB
dpc-4075	105	8	naldi	naldi	ADV
dpc-4075	105	9	[	[	X
dpc-4075	105	10	29	29	NUM
dpc-4075	105	11	]	]	SYM
dpc-4075	105	12	2004	2004	NUM
dpc-4075	105	13	lifetime	lifetime	NOUN
dpc-4075	105	14	prevalence	prevalence	NOUN
dpc-4075	105	15	random	random	ADJ
dpc-4075	105	16	sample	sample	NOUN
dpc-4075	105	17	of	of	ADP
dpc-4075	105	18	12,483	12,483	NUM
dpc-4075	105	19	italian	italian	ADJ
dpc-4075	105	20	citizens	citizen	NOUN
dpc-4075	105	21	aged	age	VERB
dpc-4075	105	22	>	>	PUNCT
dpc-4075	105	23	45	45	NUM
dpc-4075	105	24	lifetime	lifetime	NOUN
dpc-4075	105	25	prevalence	prevalence	NOUN
dpc-4075	105	26	0.06	0.06	NUM
dpc-4075	105	27	%	%	NOUN
dpc-4075	105	28	with	with	ADP
dpc-4075	105	29	no	no	DET
dpc-4075	105	30	difference	difference	NOUN
dpc-4075	105	31	based	base	VERB
dpc-4075	105	32	on	on	ADP
dpc-4075	105	33	age	age	NOUN
dpc-4075	105	34	and	and	CCONJ
dpc-4075	105	35	sex	sex	NOUN
dpc-4075	105	36	ingordo	ingordo	NOUN
dpc-4075	106	1	[	[	X
dpc-4075	106	2	3	3	NUM
dpc-4075	106	3	]	]	SYM
dpc-4075	106	4	2007	2007	NUM
dpc-4075	106	5	point	point	NOUN
dpc-4075	106	6	prevalence	prevalence	NOUN
dpc-4075	106	7	23,468	23,468	NUM
dpc-4075	106	8	conscripts	conscript	NOUN
dpc-4075	106	9	in	in	ADP
dpc-4075	106	10	southern	southern	PROPN
dpc-4075	106	11	italy	italy	PROPN
dpc-4075	106	12	,	,	PUNCT
dpc-4075	106	13	aged	age	VERB
dpc-4075	106	14	18	18	NUM
dpc-4075	106	15	-	-	SYM
dpc-4075	106	16	21	21	NUM
dpc-4075	106	17	point	point	NOUN
dpc-4075	106	18	prevalence	prevalence	NOUN
dpc-4075	106	19	0.19	0.19	NUM
dpc-4075	106	20	%	%	NOUN
dpc-4075	106	21	sampogna	sampogna	NOUN
dpc-4075	107	1	[	[	X
dpc-4075	107	2	30	30	NUM
dpc-4075	107	3	]	]	SYM
dpc-4075	107	4	2008	2008	NUM
dpc-4075	107	5	quality	quality	NOUN
dpc-4075	107	6	of	of	ADP
dpc-4075	107	7	life	life	NOUN
dpc-4075	107	8	181	181	NUM
dpc-4075	107	9	consecutive	consecutive	ADJ
dpc-4075	107	10	vitiligo	vitiligo	NOUN
dpc-4075	107	11	patients	patient	NOUN
dpc-4075	107	12	at	at	ADP
dpc-4075	107	13	a	a	DET
dpc-4075	107	14	roman	roman	ADJ
dpc-4075	107	15	institution	institution	NOUN
dpc-4075	107	16	,	,	PUNCT
dpc-4075	107	17	using	use	VERB
dpc-4075	107	18	skindex-29	skindex-29	PROPN
dpc-4075	107	19	tool	tool	NOUN
dpc-4075	107	20	,	,	PUNCT
dpc-4075	107	21	12	12	NUM
dpc-4075	107	22	-	-	PUNCT
dpc-4075	107	23	item	item	NOUN
dpc-4075	107	24	general	general	ADJ
dpc-4075	107	25	health	health	NOUN
dpc-4075	107	26	questionnaire	questionnaire	NOUN
dpc-4075	107	27	problems	problem	NOUN
dpc-4075	107	28	frequently	frequently	ADV
dpc-4075	107	29	experienced	experience	VERB
dpc-4075	107	30	:	:	PUNCT
dpc-4075	107	31	worry	worry	NOUN
dpc-4075	107	32	of	of	ADP
dpc-4075	107	33	getting	get	VERB
dpc-4075	107	34	worse	bad	ADJ
dpc-4075	107	35	(	(	PUNCT
dpc-4075	107	36	60	60	NUM
dpc-4075	107	37	%	%	NOUN
dpc-4075	107	38	)	)	PUNCT
dpc-4075	107	39	,	,	PUNCT
dpc-4075	107	40	anger	anger	NOUN
dpc-4075	107	41	(	(	PUNCT
dpc-4075	107	42	37	37	NUM
dpc-4075	107	43	%	%	NOUN
dpc-4075	107	44	)	)	PUNCT
dpc-4075	107	45	,	,	PUNCT
dpc-4075	107	46	embarrassment	embarrassment	NOUN
dpc-4075	107	47	(	(	PUNCT
dpc-4075	107	48	34	34	NUM
dpc-4075	107	49	%	%	NOUN
dpc-4075	107	50	)	)	PUNCT
dpc-4075	107	51	,	,	PUNCT
dpc-4075	107	52	depression	depression	NOUN
dpc-4075	107	53	(	(	PUNCT
dpc-4075	107	54	31	31	NUM
dpc-4075	107	55	%	%	NOUN
dpc-4075	107	56	)	)	PUNCT
dpc-4075	107	57	.	.	PUNCT
dpc-4075	108	1	the	the	DET
dpc-4075	108	2	prevalence	prevalence	NOUN
dpc-4075	108	3	of	of	ADP
dpc-4075	108	4	patients	patient	NOUN
dpc-4075	108	5	with	with	ADP
dpc-4075	108	6	probable	probable	ADJ
dpc-4075	108	7	depression	depression	NOUN
dpc-4075	108	8	or	or	CCONJ
dpc-4075	108	9	anxiety	anxiety	NOUN
dpc-4075	108	10	was	be	AUX
dpc-4075	108	11	39	39	NUM
dpc-4075	108	12	%	%	NOUN
dpc-4075	108	13	naldi	naldi	ADV
dpc-4075	108	14	[	[	X
dpc-4075	108	15	31	31	NUM
dpc-4075	108	16	]	]	SYM
dpc-4075	108	17	2009	2009	NUM
dpc-4075	108	18	risk	risk	NOUN
dpc-4075	108	19	factors	factor	NOUN
dpc-4075	108	20	and	and	CCONJ
dpc-4075	108	21	diseases	disease	NOUN
dpc-4075	108	22	associated	associate	VERB
dpc-4075	108	23	with	with	ADP
dpc-4075	108	24	atopic	atopic	NOUN
dpc-4075	108	25	dermatitis	dermatitis	NOUN
dpc-4075	108	26	3,179	3,179	NUM
dpc-4075	108	27	schoolchildren	schoolchildren	NOUN
dpc-4075	108	28	aged	age	VERB
dpc-4075	108	29	12	12	NUM
dpc-4075	108	30	-	-	SYM
dpc-4075	108	31	17	17	NUM
dpc-4075	108	32	years	year	NOUN
dpc-4075	108	33	lifetime	lifetime	NOUN
dpc-4075	108	34	prevalence	prevalence	NOUN
dpc-4075	108	35	of	of	ADP
dpc-4075	108	36	vitiligo	vitiligo	ADJ
dpc-4075	108	37	0.6	0.6	NUM
dpc-4075	108	38	%	%	NOUN
dpc-4075	108	39	ingordo	ingordo	NOUN
dpc-4075	109	1	[	[	X
dpc-4075	109	2	32	32	NUM
dpc-4075	109	3	]	]	SYM
dpc-4075	109	4	2011	2011	NUM
dpc-4075	109	5	autoimmunity	autoimmunity	NOUN
dpc-4075	109	6	in	in	ADP
dpc-4075	109	7	vitiligo	vitiligo	PROPN
dpc-4075	109	8	40	40	NUM
dpc-4075	109	9	conscripts	conscript	NOUN
dpc-4075	109	10	with	with	ADP
dpc-4075	109	11	vitiligo	vitiligo	NOUN
dpc-4075	109	12	systematically	systematically	ADV
dpc-4075	109	13	assessed	assess	VERB
dpc-4075	109	14	for	for	ADP
dpc-4075	109	15	autoantibodies	autoantibody	NOUN
dpc-4075	109	16	and	and	CCONJ
dpc-4075	109	17	history	history	NOUN
dpc-4075	109	18	of	of	ADP
dpc-4075	109	19	immune	immune	NOUN
dpc-4075	109	20	-	-	PUNCT
dpc-4075	109	21	related	relate	VERB
dpc-4075	109	22	disease	disease	NOUN
dpc-4075	109	23	circulating	circulate	VERB
dpc-4075	109	24	autoantibodies	autoantibody	NOUN
dpc-4075	109	25	detected	detect	VERB
dpc-4075	109	26	in	in	ADP
dpc-4075	109	27	42.5	42.5	NUM
dpc-4075	109	28	%	%	NOUN
dpc-4075	109	29	of	of	ADP
dpc-4075	109	30	subjects	subject	NOUN
dpc-4075	109	31	ingordo	ingordo	NOUN
dpc-4075	110	1	[	[	X
dpc-4075	110	2	33	33	NUM
dpc-4075	110	3	]	]	SYM
dpc-4075	110	4	2012	2012	NUM
dpc-4075	110	5	quality	quality	NOUN
dpc-4075	110	6	of	of	ADP
dpc-4075	110	7	life	life	NOUN
dpc-4075	110	8	40	40	NUM
dpc-4075	110	9	conscripts	conscript	NOUN
dpc-4075	110	10	with	with	ADP
dpc-4075	110	11	vitiligo	vitiligo	NOUN
dpc-4075	110	12	assessed	assess	VERB
dpc-4075	110	13	through	through	ADP
dpc-4075	110	14	dlqi	dlqi	ADJ
dpc-4075	110	15	mean	mean	PROPN
dpc-4075	110	16	total	total	ADJ
dpc-4075	110	17	dlqi	dlqi	ADJ
dpc-4075	110	18	score	score	NOUN
dpc-4075	110	19	1.82	1.82	NUM
dpc-4075	110	20	(	(	PUNCT
dpc-4075	110	21	sd±	sd±	ADP
dpc-4075	110	22	2.95	2.95	NUM
dpc-4075	110	23	;	;	PUNCT
dpc-4075	110	24	min	min	PROPN
dpc-4075	110	25	/	/	SYM
dpc-4075	110	26	max	max	PROPN
dpc-4075	110	27	:	:	PUNCT
dpc-4075	110	28	0	0	NUM
dpc-4075	110	29	-	-	SYM
dpc-4075	110	30	13	13	NUM
dpc-4075	110	31	)	)	PUNCT
dpc-4075	110	32	.	.	PUNCT
dpc-4075	111	1	the	the	DET
dpc-4075	111	2	localization	localization	NOUN
dpc-4075	111	3	on	on	ADP
dpc-4075	111	4	the	the	DET
dpc-4075	111	5	hands	hand	NOUN
dpc-4075	111	6	(	(	PUNCT
dpc-4075	111	7	or:6.32	or:6.32	NUM
dpc-4075	111	8	)	)	PUNCT
dpc-4075	111	9	and	and	CCONJ
dpc-4075	111	10	on	on	ADP
dpc-4075	111	11	the	the	DET
dpc-4075	111	12	face	face	NOUN
dpc-4075	111	13	(	(	PUNCT
dpc-4075	111	14	or:5.03	or:5.03	NOUN
dpc-4075	111	15	)	)	PUNCT
dpc-4075	111	16	influenced	influence	VERB
dpc-4075	111	17	significantly	significantly	ADV
dpc-4075	111	18	the	the	DET
dpc-4075	111	19	mean	mean	ADJ
dpc-4075	111	20	dlqi	dlqi	ADJ
dpc-4075	111	21	ingordo	ingordo	NOUN
dpc-4075	112	1	[	[	X
dpc-4075	112	2	34	34	NUM
dpc-4075	112	3	]	]	SYM
dpc-4075	112	4	2014	2014	NUM
dpc-4075	112	5	quality	quality	NOUN
dpc-4075	112	6	of	of	ADP
dpc-4075	112	7	life	life	NOUN
dpc-4075	112	8	161	161	NUM
dpc-4075	112	9	vitiligo	vitiligo	NOUN
dpc-4075	112	10	patients	patient	NOUN
dpc-4075	112	11	referred	refer	VERB
dpc-4075	112	12	to	to	ADP
dpc-4075	112	13	dermatological	dermatological	ADJ
dpc-4075	112	14	departments	department	NOUN
dpc-4075	112	15	in	in	ADP
dpc-4075	112	16	italy	italy	PROPN
dpc-4075	112	17	assessed	assess	VERB
dpc-4075	112	18	by	by	ADP
dpc-4075	112	19	dlqi	dlqi	PROPN
dpc-4075	112	20	dlqi	dlqi	PROPN
dpc-4075	112	21	score	score	VERB
dpc-4075	112	22	4.3	4.3	NUM
dpc-4075	112	23	(	(	PUNCT
dpc-4075	112	24	sd	sd	ADP
dpc-4075	112	25	±4.9	±4.9	PROPN
dpc-4075	112	26	;	;	PUNCT
dpc-4075	112	27	range	range	NOUN
dpc-4075	112	28	:	:	PUNCT
dpc-4075	112	29	0	0	NUM
dpc-4075	112	30	-	-	SYM
dpc-4075	112	31	22	22	NUM
dpc-4075	112	32	)	)	PUNCT
dpc-4075	112	33	.	.	PUNCT
dpc-4075	113	1	in	in	ADP
dpc-4075	113	2	multivariate	multivariate	NOUN
dpc-4075	113	3	analysis	analysis	NOUN
dpc-4075	113	4	,	,	PUNCT
dpc-4075	113	5	dlqi	dlqi	VERB
dpc-4075	113	6	>	>	SYM
dpc-4075	113	7	5	5	NUM
dpc-4075	113	8	was	be	AUX
dpc-4075	113	9	associated	associate	VERB
dpc-4075	113	10	with	with	ADP
dpc-4075	113	11	female	female	ADJ
dpc-4075	113	12	gender	gender	NOUN
dpc-4075	113	13	,	,	PUNCT
dpc-4075	113	14	stability	stability	NOUN
dpc-4075	113	15	of	of	ADP
dpc-4075	113	16	the	the	DET
dpc-4075	113	17	disease	disease	NOUN
dpc-4075	113	18	over	over	ADP
dpc-4075	113	19	time	time	NOUN
dpc-4075	113	20	and	and	CCONJ
dpc-4075	113	21	involvement	involvement	NOUN
dpc-4075	113	22	of	of	ADP
dpc-4075	113	23	the	the	DET
dpc-4075	113	24	face	face	NOUN
dpc-4075	113	25	at	at	ADP
dpc-4075	113	26	disease	disease	NOUN
dpc-4075	113	27	onset	onset	VERB
dpc-4075	113	28	svensson	svensson	PROPN
dpc-4075	114	1	[	[	X
dpc-4075	114	2	35	35	NUM
dpc-4075	114	3	]	]	SYM
dpc-4075	114	4	2018	2018	NUM
dpc-4075	114	5	lifetime	lifetime	NOUN
dpc-4075	114	6	prevalence	prevalence	NOUN
dpc-4075	114	7	of	of	ADP
dpc-4075	114	8	vitiligo	vitiligo	NOUN
dpc-4075	114	9	in	in	ADP
dpc-4075	114	10	a	a	DET
dpc-4075	114	11	survey	survey	NOUN
dpc-4075	114	12	on	on	ADP
dpc-4075	114	13	contact	contact	NOUN
dpc-4075	114	14	dermatitis	dermatitis	NOUN
dpc-4075	114	15	random	random	ADJ
dpc-4075	114	16	sample	sample	NOUN
dpc-4075	114	17	of	of	ADP
dpc-4075	114	18	2,035	2,035	NUM
dpc-4075	114	19	people	people	NOUN
dpc-4075	114	20	aged	age	VERB
dpc-4075	114	21	>	>	X
dpc-4075	114	22	18	18	NUM
dpc-4075	114	23	in	in	ADP
dpc-4075	114	24	bergamo	bergamo	NOUN
dpc-4075	114	25	lifetime	lifetime	NOUN
dpc-4075	114	26	prevalence	prevalence	NOUN
dpc-4075	114	27	of	of	ADP
dpc-4075	114	28	vitiligo	vitiligo	NOUN
dpc-4075	114	29	0.4	0.4	NUM
dpc-4075	114	30	%	%	NOUN
dpc-4075	114	31	with	with	ADP
dpc-4075	114	32	no	no	DET
dpc-4075	114	33	significant	significant	ADJ
dpc-4075	114	34	difference	difference	NOUN
dpc-4075	114	35	according	accord	VERB
dpc-4075	114	36	to	to	ADP
dpc-4075	114	37	gender	gender	NOUN
dpc-4075	114	38	figure	figure	NOUN
dpc-4075	114	39	1	1	NUM
dpc-4075	114	40	.	.	PUNCT
dpc-4075	114	41	nsv	nsv	PROPN
dpc-4075	114	42	treatment	treatment	NOUN
dpc-4075	114	43	preference	preference	NOUN
dpc-4075	114	44	by	by	ADP
dpc-4075	114	45	patient	patient	ADJ
dpc-4075	114	46	class	class	NOUN
dpc-4075	114	47	(	(	PUNCT
dpc-4075	114	48	%	%	INTJ
dpc-4075	114	49	)	)	PUNCT
dpc-4075	114	50	review	review	NOUN
dpc-4075	114	51	|	|	ADV
dpc-4075	114	52	dermatol	dermatol	ADJ
dpc-4075	114	53	pract	pract	NOUN
dpc-4075	114	54	concept	concept	NOUN
dpc-4075	114	55	.	.	PUNCT
dpc-4075	115	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	115	2	:	:	PUNCT
dpc-4075	115	3	e2023315s	e2023315s	PROPN
dpc-4075	115	4	5	5	NUM
dpc-4075	115	5	major	major	ADJ
dpc-4075	115	6	depressive	depressive	ADJ
dpc-4075	115	7	disorder	disorder	NOUN
dpc-4075	115	8	(	(	PUNCT
dpc-4075	115	9	mdd	mdd	PROPN
dpc-4075	115	10	)	)	PUNCT
dpc-4075	115	11	and	and	CCONJ
dpc-4075	115	12	anxiety	anxiety	NOUN
dpc-4075	115	13	(	(	PUNCT
dpc-4075	115	14	referred	refer	VERB
dpc-4075	115	15	to	to	ADP
dpc-4075	115	16	as	as	ADP
dpc-4075	115	17	generalized	generalized	ADJ
dpc-4075	115	18	anxiety	anxiety	NOUN
dpc-4075	115	19	disorder	disorder	NOUN
dpc-4075	115	20	,	,	PUNCT
dpc-4075	115	21	social	social	ADJ
dpc-4075	115	22	phobia	phobia	NOUN
dpc-4075	115	23	,	,	PUNCT
dpc-4075	115	24	specific	specific	ADJ
dpc-4075	115	25	phobia	phobia	NOUN
dpc-4075	115	26	,	,	PUNCT
dpc-4075	115	27	post	post	ADJ
dpc-4075	115	28	-	-	ADJ
dpc-4075	115	29	traumatic	traumatic	ADJ
dpc-4075	115	30	stress	stress	NOUN
dpc-4075	115	31	disorder	disorder	NOUN
dpc-4075	115	32	,	,	PUNCT
dpc-4075	115	33	agoraphobia	agoraphobia	PROPN
dpc-4075	115	34	,	,	PUNCT
dpc-4075	115	35	agoraphobia	agoraphobia	PROPN
dpc-4075	115	36	with	with	ADP
dpc-4075	115	37	panic	panic	NOUN
dpc-4075	115	38	disorder	disorder	NOUN
dpc-4075	115	39	and	and	CCONJ
dpc-4075	115	40	panic	panic	NOUN
dpc-4075	115	41	disorder	disorder	NOUN
dpc-4075	115	42	)	)	PUNCT
dpc-4075	115	43	were	be	AUX
dpc-4075	115	44	the	the	DET
dpc-4075	115	45	most	most	ADV
dpc-4075	115	46	reported	report	VERB
dpc-4075	115	47	.	.	PUNCT
dpc-4075	116	1	moreover	moreover	ADV
dpc-4075	116	2	,	,	PUNCT
dpc-4075	116	3	patients	patient	NOUN
dpc-4075	116	4	with	with	ADP
dpc-4075	116	5	vitiligo	vitiligo	NOUN
dpc-4075	116	6	recur	recur	NOUN
dpc-4075	116	7	to	to	ADP
dpc-4075	116	8	psychotherapy	psychotherapy	NOUN
dpc-4075	116	9	more	more	ADV
dpc-4075	116	10	often	often	ADV
dpc-4075	116	11	than	than	ADP
dpc-4075	116	12	the	the	DET
dpc-4075	116	13	general	general	ADJ
dpc-4075	116	14	population	population	NOUN
dpc-4075	116	15	.	.	PUNCT
dpc-4075	117	1	we	we	PRON
dpc-4075	117	2	argue	argue	VERB
dpc-4075	117	3	that	that	SCONJ
dpc-4075	117	4	the	the	DET
dpc-4075	117	5	cost	cost	NOUN
dpc-4075	117	6	of	of	ADP
dpc-4075	117	7	mental	mental	ADJ
dpc-4075	117	8	health	health	NOUN
dpc-4075	117	9	issues	issue	NOUN
dpc-4075	117	10	can	can	AUX
dpc-4075	117	11	be	be	AUX
dpc-4075	117	12	part	part	NOUN
dpc-4075	117	13	of	of	ADP
dpc-4075	117	14	the	the	DET
dpc-4075	117	15	overall	overall	ADJ
dpc-4075	117	16	cost	cost	NOUN
dpc-4075	117	17	of	of	ADP
dpc-4075	117	18	vitiligo	vitiligo	NOUN
dpc-4075	117	19	.	.	PUNCT
dpc-4075	118	1	this	this	PRON
dpc-4075	118	2	is	be	AUX
dpc-4075	118	3	because	because	SCONJ
dpc-4075	118	4	the	the	DET
dpc-4075	118	5	increased	increase	VERB
dpc-4075	118	6	psychological	psychological	ADJ
dpc-4075	118	7	distress	distress	NOUN
dpc-4075	118	8	in	in	ADP
dpc-4075	118	9	this	this	DET
dpc-4075	118	10	group	group	NOUN
dpc-4075	118	11	mostly	mostly	ADV
dpc-4075	118	12	arises	arise	VERB
dpc-4075	118	13	from	from	ADP
dpc-4075	118	14	the	the	DET
dpc-4075	118	15	difficulties	difficulty	NOUN
dpc-4075	118	16	caused	cause	VERB
dpc-4075	118	17	by	by	ADP
dpc-4075	118	18	the	the	DET
dpc-4075	118	19	disease	disease	NOUN
dpc-4075	118	20	itself	itself	PRON
dpc-4075	118	21	.	.	PUNCT
dpc-4075	119	1	therefore	therefore	ADV
dpc-4075	119	2	,	,	PUNCT
dpc-4075	119	3	we	we	PRON
dpc-4075	119	4	collected	collect	VERB
dpc-4075	119	5	literature	literature	NOUN
dpc-4075	119	6	evidence	evidence	NOUN
dpc-4075	119	7	for	for	ADP
dpc-4075	119	8	direct	direct	ADJ
dpc-4075	119	9	costs	cost	NOUN
dpc-4075	119	10	of	of	ADP
dpc-4075	119	11	depression	depression	NOUN
dpc-4075	119	12	(	(	PUNCT
dpc-4075	119	13	i.e.	i.e.	X
dpc-4075	119	14	,	,	PUNCT
dpc-4075	119	15	costs	cost	NOUN
dpc-4075	119	16	for	for	ADP
dpc-4075	119	17	residential	residential	ADJ
dpc-4075	119	18	structures	structure	NOUN
dpc-4075	119	19	,	,	PUNCT
dpc-4075	119	20	psychiatry	psychiatry	NOUN
dpc-4075	119	21	-	-	PUNCT
dpc-4075	119	22	related	relate	VERB
dpc-4075	119	23	tests	test	NOUN
dpc-4075	119	24	,	,	PUNCT
dpc-4075	119	25	hospitalizations	hospitalization	NOUN
dpc-4075	119	26	,	,	PUNCT
dpc-4075	119	27	antidepressants	antidepressant	VERB
dpc-4075	119	28	[	[	X
dpc-4075	119	29	55	55	NUM
dpc-4075	119	30	,	,	PUNCT
dpc-4075	119	31	56	56	NUM
dpc-4075	119	32	]	]	NUM
dpc-4075	119	33	)	)	PUNCT
dpc-4075	119	34	,	,	PUNCT
dpc-4075	119	35	costs	cost	VERB
dpc-4075	119	36	for	for	ADP
dpc-4075	119	37	anxiety	anxiety	NOUN
dpc-4075	119	38	with	with	ADP
dpc-4075	119	39	hypothyroidism	hypothyroidism	NOUN
dpc-4075	119	40	and	and	CCONJ
dpc-4075	119	41	rheumatoid	rheumatoid	VERB
dpc-4075	119	42	arthritis	arthritis	NOUN
dpc-4075	119	43	being	be	AUX
dpc-4075	119	44	the	the	DET
dpc-4075	119	45	most	most	ADV
dpc-4075	119	46	common	common	ADJ
dpc-4075	119	47	[	[	X
dpc-4075	119	48	17	17	NUM
dpc-4075	119	49	]	]	PUNCT
dpc-4075	119	50	.	.	PUNCT
dpc-4075	120	1	vitiligo	vitiligo	PROPN
dpc-4075	120	2	patients	patient	NOUN
dpc-4075	120	3	incur	incur	VERB
dpc-4075	120	4	direct	direct	ADJ
dpc-4075	120	5	and	and	CCONJ
dpc-4075	120	6	indirect	indirect	ADJ
dpc-4075	120	7	costs	cost	NOUN
dpc-4075	120	8	due	due	ADJ
dpc-4075	120	9	to	to	ADP
dpc-4075	120	10	autoimmune	autoimmune	ADJ
dpc-4075	120	11	comorbidities	comorbiditie	NOUN
dpc-4075	121	1	[	[	X
dpc-4075	121	2	42	42	NUM
dpc-4075	121	3	-	-	SYM
dpc-4075	121	4	53	53	NUM
dpc-4075	121	5	]	]	PUNCT
dpc-4075	121	6	.	.	PUNCT
dpc-4075	122	1	direct	direct	ADJ
dpc-4075	122	2	costs	cost	NOUN
dpc-4075	122	3	include	include	VERB
dpc-4075	122	4	healthcare	healthcare	NOUN
dpc-4075	122	5	and	and	CCONJ
dpc-4075	122	6	non	non	ADJ
dpc-4075	122	7	-	-	ADJ
dpc-4075	122	8	healthcare	healthcare	ADJ
dpc-4075	122	9	costs	cost	NOUN
dpc-4075	122	10	(	(	PUNCT
dpc-4075	122	11	e.g.	e.g.	ADV
dpc-4075	122	12	,	,	PUNCT
dpc-4075	122	13	inpatient	inpatient	NOUN
dpc-4075	122	14	care	care	NOUN
dpc-4075	122	15	,	,	PUNCT
dpc-4075	122	16	drug	drug	NOUN
dpc-4075	122	17	costs	cost	NOUN
dpc-4075	122	18	,	,	PUNCT
dpc-4075	122	19	tests	test	NOUN
dpc-4075	122	20	,	,	PUNCT
dpc-4075	122	21	transportation	transportation	NOUN
dpc-4075	122	22	)	)	PUNCT
dpc-4075	122	23	.	.	PUNCT
dpc-4075	123	1	indirect	indirect	ADJ
dpc-4075	123	2	costs	cost	NOUN
dpc-4075	123	3	include	include	VERB
dpc-4075	123	4	productivity	productivity	NOUN
dpc-4075	123	5	losses	loss	NOUN
dpc-4075	123	6	due	due	ADJ
dpc-4075	123	7	to	to	ADP
dpc-4075	123	8	morbidity	morbidity	NOUN
dpc-4075	123	9	/	/	SYM
dpc-4075	123	10	mortality	mortality	NOUN
dpc-4075	123	11	,	,	PUNCT
dpc-4075	123	12	borne	bear	VERB
dpc-4075	123	13	by	by	ADP
dpc-4075	123	14	the	the	DET
dpc-4075	123	15	individual	individual	ADJ
dpc-4075	123	16	,	,	PUNCT
dpc-4075	123	17	family	family	NOUN
dpc-4075	123	18	,	,	PUNCT
dpc-4075	123	19	society	society	NOUN
dpc-4075	123	20	,	,	PUNCT
dpc-4075	123	21	or	or	CCONJ
dpc-4075	123	22	the	the	DET
dpc-4075	123	23	employer	employer	NOUN
dpc-4075	123	24	(	(	PUNCT
dpc-4075	123	25	e.g.	e.g.	ADJ
dpc-4075	123	26	,	,	PUNCT
dpc-4075	123	27	sick	sick	ADJ
dpc-4075	123	28	leave	leave	VERB
dpc-4075	123	29	,	,	PUNCT
dpc-4075	123	30	early	early	ADJ
dpc-4075	123	31	retirement	retirement	NOUN
dpc-4075	123	32	)	)	PUNCT
dpc-4075	123	33	.	.	PUNCT
dpc-4075	124	1	indirect	indirect	ADJ
dpc-4075	124	2	costs	cost	NOUN
dpc-4075	124	3	were	be	AUX
dpc-4075	124	4	assessed	assess	VERB
dpc-4075	124	5	by	by	ADP
dpc-4075	124	6	the	the	DET
dpc-4075	124	7	human	human	ADJ
dpc-4075	124	8	capital	capital	NOUN
dpc-4075	124	9	approach	approach	NOUN
dpc-4075	124	10	(	(	PUNCT
dpc-4075	124	11	hca	hca	NOUN
dpc-4075	124	12	)	)	PUNCT
dpc-4075	124	13	and	and	CCONJ
dpc-4075	124	14	the	the	DET
dpc-4075	124	15	friction	friction	NOUN
dpc-4075	124	16	cost	cost	NOUN
dpc-4075	124	17	approach	approach	NOUN
dpc-4075	124	18	(	(	PUNCT
dpc-4075	124	19	fca	fca	PROPN
dpc-4075	124	20	)	)	PUNCT
dpc-4075	124	21	.	.	PUNCT
dpc-4075	125	1	mental	mental	ADJ
dpc-4075	125	2	health	health	NOUN
dpc-4075	125	3	costs	cost	NOUN
dpc-4075	125	4	according	accord	VERB
dpc-4075	125	5	to	to	ADP
dpc-4075	125	6	a	a	DET
dpc-4075	125	7	systematic	systematic	ADJ
dpc-4075	125	8	review	review	NOUN
dpc-4075	125	9	on	on	ADP
dpc-4075	125	10	psychosocial	psychosocial	ADJ
dpc-4075	125	11	effects	effect	NOUN
dpc-4075	125	12	of	of	ADP
dpc-4075	125	13	vitiligo	vitiligo	NOUN
dpc-4075	126	1	[	[	X
dpc-4075	126	2	3,15,23,54,55	3,15,23,54,55	X
dpc-4075	126	3	]	]	X
dpc-4075	126	4	,	,	PUNCT
dpc-4075	126	5	disorders	disorder	NOUN
dpc-4075	126	6	including	include	VERB
dpc-4075	126	7	or	or	CCONJ
dpc-4075	126	8	related	relate	VERB
dpc-4075	126	9	to	to	ADP
dpc-4075	126	10	table	table	NOUN
dpc-4075	126	11	2	2	NUM
dpc-4075	126	12	.	.	PUNCT
dpc-4075	127	1	nsv	nsv	PROPN
dpc-4075	127	2	treatment	treatment	NOUN
dpc-4075	127	3	options	option	NOUN
dpc-4075	127	4	costs	cost	NOUN
dpc-4075	127	5	(	(	PUNCT
dpc-4075	127	6	€	€	NOUN
dpc-4075	127	7	,	,	PUNCT
dpc-4075	127	8	yearly	yearly	ADJ
dpc-4075	127	9	)	)	PUNCT
dpc-4075	127	10	.	.	PUNCT
dpc-4075	128	1	overall	overall	ADJ
dpc-4075	128	2	cost	cost	NOUN
dpc-4075	128	3	of	of	ADP
dpc-4075	128	4	which	which	PRON
dpc-4075	128	5	on	on	ADP
dpc-4075	128	6	patient	patient	NOUN
dpc-4075	128	7	of	of	ADP
dpc-4075	128	8	which	which	PRON
dpc-4075	128	9	on	on	ADP
dpc-4075	128	10	nhs	nhs	PROPN
dpc-4075	128	11	induction	induction	NOUN
dpc-4075	128	12	therapy	therapy	NOUN
dpc-4075	128	13	cs	cs	PROPN
dpc-4075	128	14	systemic	systemic	PROPN
dpc-4075	128	15	(	(	PUNCT
dpc-4075	128	16	±	±	NUM
dpc-4075	128	17	tcs	tcs	NOUN
dpc-4075	128	18	)	)	PUNCT
dpc-4075	128	19	351	351	NUM
dpc-4075	128	20	192	192	NUM
dpc-4075	128	21	159	159	NUM
dpc-4075	128	22	induction	induction	NOUN
dpc-4075	128	23	therapy	therapy	NOUN
dpc-4075	128	24	tcs	tcs	NOUN
dpc-4075	128	25	291	291	NUM
dpc-4075	128	26	192	192	NUM
dpc-4075	128	27	99	99	NUM
dpc-4075	128	28	induction	induction	NOUN
dpc-4075	128	29	therapy	therapy	NOUN
dpc-4075	128	30	tci	tci	VERB
dpc-4075	128	31	461	461	NUM
dpc-4075	128	32	236	236	NUM
dpc-4075	128	33	225	225	NUM
dpc-4075	128	34	maintenance	maintenance	NOUN
dpc-4075	128	35	therapy	therapy	NOUN
dpc-4075	128	36	tcs	tcs	NOUN
dpc-4075	128	37	(	(	PUNCT
dpc-4075	128	38	lower	low	ADJ
dpc-4075	128	39	dose	dose	NOUN
dpc-4075	128	40	)	)	PUNCT
dpc-4075	128	41	84	84	NUM
dpc-4075	128	42	55	55	NUM
dpc-4075	128	43	29	29	NUM
dpc-4075	128	44	maintenance	maintenance	NOUN
dpc-4075	128	45	therapy	therapy	NOUN
dpc-4075	128	46	tci	tci	NOUN
dpc-4075	128	47	(	(	PUNCT
dpc-4075	128	48	lower	low	ADJ
dpc-4075	128	49	dose	dose	NOUN
dpc-4075	128	50	)	)	PUNCT
dpc-4075	128	51	200	200	NUM
dpc-4075	128	52	102	102	NUM
dpc-4075	128	53	97	97	NUM
dpc-4075	128	54	uvb	uvb	ADJ
dpc-4075	128	55	phototherapy	phototherapy	NOUN
dpc-4075	128	56	(	(	PUNCT
dpc-4075	128	57	e.g.	e.g.	ADV
dpc-4075	128	58	,	,	PUNCT
dpc-4075	128	59	nb	nb	NOUN
dpc-4075	128	60	-	-	PUNCT
dpc-4075	128	61	uvb	uvb	ADJ
dpc-4075	128	62	,	,	PUNCT
dpc-4075	128	63	excimer	excimer	NOUN
dpc-4075	128	64	laser	laser	NOUN
dpc-4075	128	65	)	)	PUNCT
dpc-4075	128	66	4,077	4,077	NUM
dpc-4075	128	67	3,947	3,947	NUM
dpc-4075	128	68	130	130	NUM
dpc-4075	128	69	uvb	uvb	ADJ
dpc-4075	128	70	phototherapy	phototherapy	NOUN
dpc-4075	128	71	+	+	CCONJ
dpc-4075	128	72	tcs	tcs	NOUN
dpc-4075	128	73	or	or	CCONJ
dpc-4075	128	74	tci	tci	VERB
dpc-4075	128	75	4,198	4,198	NUM
dpc-4075	128	76	4,014	4,014	NUM
dpc-4075	128	77	184	184	NUM
dpc-4075	128	78	puva	puva	NOUN
dpc-4075	128	79	4,373	4,373	NUM
dpc-4075	128	80	4,247	4,247	NUM
dpc-4075	128	81	125	125	NUM
dpc-4075	128	82	candidate	candidate	NOUN
dpc-4075	128	83	for	for	ADP
dpc-4075	128	84	surgery	surgery	NOUN
dpc-4075	128	85	(	(	PUNCT
dpc-4075	128	86	scheduled	schedule	VERB
dpc-4075	128	87	/	/	SYM
dpc-4075	128	88	operated	operate	VERB
dpc-4075	128	89	)	)	PUNCT
dpc-4075	128	90	2,488	2,488	NUM
dpc-4075	128	91	33	33	NUM
dpc-4075	128	92	2,454	2,454	NUM
dpc-4075	128	93	depigmentation	depigmentation	NOUN
dpc-4075	128	94	800	800	NUM
dpc-4075	128	95	800	800	NUM
dpc-4075	128	96	table	table	NOUN
dpc-4075	128	97	3	3	NUM
dpc-4075	128	98	.	.	PUNCT
dpc-4075	128	99	disease	disease	NOUN
dpc-4075	128	100	costs	cost	NOUN
dpc-4075	128	101	for	for	ADP
dpc-4075	128	102	selected	select	VERB
dpc-4075	128	103	autoimmune	autoimmune	ADJ
dpc-4075	128	104	diseases	disease	NOUN
dpc-4075	128	105	(	(	PUNCT
dpc-4075	128	106	€	€	NOUN
dpc-4075	128	107	,	,	PUNCT
dpc-4075	128	108	yearly	yearly	ADJ
dpc-4075	128	109	)	)	PUNCT
dpc-4075	128	110	.	.	PUNCT
dpc-4075	129	1	overall	overall	ADJ
dpc-4075	129	2	cost	cost	NOUN
dpc-4075	129	3	of	of	ADP
dpc-4075	129	4	which	which	PRON
dpc-4075	129	5	direct	direct	ADJ
dpc-4075	129	6	cost	cost	NOUN
dpc-4075	129	7	of	of	ADP
dpc-4075	129	8	which	which	PRON
dpc-4075	129	9	indirect	indirect	ADJ
dpc-4075	129	10	cost	cost	NOUN
dpc-4075	129	11	hypothyroidism	hypothyroidism	NOUN
dpc-4075	129	12	953	953	NUM
dpc-4075	129	13	250	250	NUM
dpc-4075	129	14	702	702	NUM
dpc-4075	129	15	rheumatoid	rheumatoid	NOUN
dpc-4075	129	16	arthritis	arthritis	NOUN
dpc-4075	129	17	12,341	12,341	NUM
dpc-4075	129	18	5,891	5,891	NUM
dpc-4075	129	19	6,450	6,450	NUM
dpc-4075	129	20	inflammatory	inflammatory	ADJ
dpc-4075	129	21	bowel	bowel	NOUN
dpc-4075	129	22	disease	disease	NOUN
dpc-4075	129	23	3,032	3,032	NUM
dpc-4075	129	24	2,817	2,817	NUM
dpc-4075	129	25	215	215	NUM
dpc-4075	129	26	lymphoma	lymphoma	NOUN
dpc-4075	129	27	52,992	52,992	NUM
dpc-4075	129	28	47,004	47,004	NUM
dpc-4075	129	29	5,988	5,988	NUM
dpc-4075	129	30	systemic	systemic	ADJ
dpc-4075	129	31	lupus	lupus	NOUN
dpc-4075	129	32	erythematosus	erythematosus	NOUN
dpc-4075	129	33	18,574	18,574	NUM
dpc-4075	129	34	2,637	2,637	NUM
dpc-4075	129	35	15,937	15,937	NUM
dpc-4075	129	36	seronegative	seronegative	ADJ
dpc-4075	129	37	arthritis	arthritis	NOUN
dpc-4075	129	38	12,341	12,341	NUM
dpc-4075	129	39	5,891	5,891	NUM
dpc-4075	129	40	6,450	6,450	NUM
dpc-4075	129	41	idiopathic	idiopathic	ADJ
dpc-4075	129	42	thrombocytopenic	thrombocytopenic	ADJ
dpc-4075	129	43	purpura	purpura	NOUN
dpc-4075	129	44	8,417	8,417	NUM
dpc-4075	129	45	7,294	7,294	NUM
dpc-4075	129	46	1,123	1,123	NUM
dpc-4075	129	47	multiple	multiple	ADJ
dpc-4075	129	48	sclerosis	sclerosis	NOUN
dpc-4075	129	49	38,000	38,000	NUM
dpc-4075	129	50	17,351	17,351	NUM
dpc-4075	129	51	20,649	20,649	NUM
dpc-4075	129	52	pernicious	pernicious	ADJ
dpc-4075	129	53	anemia	anemia	NOUN
dpc-4075	129	54	393	393	NUM
dpc-4075	129	55	103	103	NUM
dpc-4075	129	56	289	289	NUM
dpc-4075	129	57	myasthenia	myasthenia	NOUN
dpc-4075	129	58	gravis	gravis	NOUN
dpc-4075	129	59	14,950	14,950	NUM
dpc-4075	129	60	12,160	12,160	NUM
dpc-4075	129	61	2,790	2,790	NUM
dpc-4075	129	62	table	table	NOUN
dpc-4075	129	63	4	4	NUM
dpc-4075	129	64	.	.	PUNCT
dpc-4075	130	1	direct	direct	ADJ
dpc-4075	130	2	costs	cost	NOUN
dpc-4075	130	3	associated	associate	VERB
dpc-4075	130	4	to	to	ADP
dpc-4075	130	5	mental	mental	ADJ
dpc-4075	130	6	health	health	NOUN
dpc-4075	130	7	.	.	PUNCT
dpc-4075	131	1	overall	overall	ADJ
dpc-4075	131	2	cost	cost	NOUN
dpc-4075	131	3	of	of	ADP
dpc-4075	131	4	which	which	PRON
dpc-4075	131	5	on	on	ADP
dpc-4075	131	6	patient	patient	NOUN
dpc-4075	131	7	of	of	ADP
dpc-4075	131	8	which	which	PRON
dpc-4075	131	9	on	on	ADP
dpc-4075	131	10	nhs	nhs	PROPN
dpc-4075	131	11	depression	depression	NOUN
dpc-4075	131	12	treatment	treatment	NOUN
dpc-4075	131	13	2,879	2,879	NUM
dpc-4075	131	14	374	374	NUM
dpc-4075	131	15	2,504	2,504	NUM
dpc-4075	131	16	overall	overall	ADJ
dpc-4075	131	17	cost	cost	NOUN
dpc-4075	131	18	of	of	ADP
dpc-4075	131	19	which	which	PRON
dpc-4075	131	20	on	on	ADP
dpc-4075	131	21	patient	patient	NOUN
dpc-4075	131	22	of	of	ADP
dpc-4075	131	23	which	which	PRON
dpc-4075	131	24	on	on	ADP
dpc-4075	131	25	nhs	nhs	PROPN
dpc-4075	131	26	anxiety	anxiety	NOUN
dpc-4075	131	27	treatment	treatment	NOUN
dpc-4075	131	28	2,431	2,431	NUM
dpc-4075	131	29	615	615	NUM
dpc-4075	131	30	1,816	1,816	NUM
dpc-4075	131	31	overall	overall	ADJ
dpc-4075	131	32	cost	cost	NOUN
dpc-4075	131	33	of	of	ADP
dpc-4075	131	34	which	which	PRON
dpc-4075	131	35	on	on	ADP
dpc-4075	131	36	patient	patient	NOUN
dpc-4075	131	37	of	of	ADP
dpc-4075	131	38	which	which	PRON
dpc-4075	131	39	on	on	ADP
dpc-4075	131	40	nhs	nhs	NOUN
dpc-4075	131	41	psychotherapy	psychotherapy	NOUN
dpc-4075	131	42	session	session	NOUN
dpc-4075	131	43	76	76	NUM
dpc-4075	131	44	76	76	NUM
dpc-4075	131	45	~0	~0	NUM
dpc-4075	131	46	6	6	NUM
dpc-4075	131	47	review	review	NOUN
dpc-4075	131	48	|	|	ADV
dpc-4075	131	49	dermatol	dermatol	ADJ
dpc-4075	131	50	pract	pract	NOUN
dpc-4075	131	51	concept	concept	NOUN
dpc-4075	131	52	.	.	PUNCT
dpc-4075	132	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	132	2	:	:	PUNCT
dpc-4075	132	3	e2023315s	e2023315s	PROPN
dpc-4075	132	4	value	value	NOUN
dpc-4075	132	5	of	of	ADP
dpc-4075	132	6	the	the	DET
dpc-4075	132	7	hc	hc	NOUN
dpc-4075	132	8	is	be	AUX
dpc-4075	132	9	approximated	approximate	VERB
dpc-4075	132	10	by	by	ADP
dpc-4075	132	11	the	the	DET
dpc-4075	132	12	value	value	NOUN
dpc-4075	132	13	of	of	ADP
dpc-4075	132	14	an	an	DET
dpc-4075	132	15	individual	individual	NOUN
dpc-4075	132	16	’s	’s	PART
dpc-4075	132	17	earning	earning	NOUN
dpc-4075	132	18	,	,	PUNCT
dpc-4075	132	19	so	so	SCONJ
dpc-4075	132	20	that	that	SCONJ
dpc-4075	132	21	the	the	DET
dpc-4075	132	22	period	period	NOUN
dpc-4075	132	23	of	of	ADP
dpc-4075	132	24	absence	absence	NOUN
dpc-4075	132	25	from	from	ADP
dpc-4075	132	26	work	work	NOUN
dpc-4075	132	27	due	due	ADP
dpc-4075	132	28	to	to	ADP
dpc-4075	132	29	illness	illness	NOUN
dpc-4075	132	30	/	/	SYM
dpc-4075	132	31	treatment	treatment	NOUN
dpc-4075	132	32	is	be	AUX
dpc-4075	132	33	considered	consider	VERB
dpc-4075	132	34	and	and	CCONJ
dpc-4075	132	35	valued	value	VERB
dpc-4075	132	36	by	by	ADP
dpc-4075	132	37	the	the	DET
dpc-4075	132	38	achievable	achievable	ADJ
dpc-4075	132	39	gross	gross	ADJ
dpc-4075	132	40	income	income	NOUN
dpc-4075	133	1	[	[	X
dpc-4075	133	2	59	59	NUM
dpc-4075	133	3	]	]	PUNCT
dpc-4075	133	4	.	.	PUNCT
dpc-4075	134	1	the	the	DET
dpc-4075	134	2	hc	hc	PROPN
dpc-4075	134	3	method	method	NOUN
dpc-4075	134	4	does	do	AUX
dpc-4075	134	5	not	not	PART
dpc-4075	134	6	address	address	VERB
dpc-4075	134	7	the	the	DET
dpc-4075	134	8	issue	issue	NOUN
dpc-4075	134	9	of	of	ADP
dpc-4075	134	10	the	the	DET
dpc-4075	134	11	categories	category	NOUN
dpc-4075	134	12	not	not	PART
dpc-4075	134	13	receiving	receive	VERB
dpc-4075	134	14	any	any	DET
dpc-4075	134	15	income	income	NOUN
dpc-4075	134	16	(	(	PUNCT
dpc-4075	134	17	typically	typically	ADV
dpc-4075	134	18	stayat	stayat	ADJ
dpc-4075	134	19	-	-	PUNCT
dpc-4075	134	20	home	home	NOUN
dpc-4075	134	21	spouses	spouse	NOUN
dpc-4075	134	22	,	,	PUNCT
dpc-4075	134	23	unemployed	unemployed	ADJ
dpc-4075	134	24	and	and	CCONJ
dpc-4075	134	25	students	student	NOUN
dpc-4075	134	26	)	)	PUNCT
dpc-4075	135	1	[	[	X
dpc-4075	135	2	60	60	NUM
dpc-4075	135	3	]	]	PUNCT
dpc-4075	135	4	and	and	CCONJ
dpc-4075	135	5	their	their	PRON
dpc-4075	135	6	inclusion	inclusion	NOUN
dpc-4075	135	7	in	in	ADP
dpc-4075	135	8	indirect	indirect	ADJ
dpc-4075	135	9	costs	cost	NOUN
dpc-4075	135	10	computation	computation	NOUN
dpc-4075	135	11	is	be	AUX
dpc-4075	135	12	at	at	ADP
dpc-4075	135	13	the	the	DET
dpc-4075	135	14	researcher	researcher	NOUN
dpc-4075	135	15	’s	’s	PART
dpc-4075	135	16	discretion	discretion	NOUN
dpc-4075	135	17	.	.	PUNCT
dpc-4075	136	1	to	to	PART
dpc-4075	136	2	address	address	VERB
dpc-4075	136	3	the	the	DET
dpc-4075	136	4	limits	limit	NOUN
dpc-4075	136	5	of	of	ADP
dpc-4075	136	6	hc	hc	PROPN
dpc-4075	136	7	method	method	NOUN
dpc-4075	136	8	,	,	PUNCT
dpc-4075	136	9	in	in	ADP
dpc-4075	136	10	this	this	DET
dpc-4075	136	11	study	study	NOUN
dpc-4075	136	12	we	we	PRON
dpc-4075	136	13	valued	value	VERB
dpc-4075	136	14	the	the	DET
dpc-4075	136	15	“	"	PUNCT
dpc-4075	136	16	unemployed	unemployed	ADJ
dpc-4075	136	17	lost	lose	VERB
dpc-4075	136	18	time	time	NOUN
dpc-4075	136	19	”	"	PUNCT
dpc-4075	136	20	at	at	ADP
dpc-4075	136	21	the	the	DET
dpc-4075	136	22	value	value	NOUN
dpc-4075	136	23	of	of	ADP
dpc-4075	136	24	governmental	governmental	ADJ
dpc-4075	136	25	unemployed	unemployed	ADJ
dpc-4075	136	26	benefit	benefit	NOUN
dpc-4075	136	27	(	(	PUNCT
dpc-4075	136	28	naspi	naspi	ADP
dpc-4075	136	29	[	[	X
dpc-4075	136	30	61	61	NUM
dpc-4075	136	31	]	]	NUM
dpc-4075	136	32	)	)	PUNCT
dpc-4075	136	33	;	;	PUNCT
dpc-4075	136	34	“	"	PUNCT
dpc-4075	136	35	inactive	inactive	ADJ
dpc-4075	136	36	caregivers	caregiver	NOUN
dpc-4075	136	37	’	’	PART
dpc-4075	136	38	time	time	NOUN
dpc-4075	136	39	”	"	PUNCT
dpc-4075	136	40	at	at	ADP
dpc-4075	136	41	the	the	DET
dpc-4075	136	42	value	value	NOUN
dpc-4075	136	43	of	of	ADP
dpc-4075	136	44	minimum	minimum	ADJ
dpc-4075	136	45	domestic	domestic	ADJ
dpc-4075	136	46	labor	labor	NOUN
dpc-4075	136	47	wage	wage	NOUN
dpc-4075	136	48	;	;	PUNCT
dpc-4075	136	49	“	"	PUNCT
dpc-4075	136	50	time	time	NOUN
dpc-4075	136	51	lost	lose	VERB
dpc-4075	136	52	out	out	ADP
dpc-4075	136	53	of	of	ADP
dpc-4075	136	54	working	work	VERB
dpc-4075	136	55	time	time	NOUN
dpc-4075	136	56	for	for	ADP
dpc-4075	136	57	vitiligo	vitiligo	ADJ
dpc-4075	136	58	treatment	treatment	NOUN
dpc-4075	136	59	”	"	PUNCT
dpc-4075	136	60	(	(	PUNCT
dpc-4075	136	61	e.g.	e.g.	ADV
dpc-4075	136	62	,	,	PUNCT
dpc-4075	136	63	ointment	ointment	NOUN
dpc-4075	136	64	application	application	NOUN
dpc-4075	136	65	,	,	PUNCT
dpc-4075	136	66	make	make	VERB
dpc-4075	136	67	-	-	PUNCT
dpc-4075	136	68	up	up	NOUN
dpc-4075	136	69	)	)	PUNCT
dpc-4075	136	70	at	at	ADP
dpc-4075	136	71	the	the	DET
dpc-4075	136	72	value	value	NOUN
dpc-4075	136	73	of	of	ADP
dpc-4075	136	74	willingness	willingness	NOUN
dpc-4075	136	75	to	to	PART
dpc-4075	136	76	pay	pay	VERB
dpc-4075	136	77	for	for	ADP
dpc-4075	136	78	an	an	DET
dpc-4075	136	79	additional	additional	ADJ
dpc-4075	136	80	hour	hour	NOUN
dpc-4075	136	81	of	of	ADP
dpc-4075	136	82	leisure	leisure	NOUN
dpc-4075	136	83	time	time	NOUN
dpc-4075	136	84	vs.	vs.	ADP
dpc-4075	136	85	unpaid	unpaid	ADJ
dpc-4075	136	86	work	work	NOUN
dpc-4075	136	87	[	[	X
dpc-4075	136	88	62	62	NUM
dpc-4075	136	89	]	]	PUNCT
dpc-4075	136	90	,	,	PUNCT
dpc-4075	136	91	assuming	assume	VERB
dpc-4075	136	92	that	that	SCONJ
dpc-4075	136	93	the	the	DET
dpc-4075	136	94	burden	burden	NOUN
dpc-4075	136	95	of	of	ADP
dpc-4075	136	96	treatment	treatment	NOUN
dpc-4075	136	97	is	be	AUX
dpc-4075	136	98	comparable	comparable	ADJ
dpc-4075	136	99	to	to	ADP
dpc-4075	136	100	unpaid	unpaid	ADJ
dpc-4075	136	101	work	work	NOUN
dpc-4075	136	102	.	.	PUNCT
dpc-4075	137	1	the	the	DET
dpc-4075	137	2	data	datum	NOUN
dpc-4075	137	3	for	for	ADP
dpc-4075	137	4	this	this	DET
dpc-4075	137	5	section	section	NOUN
dpc-4075	137	6	comes	come	VERB
dpc-4075	137	7	from	from	ADP
dpc-4075	137	8	scientific	scientific	ADJ
dpc-4075	137	9	publications	publication	NOUN
dpc-4075	137	10	,	,	PUNCT
dpc-4075	137	11	public	public	ADJ
dpc-4075	137	12	entities	entity	NOUN
dpc-4075	137	13	’	'	PUNCT
dpc-4075	137	14	websites	website	NOUN
dpc-4075	137	15	(	(	PUNCT
dpc-4075	137	16	e.g.	e.g.	ADV
dpc-4075	137	17	,	,	PUNCT
dpc-4075	137	18	inps	inps	ADJ
dpc-4075	137	19	)	)	PUNCT
dpc-4075	137	20	,	,	PUNCT
dpc-4075	137	21	statistics	statistic	NOUN
dpc-4075	137	22	institutes	institutes	PROPN
dpc-4075	137	23	(	(	PUNCT
dpc-4075	137	24	e.g.	e.g.	ADV
dpc-4075	137	25	,	,	PUNCT
dpc-4075	137	26	instat	instat	NOUN
dpc-4075	137	27	)	)	PUNCT
dpc-4075	137	28	.	.	PUNCT
dpc-4075	138	1	our	our	PRON
dpc-4075	138	2	analysis	analysis	NOUN
dpc-4075	138	3	shows	show	VERB
dpc-4075	138	4	that	that	SCONJ
dpc-4075	138	5	the	the	DET
dpc-4075	138	6	indirect	indirect	ADJ
dpc-4075	138	7	costs	cost	NOUN
dpc-4075	138	8	associated	associate	VERB
dpc-4075	138	9	to	to	PART
dpc-4075	138	10	vitiligo	vitiligo	VERB
dpc-4075	138	11	amount	amount	NOUN
dpc-4075	138	12	to	to	ADP
dpc-4075	138	13	€	€	SYM
dpc-4075	138	14	91mln	91mln	NOUN
dpc-4075	138	15	/	/	SYM
dpc-4075	138	16	year	year	NOUN
dpc-4075	138	17	:	:	PUNCT
dpc-4075	138	18	30	30	NUM
dpc-4075	138	19	%	%	NOUN
dpc-4075	138	20	of	of	ADP
dpc-4075	138	21	this	this	DET
dpc-4075	138	22	cost	cost	NOUN
dpc-4075	138	23	(	(	PUNCT
dpc-4075	138	24	€	€	SYM
dpc-4075	138	25	31mln	31mln	NOUN
dpc-4075	138	26	)	)	PUNCT
dpc-4075	138	27	is	be	AUX
dpc-4075	138	28	associated	associate	VERB
dpc-4075	138	29	to	to	ADP
dpc-4075	138	30	mental	mental	ADJ
dpc-4075	138	31	health	health	NOUN
dpc-4075	138	32	(	(	PUNCT
dpc-4075	138	33	for	for	ADP
dpc-4075	138	34	either	either	CCONJ
dpc-4075	138	35	productivity	productivity	NOUN
dpc-4075	138	36	loss	loss	NOUN
dpc-4075	138	37	related	relate	VERB
dpc-4075	138	38	to	to	ADP
dpc-4075	138	39	treatment	treatment	NOUN
dpc-4075	138	40	time	time	NOUN
dpc-4075	138	41	or	or	CCONJ
dpc-4075	138	42	unemployment	unemployment	NOUN
dpc-4075	138	43	)	)	PUNCT
dpc-4075	138	44	.	.	PUNCT
dpc-4075	139	1	the	the	DET
dpc-4075	139	2	annual	annual	ADJ
dpc-4075	139	3	indirect	indirect	ADJ
dpc-4075	139	4	social	social	ADJ
dpc-4075	139	5	cost	cost	NOUN
dpc-4075	139	6	per	per	ADP
dpc-4075	139	7	diagnosed	diagnose	VERB
dpc-4075	139	8	patient	patient	NOUN
dpc-4075	139	9	ranges	range	VERB
dpc-4075	139	10	from	from	ADP
dpc-4075	139	11	€	€	SYM
dpc-4075	139	12	288	288	NUM
dpc-4075	139	13	for	for	ADP
dpc-4075	139	14	not	not	PART
dpc-4075	139	15	severe	severe	ADJ
dpc-4075	139	16	cases	case	NOUN
dpc-4075	139	17	to	to	ADP
dpc-4075	139	18	€	€	SYM
dpc-4075	139	19	1,182	1,182	NUM
dpc-4075	139	20	for	for	ADP
dpc-4075	139	21	moderate	moderate	ADJ
dpc-4075	139	22	-	-	PUNCT
dpc-4075	139	23	severe	severe	ADJ
dpc-4075	139	24	older	old	ADJ
dpc-4075	139	25	males	male	NOUN
dpc-4075	139	26	.	.	PUNCT
dpc-4075	140	1	conclusions	conclusion	NOUN
dpc-4075	140	2	in	in	ADP
dpc-4075	140	3	summary	summary	NOUN
dpc-4075	140	4	,	,	PUNCT
dpc-4075	140	5	data	datum	NOUN
dpc-4075	140	6	indicate	indicate	VERB
dpc-4075	140	7	that	that	SCONJ
dpc-4075	140	8	vitiligo	vitiligo	ADJ
dpc-4075	140	9	prevalence	prevalence	NOUN
dpc-4075	140	10	increases	increase	NOUN
dpc-4075	140	11	with	with	ADP
dpc-4075	140	12	age	age	NOUN
dpc-4075	140	13	in	in	ADP
dpc-4075	140	14	italy	italy	PROPN
dpc-4075	140	15	,	,	PUNCT
dpc-4075	140	16	ranging	range	VERB
dpc-4075	140	17	from	from	ADP
dpc-4075	140	18	0.19	0.19	NUM
dpc-4075	140	19	%	%	NOUN
dpc-4075	140	20	at	at	ADP
dpc-4075	140	21	18	18	NUM
dpc-4075	140	22	-	-	SYM
dpc-4075	140	23	21	21	NUM
dpc-4075	140	24	years	year	NOUN
dpc-4075	140	25	to	to	ADP
dpc-4075	140	26	0.6	0.6	NUM
dpc-4075	140	27	%	%	NOUN
dpc-4075	140	28	after	after	ADP
dpc-4075	140	29	age	age	NOUN
dpc-4075	140	30	45	45	NUM
dpc-4075	140	31	.	.	PUNCT
dpc-4075	141	1	real	real	ADJ
dpc-4075	141	2	world	world	NOUN
dpc-4075	141	3	evidence	evidence	NOUN
dpc-4075	141	4	-	-	PUNCT
dpc-4075	141	5	based	base	VERB
dpc-4075	141	6	prevalence	prevalence	NOUN
dpc-4075	141	7	was	be	AUX
dpc-4075	141	8	estimated	estimate	VERB
dpc-4075	141	9	at	at	ADP
dpc-4075	141	10	0.55	0.55	NUM
dpc-4075	141	11	%	%	NOUN
dpc-4075	141	12	.	.	PUNCT
dpc-4075	142	1	these	these	DET
dpc-4075	142	2	figures	figure	NOUN
dpc-4075	142	3	align	align	VERB
dpc-4075	142	4	with	with	ADP
dpc-4075	142	5	the	the	DET
dpc-4075	142	6	findings	finding	NOUN
dpc-4075	142	7	reported	report	VERB
dpc-4075	142	8	in	in	ADP
dpc-4075	142	9	systematic	systematic	ADJ
dpc-4075	142	10	reviews	review	NOUN
dpc-4075	142	11	and	and	CCONJ
dpc-4075	142	12	recent	recent	ADJ
dpc-4075	142	13	studies	study	NOUN
dpc-4075	142	14	.	.	PUNCT
dpc-4075	143	1	analyzing	analyze	VERB
dpc-4075	143	2	five	five	NUM
dpc-4075	143	3	cost	cost	NOUN
dpc-4075	143	4	components	component	NOUN
dpc-4075	143	5	,	,	PUNCT
dpc-4075	143	6	the	the	DET
dpc-4075	143	7	annual	annual	ADJ
dpc-4075	143	8	social	social	ADJ
dpc-4075	143	9	cost	cost	NOUN
dpc-4075	143	10	of	of	ADP
dpc-4075	143	11	vitiligo	vitiligo	PROPN
dpc-4075	143	12	in	in	ADP
dpc-4075	143	13	italy	italy	PROPN
dpc-4075	143	14	is	be	AUX
dpc-4075	143	15	€	€	SYM
dpc-4075	143	16	500	500	NUM
dpc-4075	143	17	million	million	NUM
dpc-4075	143	18	,	,	PUNCT
dpc-4075	143	19	with	with	ADP
dpc-4075	143	20	costs	cost	NOUN
dpc-4075	143	21	per	per	ADP
dpc-4075	143	22	patient	patient	NOUN
dpc-4075	143	23	ranging	range	VERB
dpc-4075	143	24	from	from	ADP
dpc-4075	143	25	€	€	SYM
dpc-4075	143	26	2,200	2,200	NUM
dpc-4075	143	27	to	to	PART
dpc-4075	143	28	€	€	SYM
dpc-4075	143	29	4,600	4,600	NUM
dpc-4075	143	30	/	/	SYM
dpc-4075	143	31	year	year	NOUN
dpc-4075	143	32	.	.	PUNCT
dpc-4075	144	1	patients	patient	NOUN
dpc-4075	144	2	bear	bear	VERB
dpc-4075	144	3	55	55	NUM
dpc-4075	144	4	%	%	NOUN
dpc-4075	144	5	of	of	ADP
dpc-4075	144	6	the	the	DET
dpc-4075	144	7	cost	cost	NOUN
dpc-4075	144	8	,	,	PUNCT
dpc-4075	144	9	the	the	DET
dpc-4075	144	10	nhs	nhs	NOUN
dpc-4075	144	11	covers	cover	VERB
dpc-4075	144	12	18	18	NUM
dpc-4075	144	13	%	%	NOUN
dpc-4075	144	14	,	,	PUNCT
dpc-4075	144	15	and	and	CCONJ
dpc-4075	144	16	27	27	NUM
dpc-4075	144	17	%	%	NOUN
dpc-4075	144	18	is	be	AUX
dpc-4075	144	19	borne	bear	VERB
dpc-4075	144	20	by	by	ADP
dpc-4075	144	21	society	society	NOUN
dpc-4075	144	22	.	.	PUNCT
dpc-4075	145	1	this	this	DET
dpc-4075	145	2	distribution	distribution	NOUN
dpc-4075	145	3	results	result	NOUN
dpc-4075	145	4	in	in	ADP
dpc-4075	145	5	significant	significant	ADJ
dpc-4075	145	6	inequity	inequity	NOUN
dpc-4075	145	7	,	,	PUNCT
dpc-4075	145	8	with	with	ADP
dpc-4075	145	9	over	over	ADP
dpc-4075	145	10	half	half	NOUN
dpc-4075	145	11	of	of	ADP
dpc-4075	145	12	the	the	DET
dpc-4075	145	13	social	social	ADJ
dpc-4075	145	14	cost	cost	NOUN
dpc-4075	145	15	being	be	AUX
dpc-4075	145	16	paid	pay	VERB
dpc-4075	145	17	directly	directly	ADV
dpc-4075	145	18	by	by	ADP
dpc-4075	145	19	patients	patient	NOUN
dpc-4075	145	20	or	or	CCONJ
dpc-4075	145	21	caregivers	caregiver	NOUN
dpc-4075	145	22	.	.	PUNCT
dpc-4075	146	1	(	(	PUNCT
dpc-4075	146	2	drugs	drug	NOUN
dpc-4075	146	3	,	,	PUNCT
dpc-4075	146	4	hospitalizations	hospitalization	NOUN
dpc-4075	146	5	,	,	PUNCT
dpc-4075	146	6	outpatient	outpatient	NOUN
dpc-4075	146	7	care	care	NOUN
dpc-4075	146	8	,	,	PUNCT
dpc-4075	146	9	medical	medical	ADJ
dpc-4075	146	10	devices	device	NOUN
dpc-4075	146	11	[	[	X
dpc-4075	146	12	57,58	57,58	NUM
dpc-4075	146	13	]	]	PUNCT
dpc-4075	146	14	)	)	PUNCT
dpc-4075	146	15	and	and	CCONJ
dpc-4075	146	16	costs	cost	NOUN
dpc-4075	146	17	for	for	ADP
dpc-4075	146	18	public	public	ADJ
dpc-4075	146	19	and	and	CCONJ
dpc-4075	146	20	private	private	ADJ
dpc-4075	146	21	psychotherapy	psychotherapy	NOUN
dpc-4075	146	22	.	.	PUNCT
dpc-4075	147	1	factors	factor	NOUN
dpc-4075	147	2	associated	associate	VERB
dpc-4075	147	3	with	with	ADP
dpc-4075	147	4	a	a	DET
dpc-4075	147	5	higher	high	ADJ
dpc-4075	147	6	burden	burden	NOUN
dpc-4075	147	7	of	of	ADP
dpc-4075	147	8	psychosocial	psychosocial	ADJ
dpc-4075	147	9	comorbidities	comorbiditie	NOUN
dpc-4075	147	10	include	include	VERB
dpc-4075	147	11	female	female	ADJ
dpc-4075	147	12	sex	sex	NOUN
dpc-4075	147	13	,	,	PUNCT
dpc-4075	147	14	greater	great	ADJ
dpc-4075	147	15	body	body	NOUN
dpc-4075	147	16	surface	surface	NOUN
dpc-4075	147	17	area	area	NOUN
dpc-4075	147	18	involvement	involvement	NOUN
dpc-4075	147	19	(	(	PUNCT
dpc-4075	147	20	i.e.	i.e.	X
dpc-4075	147	21	,	,	PUNCT
dpc-4075	147	22	severity	severity	NOUN
dpc-4075	147	23	)	)	PUNCT
dpc-4075	147	24	,	,	PUNCT
dpc-4075	147	25	and	and	CCONJ
dpc-4075	147	26	younger	young	ADJ
dpc-4075	147	27	age	age	NOUN
dpc-4075	147	28	.	.	PUNCT
dpc-4075	148	1	our	our	PRON
dpc-4075	148	2	analysis	analysis	NOUN
dpc-4075	148	3	shows	show	VERB
dpc-4075	148	4	that	that	SCONJ
dpc-4075	148	5	moderate	moderate	ADJ
dpc-4075	148	6	-	-	PUNCT
dpc-4075	148	7	severe	severe	ADJ
dpc-4075	148	8	nsv	nsv	PROPN
dpc-4075	148	9	females	female	NOUN
dpc-4075	148	10	are	be	AUX
dpc-4075	148	11	the	the	DET
dpc-4075	148	12	group	group	NOUN
dpc-4075	148	13	with	with	ADP
dpc-4075	148	14	the	the	DET
dpc-4075	148	15	highest	high	ADJ
dpc-4075	148	16	spend	spend	NOUN
dpc-4075	148	17	in	in	ADP
dpc-4075	148	18	mental	mental	ADJ
dpc-4075	148	19	health	health	NOUN
dpc-4075	148	20	(	(	PUNCT
dpc-4075	148	21	1,171€/year	1,171€/year	NUM
dpc-4075	148	22	)	)	PUNCT
dpc-4075	148	23	,	,	PUNCT
dpc-4075	148	24	followed	follow	VERB
dpc-4075	148	25	by	by	ADP
dpc-4075	148	26	very	very	ADV
dpc-4075	148	27	severe	severe	ADJ
dpc-4075	148	28	nsv	nsv	PROPN
dpc-4075	148	29	(	(	PUNCT
dpc-4075	148	30	1,157€/year	1,157€/year	NUM
dpc-4075	148	31	)	)	PUNCT
dpc-4075	148	32	and	and	CCONJ
dpc-4075	148	33	moderate	moderate	ADJ
dpc-4075	148	34	-	-	PUNCT
dpc-4075	148	35	severe	severe	ADJ
dpc-4075	148	36	older	old	ADJ
dpc-4075	148	37	males	male	NOUN
dpc-4075	148	38	(	(	PUNCT
dpc-4075	148	39	1,145€/year	1,145€/year	NUM
dpc-4075	148	40	)	)	PUNCT
dpc-4075	148	41	.	.	PUNCT
dpc-4075	149	1	interestingly	interestingly	ADV
dpc-4075	149	2	,	,	PUNCT
dpc-4075	149	3	another	another	DET
dpc-4075	149	4	group	group	NOUN
dpc-4075	149	5	affected	affect	VERB
dpc-4075	149	6	by	by	ADP
dpc-4075	149	7	vitiligo	vitiligo	NOUN
dpc-4075	149	8	-	-	PUNCT
dpc-4075	149	9	induced	induce	VERB
dpc-4075	149	10	mental	mental	ADJ
dpc-4075	149	11	health	health	NOUN
dpc-4075	149	12	issues	issue	NOUN
dpc-4075	149	13	are	be	AUX
dpc-4075	149	14	the	the	DET
dpc-4075	149	15	caregivers	caregiver	NOUN
dpc-4075	149	16	of	of	ADP
dpc-4075	149	17	children	child	NOUN
dpc-4075	149	18	and	and	CCONJ
dpc-4075	149	19	adolescents	adolescent	NOUN
dpc-4075	149	20	,	,	PUNCT
dpc-4075	149	21	spending	spend	VERB
dpc-4075	149	22	approximately	approximately	ADV
dpc-4075	149	23	1,062€/year	1,062€/year	NUM
dpc-4075	149	24	.	.	PUNCT
dpc-4075	150	1	the	the	DET
dpc-4075	150	2	group	group	NOUN
dpc-4075	150	3	spending	spend	VERB
dpc-4075	150	4	less	less	ADV
dpc-4075	150	5	on	on	ADP
dpc-4075	150	6	mental	mental	ADJ
dpc-4075	150	7	health	health	NOUN
dpc-4075	150	8	is	be	AUX
dpc-4075	150	9	children	child	NOUN
dpc-4075	150	10	(	(	PUNCT
dpc-4075	150	11	642€/year	642€/year	NUM
dpc-4075	150	12	)	)	PUNCT
dpc-4075	150	13	,	,	PUNCT
dpc-4075	150	14	who	who	PRON
dpc-4075	150	15	are	be	AUX
dpc-4075	150	16	mostly	mostly	ADV
dpc-4075	150	17	unaware	unaware	ADJ
dpc-4075	150	18	of	of	ADP
dpc-4075	150	19	their	their	PRON
dpc-4075	150	20	physical	physical	ADJ
dpc-4075	150	21	appearance	appearance	NOUN
dpc-4075	150	22	.	.	PUNCT
dpc-4075	151	1	non	non	ADJ
dpc-4075	151	2	-	-	ADJ
dpc-4075	151	3	drug	drug	ADJ
dpc-4075	151	4	costs	cost	NOUN
dpc-4075	151	5	non	non	ADJ
dpc-4075	151	6	-	-	ADJ
dpc-4075	151	7	drug	drug	ADJ
dpc-4075	151	8	costs	cost	NOUN
dpc-4075	151	9	consist	consist	VERB
dpc-4075	151	10	in	in	ADP
dpc-4075	151	11	purchases	purchase	NOUN
dpc-4075	151	12	of	of	ADP
dpc-4075	151	13	skin	skin	NOUN
dpc-4075	151	14	products	product	NOUN
dpc-4075	151	15	for	for	ADP
dpc-4075	151	16	vitiligo	vitiligo	NOUN
dpc-4075	151	17	(	(	PUNCT
dpc-4075	151	18	e.g.	e.g.	ADV
dpc-4075	151	19	,	,	PUNCT
dpc-4075	151	20	professional	professional	ADJ
dpc-4075	151	21	concealers	concealer	NOUN
dpc-4075	151	22	,	,	PUNCT
dpc-4075	151	23	sunscreen	sunscreen	NOUN
dpc-4075	151	24	)	)	PUNCT
dpc-4075	151	25	exceeding	exceed	VERB
dpc-4075	151	26	the	the	DET
dpc-4075	151	27	usual	usual	ADJ
dpc-4075	151	28	expenses	expense	NOUN
dpc-4075	151	29	associated	associate	VERB
dpc-4075	151	30	with	with	ADP
dpc-4075	151	31	standard	standard	ADJ
dpc-4075	151	32	skincare	skincare	NOUN
dpc-4075	151	33	,	,	PUNCT
dpc-4075	151	34	and	and	CCONJ
dpc-4075	151	35	transport	transport	NOUN
dpc-4075	151	36	costs	cost	NOUN
dpc-4075	151	37	specifically	specifically	ADV
dpc-4075	151	38	related	relate	VERB
dpc-4075	151	39	to	to	PART
dpc-4075	151	40	vitiligo	vitiligo	VERB
dpc-4075	151	41	disease	disease	NOUN
dpc-4075	151	42	(	(	PUNCT
dpc-4075	151	43	e.g.	e.g.	ADV
dpc-4075	151	44	,	,	PUNCT
dpc-4075	151	45	transport	transport	NOUN
dpc-4075	151	46	to	to	PART
dpc-4075	151	47	reach	reach	VERB
dpc-4075	151	48	phototherapy	phototherapy	NOUN
dpc-4075	151	49	center	center	NOUN
dpc-4075	151	50	)	)	PUNCT
dpc-4075	151	51	.	.	PUNCT
dpc-4075	152	1	research	research	NOUN
dpc-4075	152	2	shows	show	VERB
dpc-4075	152	3	that	that	SCONJ
dpc-4075	152	4	make	make	VERB
dpc-4075	152	5	-	-	PUNCT
dpc-4075	152	6	up	up	NOUN
dpc-4075	152	7	and	and	CCONJ
dpc-4075	152	8	concealers	concealer	NOUN
dpc-4075	152	9	are	be	AUX
dpc-4075	152	10	mostly	mostly	ADV
dpc-4075	152	11	used	use	VERB
dpc-4075	152	12	by	by	ADP
dpc-4075	152	13	moderate	moderate	ADJ
dpc-4075	152	14	/	/	SYM
dpc-4075	152	15	severe	severe	ADJ
dpc-4075	152	16	nsv	nsv	PROPN
dpc-4075	152	17	females	female	NOUN
dpc-4075	152	18	(	(	PUNCT
dpc-4075	152	19	65	65	NUM
dpc-4075	152	20	%	%	NOUN
dpc-4075	152	21	)	)	PUNCT
dpc-4075	152	22	,	,	PUNCT
dpc-4075	152	23	followed	follow	VERB
dpc-4075	152	24	my	my	PRON
dpc-4075	152	25	mild	mild	ADJ
dpc-4075	152	26	nsv	nsv	NOUN
dpc-4075	152	27	cases	case	NOUN
dpc-4075	152	28	(	(	PUNCT
dpc-4075	152	29	55	55	NUM
dpc-4075	152	30	%	%	NOUN
dpc-4075	152	31	)	)	PUNCT
dpc-4075	152	32	and	and	CCONJ
dpc-4075	152	33	moderate	moderate	ADJ
dpc-4075	152	34	/	/	SYM
dpc-4075	152	35	severe	severe	ADJ
dpc-4075	152	36	nsv	nsv	PROPN
dpc-4075	152	37	adolescents	adolescent	NOUN
dpc-4075	152	38	(	(	PUNCT
dpc-4075	152	39	55	55	NUM
dpc-4075	152	40	%	%	NOUN
dpc-4075	152	41	)	)	PUNCT
dpc-4075	152	42	;	;	PUNCT
dpc-4075	152	43	sunscreen	sunscreen	NOUN
dpc-4075	152	44	is	be	AUX
dpc-4075	152	45	widely	widely	ADV
dpc-4075	152	46	used	use	VERB
dpc-4075	152	47	across	across	ADP
dpc-4075	152	48	patient	patient	ADJ
dpc-4075	152	49	classes	class	NOUN
dpc-4075	152	50	,	,	PUNCT
dpc-4075	152	51	up	up	ADP
dpc-4075	152	52	to	to	PART
dpc-4075	152	53	95	95	NUM
dpc-4075	152	54	%	%	NOUN
dpc-4075	152	55	among	among	ADP
dpc-4075	152	56	very	very	ADV
dpc-4075	152	57	severe	severe	ADJ
dpc-4075	152	58	cases	case	NOUN
dpc-4075	152	59	.	.	PUNCT
dpc-4075	153	1	the	the	DET
dpc-4075	153	2	non	non	ADJ
dpc-4075	153	3	-	-	ADJ
dpc-4075	153	4	drug	drug	ADJ
dpc-4075	153	5	annual	annual	ADJ
dpc-4075	153	6	cost	cost	NOUN
dpc-4075	153	7	for	for	ADP
dpc-4075	153	8	diagnosed	diagnose	VERB
dpc-4075	153	9	patient	patient	NOUN
dpc-4075	153	10	ranges	range	VERB
dpc-4075	153	11	from	from	ADP
dpc-4075	153	12	117€/year	117€/year	NUM
dpc-4075	153	13	for	for	ADP
dpc-4075	153	14	not	not	PART
dpc-4075	153	15	severe	severe	ADJ
dpc-4075	153	16	cases	case	NOUN
dpc-4075	153	17	to	to	ADP
dpc-4075	153	18	789€/year	789€/year	NUM
dpc-4075	153	19	for	for	ADP
dpc-4075	153	20	moderate	moderate	ADJ
dpc-4075	153	21	/	/	SYM
dpc-4075	153	22	severe	severe	ADJ
dpc-4075	153	23	women	woman	NOUN
dpc-4075	153	24	.	.	PUNCT
dpc-4075	154	1	indirect	indirect	ADJ
dpc-4075	154	2	costs	cost	NOUN
dpc-4075	154	3	nsv	nsv	PROPN
dpc-4075	154	4	patients	patient	NOUN
dpc-4075	154	5	lose	lose	VERB
dpc-4075	154	6	time	time	NOUN
dpc-4075	154	7	managing	manage	VERB
dpc-4075	154	8	their	their	PRON
dpc-4075	154	9	condition	condition	NOUN
dpc-4075	154	10	,	,	PUNCT
dpc-4075	154	11	giving	give	VERB
dpc-4075	154	12	up	up	ADP
dpc-4075	154	13	both	both	PRON
dpc-4075	154	14	work	work	NOUN
dpc-4075	154	15	and	and	CCONJ
dpc-4075	154	16	leisure	leisure	NOUN
dpc-4075	154	17	time	time	NOUN
dpc-4075	154	18	.	.	PUNCT
dpc-4075	155	1	additionally	additionally	ADV
dpc-4075	155	2	,	,	PUNCT
dpc-4075	155	3	nsv	nsv	PROPN
dpc-4075	155	4	patients	patient	NOUN
dpc-4075	155	5	lose	lose	VERB
dpc-4075	155	6	time	time	NOUN
dpc-4075	155	7	due	due	ADP
dpc-4075	155	8	to	to	ADP
dpc-4075	155	9	mental	mental	ADJ
dpc-4075	155	10	health	health	NOUN
dpc-4075	155	11	comorbidities	comorbiditie	NOUN
dpc-4075	155	12	,	,	PUNCT
dpc-4075	155	13	either	either	CCONJ
dpc-4075	155	14	for	for	ADP
dpc-4075	155	15	treatment	treatment	NOUN
dpc-4075	155	16	(	(	PUNCT
dpc-4075	155	17	e.g.	e.g.	ADJ
dpc-4075	155	18	,	,	PUNCT
dpc-4075	155	19	psychotherapy	psychotherapy	NOUN
dpc-4075	155	20	)	)	PUNCT
dpc-4075	155	21	or	or	CCONJ
dpc-4075	155	22	due	due	ADP
dpc-4075	155	23	to	to	ADP
dpc-4075	155	24	disabling	disable	VERB
dpc-4075	155	25	symptoms	symptom	NOUN
dpc-4075	155	26	(	(	PUNCT
dpc-4075	155	27	e.g.	e.g.	ADV
dpc-4075	155	28	,	,	PUNCT
dpc-4075	155	29	hospitalizations	hospitalization	NOUN
dpc-4075	155	30	,	,	PUNCT
dpc-4075	155	31	lost	lose	VERB
dpc-4075	155	32	workdays	workday	NOUN
dpc-4075	155	33	)	)	PUNCT
dpc-4075	155	34	.	.	PUNCT
dpc-4075	156	1	to	to	PART
dpc-4075	156	2	assess	assess	VERB
dpc-4075	156	3	indirect	indirect	ADJ
dpc-4075	156	4	cost	cost	NOUN
dpc-4075	156	5	due	due	ADP
dpc-4075	156	6	to	to	ADP
dpc-4075	156	7	productivity	productivity	NOUN
dpc-4075	156	8	loss	loss	NOUN
dpc-4075	156	9	,	,	PUNCT
dpc-4075	156	10	we	we	PRON
dpc-4075	156	11	opted	opt	VERB
dpc-4075	156	12	for	for	ADP
dpc-4075	156	13	the	the	DET
dpc-4075	156	14	human	human	ADJ
dpc-4075	156	15	capital	capital	NOUN
dpc-4075	156	16	(	(	PUNCT
dpc-4075	156	17	hc	hc	NOUN
dpc-4075	156	18	)	)	PUNCT
dpc-4075	156	19	approach	approach	NOUN
dpc-4075	156	20	,	,	PUNCT
dpc-4075	156	21	which	which	PRON
dpc-4075	156	22	states	state	VERB
dpc-4075	156	23	that	that	SCONJ
dpc-4075	156	24	the	the	DET
dpc-4075	156	25	table	table	NOUN
dpc-4075	156	26	5	5	NUM
dpc-4075	156	27	.	.	PUNCT
dpc-4075	156	28	nsv	nsv	PROPN
dpc-4075	156	29	non	non	ADJ
dpc-4075	156	30	-	-	ADJ
dpc-4075	156	31	drug	drug	ADJ
dpc-4075	156	32	costs	cost	NOUN
dpc-4075	156	33	(	(	PUNCT
dpc-4075	156	34	€	€	NOUN
dpc-4075	156	35	)	)	PUNCT
dpc-4075	156	36	.	.	PUNCT
dpc-4075	157	1	cost	cost	NOUN
dpc-4075	157	2	of	of	ADP
dpc-4075	157	3	products	product	NOUN
dpc-4075	157	4	(	(	PUNCT
dpc-4075	157	5	€	€	SYM
dpc-4075	157	6	monthly	monthly	ADJ
dpc-4075	157	7	per	per	ADP
dpc-4075	157	8	patient	patient	NOUN
dpc-4075	157	9	)	)	PUNCT
dpc-4075	157	10	cost	cost	NOUN
dpc-4075	157	11	of	of	ADP
dpc-4075	157	12	products	product	NOUN
dpc-4075	157	13	(	(	PUNCT
dpc-4075	157	14	€	€	SYM
dpc-4075	157	15	yearly	yearly	ADV
dpc-4075	157	16	per	per	ADP
dpc-4075	157	17	patient	patient	NOUN
dpc-4075	157	18	)	)	PUNCT
dpc-4075	157	19	concealers	concealer	NOUN
dpc-4075	157	20	/	/	SYM
dpc-4075	157	21	make	make	VERB
dpc-4075	157	22	-	-	PUNCT
dpc-4075	157	23	up	up	NOUN
dpc-4075	157	24	13	13	NUM
dpc-4075	157	25	150	150	NUM
dpc-4075	157	26	self	self	NOUN
dpc-4075	157	27	-	-	PUNCT
dpc-4075	157	28	tanners	tanner	NOUN
dpc-4075	157	29	12	12	NUM
dpc-4075	157	30	140	140	NUM
dpc-4075	157	31	sunscreen	sunscreen	NOUN
dpc-4075	157	32	46	46	NUM
dpc-4075	157	33	285	285	NUM
dpc-4075	157	34	cost	cost	NOUN
dpc-4075	157	35	of	of	ADP
dpc-4075	157	36	transport	transport	NOUN
dpc-4075	157	37	(	(	PUNCT
dpc-4075	157	38	€	€	NOUN
dpc-4075	157	39	for	for	ADP
dpc-4075	157	40	occasion	occasion	NOUN
dpc-4075	157	41	)	)	PUNCT
dpc-4075	157	42	cost	cost	NOUN
dpc-4075	157	43	of	of	ADP
dpc-4075	157	44	transport	transport	NOUN
dpc-4075	157	45	(	(	PUNCT
dpc-4075	157	46	€	€	SYM
dpc-4075	157	47	yearly	yearly	ADV
dpc-4075	157	48	per	per	ADP
dpc-4075	157	49	patient	patient	NOUN
dpc-4075	157	50	)	)	PUNCT
dpc-4075	157	51	transport	transport	NOUN
dpc-4075	157	52	for	for	ADP
dpc-4075	157	53	testing	testing	NOUN
dpc-4075	157	54	/	/	SYM
dpc-4075	157	55	examinations	examination	NOUN
dpc-4075	157	56	8	8	NUM
dpc-4075	157	57	18	18	NUM
dpc-4075	157	58	-	-	SYM
dpc-4075	157	59	38	38	NUM
dpc-4075	157	60	transport	transport	NOUN
dpc-4075	157	61	for	for	ADP
dpc-4075	157	62	phototherapy	phototherapy	NOUN
dpc-4075	157	63	6	6	NUM
dpc-4075	157	64	824	824	NUM
dpc-4075	157	65	transport	transport	NOUN
dpc-4075	157	66	for	for	ADP
dpc-4075	157	67	surgery	surgery	NOUN
dpc-4075	157	68	12	12	NUM
dpc-4075	157	69	12	12	NUM
dpc-4075	157	70	review	review	NOUN
dpc-4075	157	71	|	|	ADV
dpc-4075	157	72	dermatol	dermatol	ADJ
dpc-4075	157	73	pract	pract	NOUN
dpc-4075	157	74	concept	concept	NOUN
dpc-4075	157	75	.	.	PUNCT
dpc-4075	158	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	158	2	:	:	PUNCT
dpc-4075	158	3	e2023315s	e2023315s	PROPN
dpc-4075	158	4	7	7	NUM
dpc-4075	158	5	20	20	NUM
dpc-4075	158	6	.	.	PUNCT
dpc-4075	159	1	ezzedine	ezzedine	PROPN
dpc-4075	160	1	k	k	NOUN
dpc-4075	160	2	,	,	PUNCT
dpc-4075	160	3	eleftheriadou	eleftheriadou	NOUN
dpc-4075	160	4	v	v	PROPN
dpc-4075	160	5	,	,	PUNCT
dpc-4075	160	6	jones	jones	PROPN
dpc-4075	160	7	h	h	PROPN
dpc-4075	160	8	,	,	PUNCT
dpc-4075	160	9	bibeau	bibeau	PROPN
dpc-4075	160	10	k	k	NOUN
dpc-4075	160	11	,	,	PUNCT
dpc-4075	160	12	kuo	kuo	PROPN
dpc-4075	160	13	f	f	PROPN
dpc-4075	160	14	,	,	PUNCT
dpc-4075	160	15	sturm	sturm	PROPN
dpc-4075	160	16	d	d	PROPN
dpc-4075	160	17	,	,	PUNCT
dpc-4075	160	18	pandya	pandya	PROPN
dpc-4075	160	19	a	a	DET
dpc-4075	160	20	eadv	eadv	ADJ
dpc-4075	160	21	2020	2020	NUM
dpc-4075	160	22	.	.	PUNCT
dpc-4075	161	1	poster	poster	NOUN
dpc-4075	161	2	p1239	p1239	NUM
dpc-4075	161	3	(	(	PUNCT
dpc-4075	161	4	paris	paris	PROPN
dpc-4075	161	5	,	,	PUNCT
dpc-4075	161	6	france	france	PROPN
dpc-4075	161	7	)	)	PUNCT
dpc-4075	161	8	prevalence	prevalence	NOUN
dpc-4075	161	9	of	of	ADP
dpc-4075	161	10	psychosocial	psychosocial	ADJ
dpc-4075	161	11	comorbidities	comorbiditie	NOUN
dpc-4075	161	12	in	in	ADP
dpc-4075	161	13	vitiligo	vitiligo	NOUN
dpc-4075	161	14	:	:	PUNCT
dpc-4075	161	15	a	a	DET
dpc-4075	161	16	systematic	systematic	ADJ
dpc-4075	161	17	literature	literature	NOUN
dpc-4075	161	18	review	review	NOUN
dpc-4075	161	19	21	21	NUM
dpc-4075	161	20	.	.	PUNCT
dpc-4075	161	21	firooz	firooz	VERB
dpc-4075	161	22	a	a	PRON
dpc-4075	161	23	,	,	PUNCT
dpc-4075	161	24	bouzari	bouzari	PROPN
dpc-4075	161	25	n	n	CCONJ
dpc-4075	161	26	,	,	PUNCT
dpc-4075	161	27	fallah	fallah	ADJ
dpc-4075	161	28	n	n	CCONJ
dpc-4075	161	29	,	,	PUNCT
dpc-4075	161	30	ghazisaidi	ghazisaidi	VERB
dpc-4075	161	31	b	b	NUM
dpc-4075	161	32	,	,	PUNCT
dpc-4075	161	33	firoozabadi	firoozabadi	PROPN
dpc-4075	161	34	mr	mr	PROPN
dpc-4075	161	35	,	,	PUNCT
dpc-4075	161	36	dowlati	dowlati	PROPN
dpc-4075	161	37	y.	y.	PROPN
dpc-4075	161	38	what	what	PRON
dpc-4075	161	39	patients	patient	NOUN
dpc-4075	161	40	with	with	ADP
dpc-4075	161	41	vitiligo	vitiligo	NOUN
dpc-4075	161	42	believe	believe	VERB
dpc-4075	161	43	about	about	ADP
dpc-4075	161	44	their	their	PRON
dpc-4075	161	45	condition	condition	NOUN
dpc-4075	161	46	.	.	PUNCT
dpc-4075	162	1	international	international	ADJ
dpc-4075	162	2	journal	journal	PROPN
dpc-4075	162	3	of	of	ADP
dpc-4075	162	4	dermatology	dermatology	NOUN
dpc-4075	162	5	.	.	PUNCT
dpc-4075	163	1	2004	2004	NUM
dpc-4075	163	2	;	;	PUNCT
dpc-4075	163	3	43(11	43(11	NUM
dpc-4075	163	4	)	)	PUNCT
dpc-4075	163	5	,	,	PUNCT
dpc-4075	163	6	811	811	NUM
dpc-4075	163	7	-	-	SYM
dpc-4075	163	8	814	814	NUM
dpc-4075	163	9	.	.	PUNCT
dpc-4075	164	1	22	22	NUM
dpc-4075	164	2	.	.	PUNCT
dpc-4075	165	1	zhang	zhang	PROPN
dpc-4075	165	2	y	y	PROPN
dpc-4075	165	3	,	,	PUNCT
dpc-4075	165	4	cai	cai	PROPN
dpc-4075	165	5	y	y	PROPN
dpc-4075	165	6	,	,	PUNCT
dpc-4075	165	7	shi	shi	PROPN
dpc-4075	165	8	m	m	PROPN
dpc-4075	165	9	,	,	PUNCT
dpc-4075	165	10	et	et	PROPN
dpc-4075	165	11	al	al	PROPN
dpc-4075	165	12	.	.	PUNCT
dpc-4075	166	1	the	the	DET
dpc-4075	166	2	prevalence	prevalence	NOUN
dpc-4075	166	3	of	of	ADP
dpc-4075	166	4	vitiligo	vitiligo	NOUN
dpc-4075	166	5	:	:	PUNCT
dpc-4075	166	6	a	a	DET
dpc-4075	166	7	meta	meta	ADJ
dpc-4075	166	8	analysis	analysis	NOUN
dpc-4075	166	9	.	.	PUNCT
dpc-4075	166	10	2016	2016	NUM
dpc-4075	166	11	;	;	PUNCT
dpc-4075	166	12	plos	plos	PROPN
dpc-4075	166	13	one	one	NUM
dpc-4075	166	14	11(9	11(9	NUM
dpc-4075	166	15	):	):	PUNCT
dpc-4075	166	16	e0163806	e0163806	NOUN
dpc-4075	166	17	.	.	PUNCT
dpc-4075	166	18	doi:10.1371/	doi:10.1371/	PROPN
dpc-4075	166	19	journal.pone.0163806	journal.pone.0163806	PROPN
dpc-4075	166	20	.	.	PROPN
dpc-4075	166	21	23	23	NUM
dpc-4075	166	22	.	.	PUNCT
dpc-4075	167	1	osinubi	osinubi	ADJ
dpc-4075	167	2	o	o	NOUN
dpc-4075	167	3	,	,	PUNCT
dpc-4075	167	4	grainge	grainge	PROPN
dpc-4075	167	5	mj	mj	PROPN
dpc-4075	167	6	,	,	PUNCT
dpc-4075	167	7	hong	hong	PROPN
dpc-4075	167	8	l	l	NOUN
dpc-4075	167	9	,	,	PUNCT
dpc-4075	167	10	ahmed	ahme	VERB
dpc-4075	167	11	a	a	PROPN
dpc-4075	167	12	,	,	PUNCT
dpc-4075	167	13	batchelor	batchelor	PROPN
dpc-4075	167	14	jm	jm	PROPN
dpc-4075	167	15	,	,	PUNCT
dpc-4075	167	16	grindlay	grindlay	PROPN
dpc-4075	167	17	d	d	PROPN
dpc-4075	167	18	,	,	PUNCT
dpc-4075	167	19	thompson	thompson	PROPN
dpc-4075	167	20	ar	ar	PROPN
dpc-4075	167	21	,	,	PUNCT
dpc-4075	167	22	ratib	ratib	PROPN
dpc-4075	167	23	s.	s.	PROPN
dpc-4075	167	24	the	the	DET
dpc-4075	167	25	prevalence	prevalence	NOUN
dpc-4075	167	26	of	of	ADP
dpc-4075	167	27	psychological	psychological	ADJ
dpc-4075	167	28	comorbidity	comorbidity	NOUN
dpc-4075	167	29	in	in	ADP
dpc-4075	167	30	people	people	NOUN
dpc-4075	167	31	with	with	ADP
dpc-4075	167	32	vitiligo	vitiligo	NOUN
dpc-4075	167	33	:	:	PUNCT
dpc-4075	167	34	a	a	DET
dpc-4075	167	35	systematic	systematic	ADJ
dpc-4075	167	36	review	review	NOUN
dpc-4075	167	37	and	and	CCONJ
dpc-4075	167	38	meta	meta	ADJ
dpc-4075	167	39	-	-	PUNCT
dpc-4075	167	40	analysis	analysis	NOUN
dpc-4075	167	41	.	.	PUNCT
dpc-4075	168	1	br	br	PROPN
dpc-4075	168	2	j	j	PROPN
dpc-4075	168	3	dermatol	dermatol	NOUN
dpc-4075	168	4	.	.	PUNCT
dpc-4075	169	1	2018	2018	NUM
dpc-4075	169	2	;	;	PUNCT
dpc-4075	170	1	178:863	178:863	NUM
dpc-4075	170	2	-	-	PUNCT
dpc-4075	170	3	878	878	NUM
dpc-4075	170	4	.	.	PUNCT
dpc-4075	170	5	24	24	NUM
dpc-4075	170	6	.	.	PUNCT
dpc-4075	171	1	liu	liu	PROPN
dpc-4075	171	2	cw	cw	PROPN
dpc-4075	171	3	,	,	PUNCT
dpc-4075	171	4	huang	huang	PROPN
dpc-4075	171	5	yc	yc	PROPN
dpc-4075	171	6	.	.	PROPN
dpc-4075	171	7	vitiligo	vitiligo	PROPN
dpc-4075	171	8	and	and	CCONJ
dpc-4075	171	9	autoantibodies	autoantibody	NOUN
dpc-4075	171	10	:	:	PUNCT
dpc-4075	171	11	a	a	DET
dpc-4075	171	12	systematic	systematic	ADJ
dpc-4075	171	13	review	review	NOUN
dpc-4075	171	14	and	and	CCONJ
dpc-4075	171	15	meta	meta	ADJ
dpc-4075	171	16	-	-	PUNCT
dpc-4075	171	17	analysis	analysis	NOUN
dpc-4075	171	18	.	.	PUNCT
dpc-4075	172	1	j	j	PROPN
dpc-4075	172	2	dtsch	dtsch	PROPN
dpc-4075	172	3	dermatol	dermatol	NOUN
dpc-4075	172	4	ges	ge	NOUN
dpc-4075	172	5	.	.	PROPN
dpc-4075	172	6	2018	2018	NUM
dpc-4075	172	7	;	;	PUNCT
dpc-4075	172	8	16:845	16:845	NUM
dpc-4075	172	9	-	-	SYM
dpc-4075	172	10	851	851	NUM
dpc-4075	172	11	.	.	PUNCT
dpc-4075	172	12	25	25	NUM
dpc-4075	172	13	.	.	PUNCT
dpc-4075	173	1	saikarthik	saikarthik	PROPN
dpc-4075	174	1	p	p	X
dpc-4075	174	2	,	,	PUNCT
dpc-4075	174	3	reddy	reddy	PROPN
dpc-4075	174	4	vh	vh	PROPN
dpc-4075	174	5	,	,	PUNCT
dpc-4075	174	6	rafi	rafi	PROPN
dpc-4075	174	7	sm	sm	PROPN
dpc-4075	174	8	,	,	PUNCT
dpc-4075	174	9	basha	basha	PROPN
dpc-4075	174	10	vw	vw	PROPN
dpc-4075	174	11	,	,	PUNCT
dpc-4075	174	12	padmakar	padmakar	PROPN
dpc-4075	174	13	s.	s.	PROPN
dpc-4075	174	14	a	a	DET
dpc-4075	174	15	systematic	systematic	ADJ
dpc-4075	174	16	review	review	NOUN
dpc-4075	174	17	on	on	ADP
dpc-4075	174	18	prevalence	prevalence	NOUN
dpc-4075	174	19	and	and	CCONJ
dpc-4075	174	20	assessment	assessment	NOUN
dpc-4075	174	21	of	of	ADP
dpc-4075	174	22	sexual	sexual	ADJ
dpc-4075	174	23	dysfunction	dysfunction	NOUN
dpc-4075	174	24	in	in	ADP
dpc-4075	174	25	vitiligo	vitiligo	NOUN
dpc-4075	174	26	.	.	PUNCT
dpc-4075	175	1	j	j	PROPN
dpc-4075	175	2	assoc	assoc	PROPN
dpc-4075	175	3	physicians	physicians	PROPN
dpc-4075	175	4	india	india	PROPN
dpc-4075	175	5	.	.	PUNCT
dpc-4075	175	6	2022	2022	NUM
dpc-4075	175	7	;	;	PUNCT
dpc-4075	175	8	70:11	70:11	NUM
dpc-4075	175	9	-	-	SYM
dpc-4075	175	10	12	12	NUM
dpc-4075	175	11	.	.	PUNCT
dpc-4075	176	1	26	26	NUM
dpc-4075	176	2	.	.	PUNCT
dpc-4075	177	1	xia	xia	PROPN
dpc-4075	177	2	j	j	PROPN
dpc-4075	177	3	,	,	PUNCT
dpc-4075	177	4	melian	melian	PROPN
dpc-4075	177	5	c	c	PROPN
dpc-4075	177	6	,	,	PUNCT
dpc-4075	177	7	guo	guo	PROPN
dpc-4075	177	8	w	w	PROPN
dpc-4075	177	9	,	,	PUNCT
dpc-4075	177	10	usmani	usmani	ADJ
dpc-4075	177	11	h	h	NOUN
dpc-4075	177	12	,	,	PUNCT
dpc-4075	177	13	clark	clark	PROPN
dpc-4075	177	14	r	r	PROPN
dpc-4075	177	15	,	,	PUNCT
dpc-4075	177	16	lozeau	lozeau	PROPN
dpc-4075	177	17	d.	d.	PROPN
dpc-4075	177	18	vitiligo	vitiligo	PROPN
dpc-4075	177	19	and	and	CCONJ
dpc-4075	177	20	metabolic	metabolic	NOUN
dpc-4075	177	21	syndrome	syndrome	NOUN
dpc-4075	177	22	:	:	PUNCT
dpc-4075	177	23	systematic	systematic	ADJ
dpc-4075	177	24	review	review	NOUN
dpc-4075	177	25	and	and	CCONJ
dpc-4075	177	26	metaanalysis	metaanalysis	NOUN
dpc-4075	177	27	.	.	PUNCT
dpc-4075	178	1	jmir	jmir	PROPN
dpc-4075	178	2	dermatol	dermatol	NOUN
dpc-4075	178	3	.	.	PUNCT
dpc-4075	179	1	2022	2022	NUM
dpc-4075	179	2	mar	mar	PROPN
dpc-4075	179	3	16	16	NUM
dpc-4075	179	4	;	;	PUNCT
dpc-4075	179	5	5(1):e34772	5(1):e34772	NUM
dpc-4075	179	6	.	.	NOUN
dpc-4075	179	7	27	27	NUM
dpc-4075	179	8	.	.	PUNCT
dpc-4075	180	1	kang	kang	PROPN
dpc-4075	180	2	p	p	PROPN
dpc-4075	180	3	,	,	PUNCT
dpc-4075	180	4	zhang	zhang	PROPN
dpc-4075	180	5	wg	wg	PROPN
dpc-4075	180	6	,	,	PUNCT
dpc-4075	180	7	ji	ji	PROPN
dpc-4075	180	8	zh	zh	PROPN
dpc-4075	180	9	,	,	PUNCT
dpc-4075	180	10	shao	shao	PROPN
dpc-4075	180	11	zj	zj	PROPN
dpc-4075	180	12	,	,	PUNCT
dpc-4075	180	13	li	li	PROPN
dpc-4075	180	14	cy	cy	PROPN
dpc-4075	180	15	.	.	PROPN
dpc-4075	180	16	association	association	PROPN
dpc-4075	180	17	between	between	ADP
dpc-4075	180	18	vitiligo	vitiligo	PROPN
dpc-4075	180	19	and	and	CCONJ
dpc-4075	180	20	relevant	relevant	ADJ
dpc-4075	180	21	components	component	NOUN
dpc-4075	180	22	of	of	ADP
dpc-4075	180	23	metabolic	metabolic	NOUN
dpc-4075	180	24	syndrome	syndrome	NOUN
dpc-4075	180	25	:	:	PUNCT
dpc-4075	180	26	a	a	DET
dpc-4075	180	27	systematic	systematic	ADJ
dpc-4075	180	28	review	review	NOUN
dpc-4075	180	29	and	and	CCONJ
dpc-4075	180	30	meta	meta	ADJ
dpc-4075	180	31	-	-	PUNCT
dpc-4075	180	32	analysis	analysis	NOUN
dpc-4075	180	33	.	.	PUNCT
dpc-4075	181	1	j	j	PROPN
dpc-4075	181	2	dtsch	dtsch	PROPN
dpc-4075	181	3	dermatol	dermatol	NOUN
dpc-4075	181	4	ges	ge	NOUN
dpc-4075	181	5	.	.	PROPN
dpc-4075	181	6	2022	2022	NUM
dpc-4075	181	7	;	;	PUNCT
dpc-4075	181	8	20:629	20:629	NUM
dpc-4075	181	9	-	-	SYM
dpc-4075	181	10	641	641	NUM
dpc-4075	181	11	.	.	PUNCT
dpc-4075	181	12	28	28	NUM
dpc-4075	181	13	.	.	PUNCT
dpc-4075	182	1	rooker	rooker	PROPN
dpc-4075	182	2	a	a	PROPN
dpc-4075	182	3	,	,	PUNCT
dpc-4075	182	4	ouwerkerk	ouwerkerk	PROPN
dpc-4075	182	5	w	w	PROPN
dpc-4075	182	6	,	,	PUNCT
dpc-4075	182	7	bekkenk	bekkenk	PROPN
dpc-4075	182	8	mw	mw	NOUN
dpc-4075	182	9	,	,	PUNCT
dpc-4075	182	10	luiten	luiten	PROPN
dpc-4075	182	11	rm	rm	PROPN
dpc-4075	182	12	,	,	PUNCT
dpc-4075	182	13	bakker	bakker	PROPN
dpc-4075	182	14	wj	wj	PROPN
dpc-4075	182	15	.	.	PUNCT
dpc-4075	183	1	the	the	DET
dpc-4075	183	2	risk	risk	NOUN
dpc-4075	183	3	of	of	ADP
dpc-4075	183	4	keratinocyte	keratinocyte	NOUN
dpc-4075	183	5	cancer	cancer	NOUN
dpc-4075	183	6	in	in	ADP
dpc-4075	183	7	vitiligo	vitiligo	PROPN
dpc-4075	183	8	and	and	CCONJ
dpc-4075	183	9	the	the	DET
dpc-4075	183	10	potential	potential	ADJ
dpc-4075	183	11	mechanisms	mechanism	NOUN
dpc-4075	183	12	involved	involve	VERB
dpc-4075	183	13	.	.	PUNCT
dpc-4075	184	1	j	j	PROPN
dpc-4075	184	2	invest	invest	VERB
dpc-4075	184	3	dermatol	dermatol	NOUN
dpc-4075	184	4	.	.	PUNCT
dpc-4075	185	1	2023	2023	NUM
dpc-4075	185	2	oct	oct	NOUN
dpc-4075	185	3	2	2	NUM
dpc-4075	185	4	;	;	PUNCT
dpc-4075	185	5	s0022	s0022	NOUN
dpc-4075	185	6	-	-	PUNCT
dpc-4075	185	7	202x(23)02566	202x(23)02566	NUM
dpc-4075	185	8	-	-	PUNCT
dpc-4075	185	9	6	6	NUM
dpc-4075	185	10	.	.	NOUN
dpc-4075	185	11	29	29	NUM
dpc-4075	185	12	.	.	PUNCT
dpc-4075	185	13	naldi	naldi	PROPN
dpc-4075	185	14	l	l	PROPN
dpc-4075	185	15	,	,	PUNCT
dpc-4075	185	16	colombo	colombo	NOUN
dpc-4075	185	17	p	p	NOUN
dpc-4075	185	18	,	,	PUNCT
dpc-4075	185	19	placchesi	placchesi	PROPN
dpc-4075	185	20	eb	eb	PROPN
dpc-4075	185	21	,	,	PUNCT
dpc-4075	185	22	et	et	PROPN
dpc-4075	185	23	al	al	PROPN
dpc-4075	185	24	.	.	PROPN
dpc-4075	185	25	study	study	NOUN
dpc-4075	185	26	design	design	NOUN
dpc-4075	185	27	and	and	CCONJ
dpc-4075	185	28	preliminary	preliminary	ADJ
dpc-4075	185	29	results	result	NOUN
dpc-4075	185	30	from	from	ADP
dpc-4075	185	31	the	the	DET
dpc-4075	185	32	pilot	pilot	NOUN
dpc-4075	185	33	phase	phase	NOUN
dpc-4075	185	34	of	of	ADP
dpc-4075	185	35	the	the	DET
dpc-4075	185	36	praktis	praktis	NOUN
dpc-4075	185	37	study	study	NOUN
dpc-4075	185	38	:	:	PUNCT
dpc-4075	185	39	self	self	NOUN
dpc-4075	185	40	reported	report	VERB
dpc-4075	185	41	diagnoses	diagnosis	NOUN
dpc-4075	185	42	of	of	ADP
dpc-4075	185	43	selected	select	VERB
dpc-4075	185	44	skin	skin	NOUN
dpc-4075	185	45	diseases	disease	NOUN
dpc-4075	185	46	in	in	ADP
dpc-4075	185	47	a	a	DET
dpc-4075	185	48	representative	representative	ADJ
dpc-4075	185	49	sample	sample	NOUN
dpc-4075	185	50	of	of	ADP
dpc-4075	185	51	the	the	DET
dpc-4075	185	52	italian	italian	ADJ
dpc-4075	185	53	population	population	NOUN
dpc-4075	185	54	.	.	PUNCT
dpc-4075	186	1	dermatology	dermatology	NOUN
dpc-4075	186	2	.	.	PUNCT
dpc-4075	187	1	2004	2004	NUM
dpc-4075	187	2	;	;	PUNCT
dpc-4075	188	1	208:38	208:38	PROPN
dpc-4075	188	2	-	-	SYM
dpc-4075	188	3	42	42	NUM
dpc-4075	188	4	.	.	PUNCT
dpc-4075	188	5	30	30	NUM
dpc-4075	188	6	.	.	PUNCT
dpc-4075	189	1	sampogna	sampogna	PROPN
dpc-4075	189	2	f	f	PROPN
dpc-4075	189	3	,	,	PUNCT
dpc-4075	189	4	raskovic	raskovic	PROPN
dpc-4075	189	5	d	d	PROPN
dpc-4075	189	6	,	,	PUNCT
dpc-4075	189	7	guerra	guerra	PROPN
dpc-4075	189	8	l	l	PROPN
dpc-4075	189	9	,	,	PUNCT
dpc-4075	189	10	pedicelli	pedicelli	PROPN
dpc-4075	189	11	c	c	PROPN
dpc-4075	189	12	,	,	PUNCT
dpc-4075	189	13	tabolli	tabolli	PROPN
dpc-4075	189	14	s	s	PART
dpc-4075	189	15	,	,	PUNCT
dpc-4075	189	16	leoni	leoni	PROPN
dpc-4075	189	17	l	l	NOUN
dpc-4075	189	18	,	,	PUNCT
dpc-4075	189	19	alessandroni	alessandroni	PROPN
dpc-4075	189	20	l	l	NOUN
dpc-4075	189	21	,	,	PUNCT
dpc-4075	189	22	abeni	abeni	PROPN
dpc-4075	189	23	d.	d.	PROPN
dpc-4075	189	24	identification	identification	NOUN
dpc-4075	189	25	of	of	ADP
dpc-4075	189	26	categories	category	NOUN
dpc-4075	189	27	at	at	ADP
dpc-4075	189	28	risk	risk	NOUN
dpc-4075	189	29	for	for	ADP
dpc-4075	189	30	high	high	ADJ
dpc-4075	189	31	quality	quality	NOUN
dpc-4075	189	32	of	of	ADP
dpc-4075	189	33	life	life	NOUN
dpc-4075	189	34	impairment	impairment	ADJ
dpc-4075	189	35	in	in	ADP
dpc-4075	189	36	patients	patient	NOUN
dpc-4075	189	37	with	with	ADP
dpc-4075	189	38	vitiligo	vitiligo	NOUN
dpc-4075	189	39	.	.	PUNCT
dpc-4075	190	1	br	br	PROPN
dpc-4075	190	2	j	j	PROPN
dpc-4075	190	3	dermatol	dermatol	NOUN
dpc-4075	190	4	.	.	PUNCT
dpc-4075	191	1	2008	2008	NUM
dpc-4075	191	2	;	;	PUNCT
dpc-4075	192	1	159:351	159:351	NOUN
dpc-4075	192	2	-	-	SYM
dpc-4075	192	3	9	9	NUM
dpc-4075	192	4	.	.	NUM
dpc-4075	192	5	31	31	NUM
dpc-4075	192	6	.	.	PUNCT
dpc-4075	192	7	naldi	naldi	PROPN
dpc-4075	192	8	l	l	PROPN
dpc-4075	192	9	,	,	PUNCT
dpc-4075	192	10	parazzini	parazzini	NOUN
dpc-4075	192	11	f	f	PROPN
dpc-4075	192	12	,	,	PUNCT
dpc-4075	192	13	gallus	gallus	PROPN
dpc-4075	192	14	s	s	PART
dpc-4075	192	15	;	;	PUNCT
dpc-4075	192	16	gised	gise	VERB
dpc-4075	192	17	study	study	NOUN
dpc-4075	192	18	centres	centre	NOUN
dpc-4075	192	19	.	.	PUNCT
dpc-4075	193	1	prevalence	prevalence	NOUN
dpc-4075	193	2	of	of	ADP
dpc-4075	193	3	atopic	atopic	NOUN
dpc-4075	193	4	dermatitis	dermatitis	NOUN
dpc-4075	193	5	in	in	ADP
dpc-4075	193	6	italian	italian	ADJ
dpc-4075	193	7	schoolchildren	schoolchildren	NOUN
dpc-4075	193	8	:	:	PUNCT
dpc-4075	193	9	factors	factor	NOUN
dpc-4075	193	10	affecting	affect	VERB
dpc-4075	193	11	its	its	PRON
dpc-4075	193	12	variation	variation	NOUN
dpc-4075	193	13	.	.	PUNCT
dpc-4075	194	1	acta	acta	PROPN
dpc-4075	194	2	derm	derm	PROPN
dpc-4075	194	3	venereol	venereol	NOUN
dpc-4075	194	4	.	.	PUNCT
dpc-4075	195	1	2009	2009	NUM
dpc-4075	195	2	;	;	PUNCT
dpc-4075	195	3	89:122	89:122	NUM
dpc-4075	195	4	-	-	SYM
dpc-4075	195	5	5	5	NUM
dpc-4075	195	6	.	.	NOUN
dpc-4075	195	7	32	32	NUM
dpc-4075	195	8	.	.	PUNCT
dpc-4075	196	1	ingordo	ingordo	PROPN
dpc-4075	196	2	v	v	PROPN
dpc-4075	196	3	,	,	PUNCT
dpc-4075	196	4	gentile	gentile	NOUN
dpc-4075	196	5	c	c	NOUN
dpc-4075	196	6	,	,	PUNCT
dpc-4075	196	7	iannazzone	iannazzone	PROPN
dpc-4075	196	8	ss	ss	PROPN
dpc-4075	196	9	,	,	PUNCT
dpc-4075	196	10	cusano	cusano	ADJ
dpc-4075	196	11	f	f	X
dpc-4075	196	12	,	,	PUNCT
dpc-4075	196	13	naldi	naldi	PROPN
dpc-4075	196	14	l.	l.	PROPN
dpc-4075	196	15	vitiligo	vitiligo	PROPN
dpc-4075	196	16	and	and	CCONJ
dpc-4075	196	17	autoimmunity	autoimmunity	NOUN
dpc-4075	196	18	:	:	PUNCT
dpc-4075	196	19	an	an	DET
dpc-4075	196	20	epidemiological	epidemiological	ADJ
dpc-4075	196	21	study	study	NOUN
dpc-4075	196	22	in	in	ADP
dpc-4075	196	23	a	a	DET
dpc-4075	196	24	representative	representative	ADJ
dpc-4075	196	25	sample	sample	NOUN
dpc-4075	196	26	of	of	ADP
dpc-4075	196	27	young	young	ADJ
dpc-4075	196	28	italian	italian	ADJ
dpc-4075	196	29	males	male	NOUN
dpc-4075	196	30	.	.	PUNCT
dpc-4075	197	1	j	j	PROPN
dpc-4075	197	2	eur	eur	PROPN
dpc-4075	197	3	acad	acad	PROPN
dpc-4075	197	4	dermatol	dermatol	NOUN
dpc-4075	197	5	venereol	venereol	NOUN
dpc-4075	197	6	.	.	PUNCT
dpc-4075	198	1	2011	2011	NUM
dpc-4075	198	2	;	;	PUNCT
dpc-4075	198	3	25:105	25:105	NUM
dpc-4075	198	4	-	-	SYM
dpc-4075	198	5	9	9	NUM
dpc-4075	198	6	.	.	NOUN
dpc-4075	198	7	33	33	NUM
dpc-4075	198	8	.	.	PUNCT
dpc-4075	199	1	ingordo	ingordo	PROPN
dpc-4075	199	2	v	v	PROPN
dpc-4075	199	3	,	,	PUNCT
dpc-4075	199	4	cazzaniga	cazzaniga	ADV
dpc-4075	199	5	s	s	PROPN
dpc-4075	199	6	,	,	PUNCT
dpc-4075	199	7	gentile	gentile	NOUN
dpc-4075	199	8	c	c	NOUN
dpc-4075	199	9	,	,	PUNCT
dpc-4075	199	10	iannazzone	iannazzone	PROPN
dpc-4075	199	11	ss	ss	PROPN
dpc-4075	199	12	,	,	PUNCT
dpc-4075	199	13	cusano	cusano	ADJ
dpc-4075	199	14	f	f	PROPN
dpc-4075	199	15	,	,	PUNCT
dpc-4075	199	16	naldi	naldi	PROPN
dpc-4075	199	17	l.	l.	PROPN
dpc-4075	199	18	dermatology	dermatology	PROPN
dpc-4075	199	19	life	life	PROPN
dpc-4075	199	20	quality	quality	NOUN
dpc-4075	199	21	index	index	NOUN
dpc-4075	199	22	score	score	NOUN
dpc-4075	199	23	in	in	ADP
dpc-4075	199	24	vitiligo	vitiligo	ADJ
dpc-4075	199	25	patients	patient	NOUN
dpc-4075	199	26	:	:	PUNCT
dpc-4075	199	27	a	a	DET
dpc-4075	199	28	pilot	pilot	NOUN
dpc-4075	199	29	study	study	NOUN
dpc-4075	199	30	among	among	ADP
dpc-4075	199	31	young	young	ADJ
dpc-4075	199	32	italian	italian	ADJ
dpc-4075	199	33	males	male	NOUN
dpc-4075	199	34	.	.	PUNCT
dpc-4075	200	1	g	g	PROPN
dpc-4075	200	2	ital	ital	ADJ
dpc-4075	200	3	dermatol	dermatol	NOUN
dpc-4075	200	4	venereol	venereol	NOUN
dpc-4075	200	5	.	.	PUNCT
dpc-4075	201	1	2012	2012	NUM
dpc-4075	201	2	;	;	PUNCT
dpc-4075	201	3	147:83	147:83	NUM
dpc-4075	201	4	-	-	SYM
dpc-4075	201	5	90	90	NUM
dpc-4075	201	6	.	.	PUNCT
dpc-4075	202	1	34	34	NUM
dpc-4075	202	2	.	.	PUNCT
dpc-4075	203	1	ingordo	ingordo	PROPN
dpc-4075	203	2	v	v	PROPN
dpc-4075	203	3	,	,	PUNCT
dpc-4075	203	4	cazzaniga	cazzaniga	ADV
dpc-4075	203	5	s	s	SYM
dpc-4075	203	6	,	,	PUNCT
dpc-4075	203	7	medri	medri	NOUN
dpc-4075	203	8	m	m	PROPN
dpc-4075	203	9	,	,	PUNCT
dpc-4075	203	10	et	et	PROPN
dpc-4075	203	11	al	al	PROPN
dpc-4075	203	12	.	.	PUNCT
dpc-4075	204	1	to	to	ADP
dpc-4075	204	2	what	what	DET
dpc-4075	204	3	extent	extent	NOUN
dpc-4075	204	4	is	be	AUX
dpc-4075	204	5	quality	quality	NOUN
dpc-4075	204	6	of	of	ADP
dpc-4075	204	7	life	life	NOUN
dpc-4075	204	8	impaired	impair	VERB
dpc-4075	204	9	in	in	ADP
dpc-4075	204	10	vitiligo	vitiligo	NOUN
dpc-4075	204	11	?	?	PUNCT
dpc-4075	205	1	a	a	DET
dpc-4075	205	2	multicenter	multicenter	ADJ
dpc-4075	205	3	study	study	NOUN
dpc-4075	205	4	on	on	ADP
dpc-4075	205	5	italian	italian	ADJ
dpc-4075	205	6	patients	patient	NOUN
dpc-4075	205	7	using	use	VERB
dpc-4075	205	8	the	the	DET
dpc-4075	205	9	dermatology	dermatology	NOUN
dpc-4075	205	10	life	life	NOUN
dpc-4075	205	11	quality	quality	NOUN
dpc-4075	205	12	index	index	NOUN
dpc-4075	205	13	.	.	PUNCT
dpc-4075	206	1	dermatology	dermatology	NOUN
dpc-4075	206	2	.	.	PUNCT
dpc-4075	207	1	2014	2014	NUM
dpc-4075	207	2	;	;	PUNCT
dpc-4075	207	3	229:240	229:240	NOUN
dpc-4075	207	4	-	-	SYM
dpc-4075	207	5	7	7	NUM
dpc-4075	207	6	35	35	NUM
dpc-4075	207	7	.	.	PUNCT
dpc-4075	208	1	svensson	svensson	PROPN
dpc-4075	208	2	a	a	DET
dpc-4075	208	3	,	,	PUNCT
dpc-4075	208	4	ofenloch	ofenloch	NOUN
dpc-4075	208	5	rf	rf	NOUN
dpc-4075	208	6	,	,	PUNCT
dpc-4075	208	7	bruze	bruze	PROPN
dpc-4075	208	8	m	m	PROPN
dpc-4075	208	9	,	,	PUNCT
dpc-4075	208	10	et	et	PROPN
dpc-4075	208	11	al	al	PROPN
dpc-4075	208	12	.	.	PUNCT
dpc-4075	209	1	prevalence	prevalence	NOUN
dpc-4075	209	2	of	of	ADP
dpc-4075	209	3	skin	skin	NOUN
dpc-4075	209	4	disease	disease	NOUN
dpc-4075	209	5	in	in	ADP
dpc-4075	209	6	a	a	DET
dpc-4075	209	7	population	population	NOUN
dpc-4075	209	8	-	-	PUNCT
dpc-4075	209	9	based	base	VERB
dpc-4075	209	10	sample	sample	NOUN
dpc-4075	209	11	of	of	ADP
dpc-4075	209	12	adults	adult	NOUN
dpc-4075	209	13	from	from	ADP
dpc-4075	209	14	five	five	NUM
dpc-4075	209	15	european	european	ADJ
dpc-4075	209	16	countries	country	NOUN
dpc-4075	209	17	.	.	PUNCT
dpc-4075	210	1	br	br	PROPN
dpc-4075	210	2	j	j	PROPN
dpc-4075	210	3	dermatol	dermatol	NOUN
dpc-4075	210	4	.	.	PUNCT
dpc-4075	211	1	2018	2018	NUM
dpc-4075	211	2	;	;	PUNCT
dpc-4075	212	1	178:1111	178:1111	NOUN
dpc-4075	212	2	-	-	SYM
dpc-4075	212	3	1118	1118	NUM
dpc-4075	212	4	.	.	PUNCT
dpc-4075	213	1	36	36	NUM
dpc-4075	213	2	.	.	PUNCT
dpc-4075	213	3	martini	martini	PROPN
dpc-4075	213	4	n.	n.	PROPN
dpc-4075	213	5	,	,	PUNCT
dpc-4075	213	6	et	et	PROPN
dpc-4075	213	7	al	al	PROPN
dpc-4075	213	8	.	.	PUNCT
dpc-4075	214	1	real	real	ADJ
dpc-4075	214	2	world	world	NOUN
dpc-4075	214	3	evidence	evidence	NOUN
dpc-4075	214	4	(	(	PUNCT
dpc-4075	214	5	rwe	rwe	NOUN
dpc-4075	214	6	)	)	PUNCT
dpc-4075	214	7	analysis	analysis	NOUN
dpc-4075	214	8	of	of	ADP
dpc-4075	214	9	vitiligo	vitiligo	ADJ
dpc-4075	214	10	patients	patient	NOUN
dpc-4075	214	11	.	.	PUNCT
dpc-4075	215	1	2022	2022	NUM
dpc-4075	215	2	references	reference	NOUN
dpc-4075	215	3	1	1	NUM
dpc-4075	215	4	.	.	PUNCT
dpc-4075	215	5	ezzedine	ezzedine	PROPN
dpc-4075	215	6	k	k	NOUN
dpc-4075	215	7	,	,	PUNCT
dpc-4075	215	8	eleftheriadou	eleftheriadou	NOUN
dpc-4075	215	9	v	v	NOUN
dpc-4075	215	10	,	,	PUNCT
dpc-4075	215	11	whitton	whitton	PROPN
dpc-4075	215	12	m	m	PROPN
dpc-4075	215	13	,	,	PUNCT
dpc-4075	215	14	van	van	PROPN
dpc-4075	215	15	geel	geel	PROPN
dpc-4075	215	16	n.	n.	PROPN
dpc-4075	215	17	vitiligo	vitiligo	PROPN
dpc-4075	215	18	.	.	PUNCT
dpc-4075	216	1	lancet	lancet	PROPN
dpc-4075	216	2	.	.	PUNCT
dpc-4075	217	1	2015	2015	NUM
dpc-4075	217	2	;	;	PUNCT
dpc-4075	217	3	386:74	386:74	PROPN
dpc-4075	217	4	-	-	SYM
dpc-4075	217	5	84	84	NUM
dpc-4075	217	6	.	.	PUNCT
dpc-4075	218	1	2	2	X
dpc-4075	218	2	.	.	X
dpc-4075	218	3	bergqvist	bergqvist	PROPN
dpc-4075	218	4	c	c	PROPN
dpc-4075	218	5	,	,	PUNCT
dpc-4075	218	6	ezzedine	ezzedine	PROPN
dpc-4075	218	7	k.	k.	PROPN
dpc-4075	218	8	vitiligo	vitiligo	PROPN
dpc-4075	218	9	:	:	PUNCT
dpc-4075	218	10	a	a	DET
dpc-4075	218	11	focus	focus	NOUN
dpc-4075	218	12	on	on	ADP
dpc-4075	218	13	pathogenesis	pathogenesis	NOUN
dpc-4075	218	14	and	and	CCONJ
dpc-4075	218	15	its	its	PRON
dpc-4075	218	16	therapeutic	therapeutic	ADJ
dpc-4075	218	17	implications	implication	NOUN
dpc-4075	218	18	.	.	PUNCT
dpc-4075	219	1	j	j	PROPN
dpc-4075	219	2	dermatol	dermatol	NOUN
dpc-4075	219	3	.	.	PUNCT
dpc-4075	219	4	2021	2021	NUM
dpc-4075	219	5	;	;	PUNCT
dpc-4075	219	6	48:252	48:252	NUM
dpc-4075	219	7	-	-	SYM
dpc-4075	219	8	270	270	NUM
dpc-4075	219	9	.	.	PUNCT
dpc-4075	220	1	3	3	X
dpc-4075	220	2	.	.	X
dpc-4075	220	3	ingordo	ingordo	PROPN
dpc-4075	220	4	v	v	PROPN
dpc-4075	220	5	,	,	PUNCT
dpc-4075	220	6	gentile	gentile	NOUN
dpc-4075	220	7	c	c	NOUN
dpc-4075	220	8	,	,	PUNCT
dpc-4075	220	9	iannazzone	iannazzone	PROPN
dpc-4075	220	10	ss	ss	PROPN
dpc-4075	220	11	,	,	PUNCT
dpc-4075	220	12	cusano	cusano	ADJ
dpc-4075	220	13	f	f	PROPN
dpc-4075	220	14	,	,	PUNCT
dpc-4075	220	15	naldi	naldi	PROPN
dpc-4075	220	16	l.	l.	PROPN
dpc-4075	220	17	the	the	DET
dpc-4075	220	18	‘	'	PUNCT
dpc-4075	220	19	epienlist	epienlist	NOUN
dpc-4075	220	20	’	'	PUNCT
dpc-4075	220	21	project	project	NOUN
dpc-4075	220	22	:	:	PUNCT
dpc-4075	220	23	a	a	DET
dpc-4075	220	24	dermo	dermo	NOUN
dpc-4075	220	25	-	-	PUNCT
dpc-4075	220	26	epidemiologic	epidemiologic	ADJ
dpc-4075	220	27	study	study	NOUN
dpc-4075	220	28	on	on	ADP
dpc-4075	220	29	a	a	DET
dpc-4075	220	30	representative	representative	ADJ
dpc-4075	220	31	sample	sample	NOUN
dpc-4075	220	32	of	of	ADP
dpc-4075	220	33	young	young	ADJ
dpc-4075	220	34	italian	italian	ADJ
dpc-4075	220	35	males	male	NOUN
dpc-4075	220	36	.	.	PUNCT
dpc-4075	221	1	prevalence	prevalence	NOUN
dpc-4075	221	2	of	of	ADP
dpc-4075	221	3	selected	select	VERB
dpc-4075	221	4	pigmentary	pigmentary	ADJ
dpc-4075	221	5	lesions	lesion	NOUN
dpc-4075	221	6	.	.	PUNCT
dpc-4075	222	1	j	j	PROPN
dpc-4075	222	2	eur	eur	PROPN
dpc-4075	222	3	acad	acad	PROPN
dpc-4075	222	4	dermatol	dermatol	NOUN
dpc-4075	222	5	venereol	venereol	NOUN
dpc-4075	222	6	.	.	PUNCT
dpc-4075	223	1	2007	2007	NUM
dpc-4075	224	1	sep;21(8):1091	sep;21(8):1091	ADJ
dpc-4075	224	2	-	-	PUNCT
dpc-4075	224	3	6	6	NUM
dpc-4075	224	4	.	.	NOUN
dpc-4075	224	5	4	4	NUM
dpc-4075	224	6	.	.	NUM
dpc-4075	224	7	naldi	naldi	PROPN
dpc-4075	224	8	l	l	PROPN
dpc-4075	224	9	,	,	PUNCT
dpc-4075	224	10	parazzini	parazzini	NOUN
dpc-4075	224	11	f	f	PROPN
dpc-4075	224	12	,	,	PUNCT
dpc-4075	224	13	gallus	gallus	PROPN
dpc-4075	224	14	s	s	PART
dpc-4075	224	15	;	;	PUNCT
dpc-4075	224	16	gised	gise	VERB
dpc-4075	224	17	study	study	NOUN
dpc-4075	224	18	centres	centre	NOUN
dpc-4075	224	19	.	.	PUNCT
dpc-4075	225	1	prevalence	prevalence	NOUN
dpc-4075	225	2	of	of	ADP
dpc-4075	225	3	atopic	atopic	NOUN
dpc-4075	225	4	dermatitis	dermatitis	NOUN
dpc-4075	225	5	in	in	ADP
dpc-4075	225	6	italian	italian	ADJ
dpc-4075	225	7	schoolchildren	schoolchildren	NOUN
dpc-4075	225	8	:	:	PUNCT
dpc-4075	225	9	factors	factor	NOUN
dpc-4075	225	10	affecting	affect	VERB
dpc-4075	225	11	its	its	PRON
dpc-4075	225	12	variation	variation	NOUN
dpc-4075	225	13	.	.	PUNCT
dpc-4075	226	1	acta	acta	PROPN
dpc-4075	226	2	derm	derm	PROPN
dpc-4075	226	3	venereol	venereol	NOUN
dpc-4075	226	4	.	.	PUNCT
dpc-4075	227	1	2009	2009	NUM
dpc-4075	227	2	;	;	PUNCT
dpc-4075	227	3	89:122	89:122	NUM
dpc-4075	227	4	-	-	SYM
dpc-4075	227	5	5	5	NUM
dpc-4075	227	6	.	.	NOUN
dpc-4075	227	7	5	5	NUM
dpc-4075	227	8	.	.	PUNCT
dpc-4075	228	1	lai	lai	PROPN
dpc-4075	228	2	yc	yc	PROPN
dpc-4075	228	3	,	,	PUNCT
dpc-4075	228	4	yew	yew	PROPN
dpc-4075	228	5	yw	yw	PROPN
dpc-4075	228	6	,	,	PUNCT
dpc-4075	228	7	kennedy	kennedy	PROPN
dpc-4075	228	8	c	c	PROPN
dpc-4075	228	9	,	,	PUNCT
dpc-4075	228	10	schwartz	schwartz	PROPN
dpc-4075	228	11	ra	ra	PROPN
dpc-4075	228	12	.	.	PROPN
dpc-4075	228	13	vitiligo	vitiligo	PROPN
dpc-4075	228	14	and	and	CCONJ
dpc-4075	228	15	depression	depression	NOUN
dpc-4075	228	16	:	:	PUNCT
dpc-4075	228	17	a	a	DET
dpc-4075	228	18	systematic	systematic	ADJ
dpc-4075	228	19	review	review	NOUN
dpc-4075	228	20	and	and	CCONJ
dpc-4075	228	21	meta	meta	ADJ
dpc-4075	228	22	-	-	PUNCT
dpc-4075	228	23	analysis	analysis	NOUN
dpc-4075	228	24	of	of	ADP
dpc-4075	228	25	observational	observational	ADJ
dpc-4075	228	26	studies	study	NOUN
dpc-4075	228	27	.	.	PUNCT
dpc-4075	229	1	br	br	PROPN
dpc-4075	229	2	j	j	PROPN
dpc-4075	229	3	dermatol	dermatol	NOUN
dpc-4075	229	4	.	.	PUNCT
dpc-4075	230	1	2017	2017	NUM
dpc-4075	230	2	;	;	PUNCT
dpc-4075	231	1	177:708	177:708	NUM
dpc-4075	231	2	-	-	SYM
dpc-4075	231	3	718	718	NUM
dpc-4075	231	4	.	.	PUNCT
dpc-4075	232	1	6	6	NUM
dpc-4075	232	2	.	.	PUNCT
dpc-4075	232	3	wang	wang	PROPN
dpc-4075	232	4	g	g	PROPN
dpc-4075	232	5	,	,	PUNCT
dpc-4075	232	6	qiu	qiu	PROPN
dpc-4075	233	1	d	d	PROPN
dpc-4075	233	2	,	,	PUNCT
dpc-4075	233	3	yang	yang	PROPN
dpc-4075	233	4	h	h	PROPN
dpc-4075	233	5	,	,	PUNCT
dpc-4075	233	6	liu	liu	PROPN
dpc-4075	233	7	w.	w.	PROPN
dpc-4075	233	8	the	the	DET
dpc-4075	233	9	prevalence	prevalence	NOUN
dpc-4075	233	10	and	and	CCONJ
dpc-4075	233	11	odds	odd	NOUN
dpc-4075	233	12	of	of	ADP
dpc-4075	233	13	depression	depression	NOUN
dpc-4075	233	14	in	in	ADP
dpc-4075	233	15	patients	patient	NOUN
dpc-4075	233	16	with	with	ADP
dpc-4075	233	17	vitiligo	vitiligo	NOUN
dpc-4075	233	18	:	:	PUNCT
dpc-4075	233	19	a	a	DET
dpc-4075	233	20	meta	meta	ADJ
dpc-4075	233	21	-	-	PUNCT
dpc-4075	233	22	analysis	analysis	NOUN
dpc-4075	233	23	.	.	PUNCT
dpc-4075	234	1	j	j	PROPN
dpc-4075	234	2	eur	eur	PROPN
dpc-4075	234	3	acad	acad	PROPN
dpc-4075	234	4	dermatol	dermatol	NOUN
dpc-4075	234	5	venereol	venereol	NOUN
dpc-4075	234	6	.	.	PUNCT
dpc-4075	235	1	2018	2018	NUM
dpc-4075	235	2	;	;	PUNCT
dpc-4075	235	3	32:1343	32:1343	X
dpc-4075	235	4	-	-	SYM
dpc-4075	235	5	1351	1351	NUM
dpc-4075	235	6	.	.	PUNCT
dpc-4075	236	1	7	7	X
dpc-4075	236	2	.	.	X
dpc-4075	236	3	kussainova	kussainova	VERB
dpc-4075	236	4	a	a	DET
dpc-4075	236	5	,	,	PUNCT
dpc-4075	236	6	kassym	kassym	ADJ
dpc-4075	236	7	l	l	PROPN
dpc-4075	236	8	,	,	PUNCT
dpc-4075	236	9	akhmetova	akhmetova	X
dpc-4075	236	10	a	a	X
dpc-4075	236	11	,	,	PUNCT
dpc-4075	236	12	et	et	PROPN
dpc-4075	236	13	al	al	PROPN
dpc-4075	236	14	.	.	PROPN
dpc-4075	236	15	vitiligo	vitiligo	PROPN
dpc-4075	236	16	and	and	CCONJ
dpc-4075	236	17	anxiety	anxiety	NOUN
dpc-4075	236	18	:	:	PUNCT
dpc-4075	236	19	a	a	DET
dpc-4075	236	20	systematic	systematic	ADJ
dpc-4075	236	21	review	review	NOUN
dpc-4075	236	22	and	and	CCONJ
dpc-4075	236	23	meta	meta	ADJ
dpc-4075	236	24	-	-	PUNCT
dpc-4075	236	25	analysis	analysis	NOUN
dpc-4075	236	26	.	.	PUNCT
dpc-4075	237	1	2020	2020	NUM
dpc-4075	237	2	;	;	PUNCT
dpc-4075	237	3	plos	plos	PROPN
dpc-4075	237	4	one	one	NUM
dpc-4075	237	5	15(11	15(11	NUM
dpc-4075	237	6	):	):	PUNCT
dpc-4075	237	7	e0241445	e0241445	PROPN
dpc-4075	237	8	.	.	PROPN
dpc-4075	238	1	8	8	NUM
dpc-4075	238	2	.	.	X
dpc-4075	238	3	ezzedine	ezzedine	PROPN
dpc-4075	238	4	k	k	NOUN
dpc-4075	238	5	,	,	PUNCT
dpc-4075	238	6	eleftheriadou	eleftheriadou	NOUN
dpc-4075	238	7	v	v	PROPN
dpc-4075	238	8	,	,	PUNCT
dpc-4075	238	9	jones	jones	PROPN
dpc-4075	238	10	h	h	PROPN
dpc-4075	238	11	,	,	PUNCT
dpc-4075	238	12	et	et	PROPN
dpc-4075	238	13	al	al	PROPN
dpc-4075	238	14	.	.	PUNCT
dpc-4075	239	1	psychosocial	psychosocial	ADJ
dpc-4075	239	2	effects	effect	NOUN
dpc-4075	239	3	of	of	ADP
dpc-4075	239	4	vitiligo	vitiligo	NOUN
dpc-4075	239	5	:	:	PUNCT
dpc-4075	239	6	a	a	DET
dpc-4075	239	7	systematic	systematic	ADJ
dpc-4075	239	8	literature	literature	PROPN
dpc-4075	239	9	review	review	NOUN
dpc-4075	239	10	.	.	PUNCT
dpc-4075	240	1	am	be	AUX
dpc-4075	240	2	j	j	PROPN
dpc-4075	240	3	clin	clin	PROPN
dpc-4075	240	4	dermatol	dermatol	NOUN
dpc-4075	240	5	.	.	PUNCT
dpc-4075	241	1	2021	2021	NUM
dpc-4075	241	2	;	;	PUNCT
dpc-4075	241	3	22:757	22:757	PROPN
dpc-4075	241	4	-	-	SYM
dpc-4075	241	5	774	774	NUM
dpc-4075	241	6	.	.	PUNCT
dpc-4075	242	1	9	9	X
dpc-4075	242	2	.	.	X
dpc-4075	242	3	picardo	picardo	PROPN
dpc-4075	242	4	m	m	PROPN
dpc-4075	242	5	,	,	PUNCT
dpc-4075	242	6	huggins	huggins	PROPN
dpc-4075	242	7	rh	rh	PROPN
dpc-4075	242	8	,	,	PUNCT
dpc-4075	242	9	jones	jones	PROPN
dpc-4075	242	10	h	h	PROPN
dpc-4075	242	11	,	,	PUNCT
dpc-4075	242	12	marino	marino	PROPN
dpc-4075	242	13	r	r	PROPN
dpc-4075	242	14	,	,	PUNCT
dpc-4075	242	15	ogunsola	ogunsola	PROPN
dpc-4075	242	16	m	m	PROPN
dpc-4075	242	17	,	,	PUNCT
dpc-4075	242	18	seneschal	seneschal	NOUN
dpc-4075	242	19	j.	j.	PROPN
dpc-4075	242	20	the	the	DET
dpc-4075	242	21	humanistic	humanistic	ADJ
dpc-4075	242	22	burden	burden	NOUN
dpc-4075	242	23	of	of	ADP
dpc-4075	242	24	vitiligo	vitiligo	NOUN
dpc-4075	242	25	:	:	PUNCT
dpc-4075	242	26	a	a	DET
dpc-4075	242	27	systematic	systematic	ADJ
dpc-4075	242	28	literature	literature	NOUN
dpc-4075	242	29	review	review	NOUN
dpc-4075	242	30	of	of	ADP
dpc-4075	242	31	quality	quality	NOUN
dpc-4075	242	32	-	-	PUNCT
dpc-4075	242	33	of	of	ADP
dpc-4075	242	34	-	-	PUNCT
dpc-4075	242	35	life	life	NOUN
dpc-4075	242	36	outcomes	outcome	NOUN
dpc-4075	242	37	.	.	PUNCT
dpc-4075	243	1	j	j	PROPN
dpc-4075	243	2	eur	eur	PROPN
dpc-4075	243	3	acad	acad	PROPN
dpc-4075	243	4	dermatol	dermatol	NOUN
dpc-4075	243	5	venereol	venereol	NOUN
dpc-4075	243	6	.	.	PUNCT
dpc-4075	244	1	2022	2022	NUM
dpc-4075	244	2	;	;	PUNCT
dpc-4075	244	3	36:1507	36:1507	NOUN
dpc-4075	244	4	-	-	SYM
dpc-4075	244	5	1523	1523	NUM
dpc-4075	244	6	.	.	PUNCT
dpc-4075	245	1	10	10	NUM
dpc-4075	245	2	.	.	PUNCT
dpc-4075	246	1	rodrigues	rodrigues	PROPN
dpc-4075	246	2	m.	m.	PROPN
dpc-4075	246	3	skin	skin	NOUN
dpc-4075	246	4	cancer	cancer	NOUN
dpc-4075	246	5	risk	risk	NOUN
dpc-4075	246	6	(	(	PUNCT
dpc-4075	246	7	nonmelanoma	nonmelanoma	VERB
dpc-4075	246	8	skin	skin	NOUN
dpc-4075	246	9	cancers/	cancers/	NUM
dpc-4075	246	10	melanoma	melanoma	NOUN
dpc-4075	246	11	)	)	PUNCT
dpc-4075	246	12	in	in	ADP
dpc-4075	246	13	vitiligo	vitiligo	NOUN
dpc-4075	246	14	patients	patient	NOUN
dpc-4075	246	15	.	.	PUNCT
dpc-4075	247	1	dermatologic	dermatologic	ADJ
dpc-4075	247	2	clinics	clinic	NOUN
dpc-4075	247	3	,	,	PUNCT
dpc-4075	247	4	2017	2017	NUM
dpc-4075	247	5	,	,	PUNCT
dpc-4075	247	6	35.2	35.2	NUM
dpc-4075	247	7	:	:	PUNCT
dpc-4075	247	8	129-134.silverberg	129-134.silverberg	NUM
dpc-4075	247	9	n.b	n.b	PROPN
dpc-4075	247	10	.	.	PROPN
dpc-4075	247	11	et	et	PROPN
dpc-4075	247	12	al	al	PROPN
dpc-4075	247	13	.	.	PROPN
dpc-4075	247	14	2010	2010	NUM
dpc-4075	247	15	11	11	NUM
dpc-4075	247	16	.	.	PUNCT
dpc-4075	248	1	gawkrodger	gawkrodger	PROPN
dpc-4075	248	2	dj	dj	PROPN
dpc-4075	248	3	,	,	PUNCT
dpc-4075	248	4	ormerod	ormerod	VERB
dpc-4075	248	5	ad	ad	NOUN
dpc-4075	248	6	,	,	PUNCT
dpc-4075	248	7	shaw	shaw	PROPN
dpc-4075	248	8	l	l	PROPN
dpc-4075	248	9	,	,	PUNCT
dpc-4075	248	10	et	et	PROPN
dpc-4075	248	11	al	al	PROPN
dpc-4075	248	12	.	.	PROPN
dpc-4075	248	13	guideline	guideline	NOUN
dpc-4075	248	14	for	for	ADP
dpc-4075	248	15	the	the	DET
dpc-4075	248	16	diagnosis	diagnosis	NOUN
dpc-4075	248	17	and	and	CCONJ
dpc-4075	248	18	management	management	NOUN
dpc-4075	248	19	of	of	ADP
dpc-4075	248	20	vitiligo	vitiligo	NOUN
dpc-4075	248	21	.	.	PUNCT
dpc-4075	249	1	british	british	ADJ
dpc-4075	249	2	journal	journal	PROPN
dpc-4075	249	3	of	of	ADP
dpc-4075	249	4	dermatology	dermatology	NOUN
dpc-4075	249	5	.	.	PUNCT
dpc-4075	250	1	2008	2008	NUM
dpc-4075	250	2	;	;	PUNCT
dpc-4075	250	3	159(5	159(5	NUM
dpc-4075	250	4	)	)	PUNCT
dpc-4075	250	5	,	,	PUNCT
dpc-4075	250	6	1051	1051	NUM
dpc-4075	250	7	-	-	SYM
dpc-4075	250	8	1076	1076	NUM
dpc-4075	250	9	.	.	PUNCT
dpc-4075	251	1	12	12	NUM
dpc-4075	251	2	.	.	PUNCT
dpc-4075	252	1	bergqvist	bergqvist	PROPN
dpc-4075	252	2	c	c	PROPN
dpc-4075	252	3	,	,	PUNCT
dpc-4075	252	4	and	and	CCONJ
dpc-4075	252	5	ezzedine	ezzedine	NOUN
dpc-4075	252	6	k	k	PROPN
dpc-4075	252	7	vitiligo	vitiligo	VERB
dpc-4075	252	8	:	:	PUNCT
dpc-4075	252	9	a	a	DET
dpc-4075	252	10	review	review	NOUN
dpc-4075	252	11	.	.	PUNCT
dpc-4075	253	1	dermatology	dermatology	NOUN
dpc-4075	253	2	236.6	236.6	NUM
dpc-4075	253	3	.	.	PUNCT
dpc-4075	254	1	2020	2020	NUM
dpc-4075	254	2	;	;	PUNCT
dpc-4075	254	3	571	571	NUM
dpc-4075	254	4	-	-	SYM
dpc-4075	254	5	592	592	NUM
dpc-4075	254	6	.	.	NOUN
dpc-4075	255	1	13	13	NUM
dpc-4075	255	2	.	.	PUNCT
dpc-4075	256	1	a	a	DET
dpc-4075	256	2	taieb	taieb	PROPN
dpc-4075	256	3	,	,	PUNCT
dpc-4075	256	4	a	a	DET
dpc-4075	256	5	alomar	alomar	PROPN
dpc-4075	256	6	,	,	PUNCT
dpc-4075	256	7	m	m	NOUN
dpc-4075	256	8	böhm	böhm	NOUN
dpc-4075	256	9	,	,	PUNCT
dpc-4075	256	10	et	et	PROPN
dpc-4075	256	11	al	al	PROPN
dpc-4075	256	12	.	.	PUNCT
dpc-4075	256	13	guidelines	guideline	NOUN
dpc-4075	256	14	for	for	ADP
dpc-4075	256	15	the	the	DET
dpc-4075	256	16	management	management	NOUN
dpc-4075	256	17	of	of	ADP
dpc-4075	256	18	vitiligo	vitiligo	NOUN
dpc-4075	256	19	:	:	PUNCT
dpc-4075	256	20	the	the	DET
dpc-4075	256	21	european	european	PROPN
dpc-4075	256	22	dermatology	dermatology	PROPN
dpc-4075	256	23	forum	forum	PROPN
dpc-4075	256	24	consensus	consensus	PROPN
dpc-4075	256	25	,	,	PUNCT
dpc-4075	256	26	br	br	PROPN
dpc-4075	256	27	j	j	PROPN
dpc-4075	256	28	dermatol	dermatol	NOUN
dpc-4075	256	29	2013	2013	NUM
dpc-4075	256	30	jan;168(1):5	jan;168(1):5	NOUN
dpc-4075	256	31	-	-	SYM
dpc-4075	256	32	19	19	NUM
dpc-4075	256	33	14	14	NUM
dpc-4075	256	34	.	.	PUNCT
dpc-4075	257	1	krüger	krüger	NOUN
dpc-4075	257	2	c	c	PROPN
dpc-4075	257	3	,	,	PUNCT
dpc-4075	257	4	schallreuter	schallreuter	PROPN
dpc-4075	257	5	ku	ku	PROPN
dpc-4075	257	6	.	.	PUNCT
dpc-4075	258	1	a	a	DET
dpc-4075	258	2	review	review	NOUN
dpc-4075	258	3	of	of	ADP
dpc-4075	258	4	the	the	DET
dpc-4075	258	5	worldwide	worldwide	ADJ
dpc-4075	258	6	prevalence	prevalence	NOUN
dpc-4075	258	7	of	of	ADP
dpc-4075	258	8	vitiligo	vitiligo	NOUN
dpc-4075	258	9	in	in	ADP
dpc-4075	258	10	children	child	NOUN
dpc-4075	258	11	/	/	SYM
dpc-4075	258	12	adolescents	adolescent	NOUN
dpc-4075	258	13	and	and	CCONJ
dpc-4075	258	14	adults	adult	NOUN
dpc-4075	258	15	.	.	PUNCT
dpc-4075	259	1	international	international	ADJ
dpc-4075	259	2	journal	journal	NOUN
dpc-4075	259	3	of	of	ADP
dpc-4075	259	4	dermatology	dermatology	NOUN
dpc-4075	259	5	51.10	51.10	NUM
dpc-4075	259	6	.	.	NOUN
dpc-4075	259	7	2012	2012	NUM
dpc-4075	259	8	;	;	PUNCT
dpc-4075	259	9	1206	1206	NUM
dpc-4075	259	10	-	-	SYM
dpc-4075	259	11	1212	1212	NUM
dpc-4075	259	12	.	.	PUNCT
dpc-4075	260	1	15	15	NUM
dpc-4075	260	2	.	.	PUNCT
dpc-4075	260	3	ezzedine	ezzedine	PROPN
dpc-4075	260	4	k	k	PROPN
dpc-4075	260	5	,	,	PUNCT
dpc-4075	260	6	seneschal	seneschal	PROPN
dpc-4075	260	7	j	j	PROPN
dpc-4075	260	8	,	,	PUNCT
dpc-4075	260	9	da	da	PROPN
dpc-4075	260	10	silva	silva	PROPN
dpc-4075	260	11	a	a	PROPN
dpc-4075	260	12	,	,	PUNCT
dpc-4075	260	13	et	et	PROPN
dpc-4075	260	14	al	al	PROPN
dpc-4075	260	15	.	.	PROPN
dpc-4075	261	1	vitiligo	vitiligo	PROPN
dpc-4075	261	2	patient	patient	ADJ
dpc-4075	261	3	population	population	NOUN
dpc-4075	261	4	and	and	CCONJ
dpc-4075	261	5	disease	disease	NOUN
dpc-4075	261	6	burden	burden	NOUN
dpc-4075	261	7	in	in	ADP
dpc-4075	261	8	france	france	PROPN
dpc-4075	261	9	:	:	PUNCT
dpc-4075	261	10	violin	violin	NOUN
dpc-4075	261	11	study	study	NOUN
dpc-4075	261	12	results	result	VERB
dpc-4075	261	13	from	from	ADP
dpc-4075	261	14	the	the	DET
dpc-4075	261	15	constances	constance	NOUN
dpc-4075	261	16	cohort	cohort	NOUN
dpc-4075	261	17	.	.	PUNCT
dpc-4075	262	1	j	j	PROPN
dpc-4075	262	2	eur	eur	PROPN
dpc-4075	262	3	acad	acad	PROPN
dpc-4075	262	4	dermatol	dermatol	NOUN
dpc-4075	262	5	venereol	venereol	NOUN
dpc-4075	262	6	.	.	PUNCT
dpc-4075	263	1	2023	2023	NUM
dpc-4075	263	2	aug	aug	PROPN
dpc-4075	263	3	21	21	NUM
dpc-4075	263	4	;	;	PUNCT
dpc-4075	263	5	epub	epub	NOUN
dpc-4075	263	6	ahead	ahead	ADV
dpc-4075	263	7	of	of	ADP
dpc-4075	263	8	print	print	NOUN
dpc-4075	263	9	16	16	NUM
dpc-4075	263	10	.	.	PUNCT
dpc-4075	264	1	picardo	picardo	PROPN
dpc-4075	264	2	m	m	PROPN
dpc-4075	264	3	,	,	PUNCT
dpc-4075	264	4	dell’anna	dell’anna	ADJ
dpc-4075	264	5	ml	ml	NOUN
dpc-4075	264	6	,	,	PUNCT
dpc-4075	264	7	ezzedine	ezzedine	PROPN
dpc-4075	264	8	k.	k.	PROPN
dpc-4075	264	9	,	,	PUNCT
dpc-4075	264	10	et	et	PROPN
dpc-4075	264	11	al	al	PROPN
dpc-4075	264	12	.	.	PROPN
dpc-4075	265	1	vitiligo	vitiligo	PROPN
dpc-4075	265	2	nature	nature	NOUN
dpc-4075	265	3	reviews	review	NOUN
dpc-4075	265	4	disease	disease	NOUN
dpc-4075	265	5	primers	primer	NOUN
dpc-4075	265	6	,	,	PUNCT
dpc-4075	265	7	15011	15011	NUM
dpc-4075	265	8	(	(	PUNCT
dpc-4075	265	9	2015	2015	NUM
dpc-4075	265	10	)	)	PUNCT
dpc-4075	265	11	17	17	NUM
dpc-4075	265	12	.	.	PUNCT
dpc-4075	266	1	hadi	hadi	PROPN
dpc-4075	266	2	a	a	PROPN
dpc-4075	266	3	,	,	PUNCT
dpc-4075	266	4	wang	wang	PROPN
dpc-4075	266	5	jf	jf	PROPN
dpc-4075	266	6	,	,	PUNCT
dpc-4075	266	7	uppal	uppal	PROPN
dpc-4075	266	8	p	p	PROPN
dpc-4075	266	9	,	,	PUNCT
dpc-4075	266	10	penn	penn	PROPN
dpc-4075	266	11	la	la	PROPN
dpc-4075	266	12	,	,	PUNCT
dpc-4075	266	13	elbuluk	elbuluk	PROPN
dpc-4075	266	14	n.	n.	PROPN
dpc-4075	266	15	comorbid	comorbid	NOUN
dpc-4075	266	16	diseases	disease	NOUN
dpc-4075	266	17	of	of	ADP
dpc-4075	266	18	vitiligo	vitiligo	NOUN
dpc-4075	266	19	:	:	PUNCT
dpc-4075	266	20	a	a	DET
dpc-4075	266	21	10	10	NUM
dpc-4075	266	22	-	-	PUNCT
dpc-4075	266	23	year	year	NOUN
dpc-4075	266	24	cross	cross	ADJ
dpc-4075	266	25	-	-	ADJ
dpc-4075	266	26	sectional	sectional	ADJ
dpc-4075	266	27	retrospective	retrospective	ADJ
dpc-4075	266	28	study	study	NOUN
dpc-4075	266	29	of	of	ADP
dpc-4075	266	30	an	an	DET
dpc-4075	266	31	urban	urban	ADJ
dpc-4075	266	32	us	us	PROPN
dpc-4075	266	33	population	population	NOUN
dpc-4075	266	34	.	.	PUNCT
dpc-4075	267	1	journal	journal	PROPN
dpc-4075	267	2	of	of	ADP
dpc-4075	267	3	the	the	DET
dpc-4075	267	4	american	american	PROPN
dpc-4075	267	5	academy	academy	PROPN
dpc-4075	267	6	of	of	ADP
dpc-4075	267	7	dermatology	dermatology	NOUN
dpc-4075	267	8	.	.	PUNCT
dpc-4075	268	1	2020	2020	NUM
dpc-4075	268	2	;	;	PUNCT
dpc-4075	268	3	82(3	82(3	NUM
dpc-4075	268	4	)	)	PUNCT
dpc-4075	268	5	,	,	PUNCT
dpc-4075	268	6	628	628	NUM
dpc-4075	268	7	-	-	SYM
dpc-4075	268	8	633	633	NUM
dpc-4075	268	9	.	.	PUNCT
dpc-4075	269	1	18	18	NUM
dpc-4075	269	2	.	.	PUNCT
dpc-4075	270	1	teasdale	teasdale	PROPN
dpc-4075	270	2	e	e	PROPN
dpc-4075	270	3	,	,	PUNCT
dpc-4075	270	4	muller	muller	PROPN
dpc-4075	270	5	i	i	PROPN
dpc-4075	270	6	,	,	PUNCT
dpc-4075	270	7	sani	sani	PROPN
dpc-4075	270	8	aa	aa	PROPN
dpc-4075	270	9	,	,	PUNCT
dpc-4075	270	10	thomas	thomas	PROPN
dpc-4075	270	11	ks	ks	PROPN
dpc-4075	270	12	,	,	PUNCT
dpc-4075	270	13	stuart	stuart	PROPN
dpc-4075	270	14	b	b	PROPN
dpc-4075	270	15	,	,	PUNCT
dpc-4075	270	16	santer	santer	PROPN
dpc-4075	270	17	m.	m.	NOUN
dpc-4075	270	18	views	view	NOUN
dpc-4075	270	19	and	and	CCONJ
dpc-4075	270	20	experiences	experience	NOUN
dpc-4075	270	21	of	of	ADP
dpc-4075	270	22	seeking	seek	VERB
dpc-4075	270	23	information	information	NOUN
dpc-4075	270	24	and	and	CCONJ
dpc-4075	270	25	help	help	VERB
dpc-4075	270	26	for	for	ADP
dpc-4075	270	27	vitiligo	vitiligo	NOUN
dpc-4075	270	28	:	:	PUNCT
dpc-4075	270	29	a	a	DET
dpc-4075	270	30	qualitative	qualitative	ADJ
dpc-4075	270	31	study	study	NOUN
dpc-4075	270	32	of	of	ADP
dpc-4075	270	33	written	write	VERB
dpc-4075	270	34	accounts	account	NOUN
dpc-4075	270	35	.	.	PUNCT
dpc-4075	271	1	bmj	bmj	PROPN
dpc-4075	271	2	open	open	ADJ
dpc-4075	271	3	.	.	PUNCT
dpc-4075	272	1	2018	2018	NUM
dpc-4075	272	2	;	;	PUNCT
dpc-4075	272	3	8(1	8(1	NOUN
dpc-4075	272	4	)	)	PUNCT
dpc-4075	272	5	,	,	PUNCT
dpc-4075	272	6	e018652	e018652	PROPN
dpc-4075	272	7	.	.	PROPN
dpc-4075	272	8	19	19	NUM
dpc-4075	272	9	.	.	NOUN
dpc-4075	273	1	radtke	radtke	PROPN
dpc-4075	273	2	ma	ma	PROPN
dpc-4075	273	3	,	,	PUNCT
dpc-4075	273	4	schäfer	schäfer	NOUN
dpc-4075	273	5	i	i	PRON
dpc-4075	273	6	,	,	PUNCT
dpc-4075	273	7	gajur	gajur	VERB
dpc-4075	273	8	a	a	NOUN
dpc-4075	273	9	,	,	PUNCT
dpc-4075	273	10	langenbruch	langenbruch	ADV
dpc-4075	273	11	a	a	PRON
dpc-4075	273	12	,	,	PUNCT
dpc-4075	273	13	&	&	CCONJ
dpc-4075	273	14	augustin	augustin	PROPN
dpc-4075	273	15	m.	m.	PROPN
dpc-4075	273	16	willingness‐to‐pay	willingness‐to‐pay	PROPN
dpc-4075	273	17	and	and	CCONJ
dpc-4075	273	18	quality	quality	NOUN
dpc-4075	273	19	of	of	ADP
dpc-4075	273	20	life	life	NOUN
dpc-4075	273	21	in	in	ADP
dpc-4075	273	22	patients	patient	NOUN
dpc-4075	273	23	with	with	ADP
dpc-4075	273	24	vitiligo	vitiligo	PROPN
dpc-4075	273	25	.	.	PUNCT
dpc-4075	274	1	british	british	ADJ
dpc-4075	274	2	journal	journal	PROPN
dpc-4075	274	3	of	of	ADP
dpc-4075	274	4	dermatology	dermatology	NOUN
dpc-4075	274	5	.	.	PUNCT
dpc-4075	275	1	2009	2009	NUM
dpc-4075	275	2	;	;	PUNCT
dpc-4075	275	3	161(1	161(1	NUM
dpc-4075	275	4	)	)	PUNCT
dpc-4075	275	5	,	,	PUNCT
dpc-4075	275	6	134	134	NUM
dpc-4075	275	7	-	-	SYM
dpc-4075	275	8	139	139	NUM
dpc-4075	275	9	.	.	X
dpc-4075	275	10	8	8	NUM
dpc-4075	275	11	review	review	NOUN
dpc-4075	275	12	|	|	ADV
dpc-4075	275	13	dermatol	dermatol	ADJ
dpc-4075	275	14	pract	pract	NOUN
dpc-4075	275	15	concept	concept	NOUN
dpc-4075	275	16	.	.	PUNCT
dpc-4075	276	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-4075	276	2	:	:	PUNCT
dpc-4075	276	3	e2023315s	e2023315s	PROPN
dpc-4075	276	4	50	50	NUM
dpc-4075	276	5	.	.	PUNCT
dpc-4075	276	6	vidal	vidal	NOUN
dpc-4075	276	7	-	-	PUNCT
dpc-4075	276	8	alaball	alaball	PROPN
dpc-4075	276	9	j	j	PROPN
dpc-4075	276	10	,	,	PUNCT
dpc-4075	276	11	butler	butler	PROPN
dpc-4075	276	12	cc	cc	PROPN
dpc-4075	276	13	,	,	PUNCT
dpc-4075	276	14	potter	potter	PROPN
dpc-4075	276	15	cc	cc	PROPN
dpc-4075	276	16	.	.	PROPN
dpc-4075	276	17	comparing	compare	VERB
dpc-4075	276	18	costs	cost	NOUN
dpc-4075	276	19	of	of	ADP
dpc-4075	276	20	intramuscular	intramuscular	ADJ
dpc-4075	276	21	and	and	CCONJ
dpc-4075	276	22	oral	oral	ADJ
dpc-4075	276	23	vitamin	vitamin	NOUN
dpc-4075	276	24	b12	b12	NOUN
dpc-4075	276	25	administration	administration	NOUN
dpc-4075	276	26	in	in	ADP
dpc-4075	276	27	primary	primary	ADJ
dpc-4075	276	28	care	care	NOUN
dpc-4075	276	29	:	:	PUNCT
dpc-4075	276	30	a	a	DET
dpc-4075	276	31	cost	cost	NOUN
dpc-4075	276	32	-	-	PUNCT
dpc-4075	276	33	minimization	minimization	NOUN
dpc-4075	276	34	analysis	analysis	NOUN
dpc-4075	276	35	.	.	PUNCT
dpc-4075	277	1	eur	eur	PROPN
dpc-4075	277	2	j	j	PROPN
dpc-4075	277	3	gen	gen	PROPN
dpc-4075	277	4	pract	pract	NOUN
dpc-4075	277	5	.	.	PUNCT
dpc-4075	278	1	2006	2006	NUM
dpc-4075	278	2	;	;	PUNCT
dpc-4075	278	3	12(4):169	12(4):169	PROPN
dpc-4075	278	4	-	-	SYM
dpc-4075	278	5	73	73	NUM
dpc-4075	278	6	.	.	PUNCT
dpc-4075	279	1	51	51	NUM
dpc-4075	279	2	.	.	PUNCT
dpc-4075	280	1	khellaf	khellaf	PROPN
dpc-4075	280	2	m	m	PROPN
dpc-4075	280	3	,	,	PUNCT
dpc-4075	280	4	le	le	PROPN
dpc-4075	280	5	moine	moine	PROPN
dpc-4075	280	6	jg	jg	PROPN
dpc-4075	280	7	,	,	PUNCT
dpc-4075	280	8	poitrinal	poitrinal	PROPN
dpc-4075	280	9	p	p	X
dpc-4075	280	10	,	,	PUNCT
dpc-4075	280	11	et	et	PROPN
dpc-4075	280	12	al	al	PROPN
dpc-4075	280	13	.	.	PUNCT
dpc-4075	281	1	costs	cost	NOUN
dpc-4075	281	2	of	of	ADP
dpc-4075	281	3	managing	manage	VERB
dpc-4075	281	4	severe	severe	ADJ
dpc-4075	281	5	immune	immune	ADJ
dpc-4075	281	6	thrombocytopenia	thrombocytopenia	NOUN
dpc-4075	281	7	in	in	ADP
dpc-4075	281	8	adults	adult	NOUN
dpc-4075	281	9	:	:	PUNCT
dpc-4075	281	10	a	a	DET
dpc-4075	281	11	retrospective	retrospective	ADJ
dpc-4075	281	12	analysis	analysis	NOUN
dpc-4075	281	13	.	.	PUNCT
dpc-4075	282	1	ann	ann	PROPN
dpc-4075	282	2	hematol	hematol	NOUN
dpc-4075	282	3	.	.	PUNCT
dpc-4075	283	1	2011	2011	NUM
dpc-4075	283	2	apr	apr	NOUN
dpc-4075	283	3	;	;	PUNCT
dpc-4075	283	4	90(4):441	90(4):441	NUM
dpc-4075	283	5	-	-	SYM
dpc-4075	283	6	6	6	NUM
dpc-4075	283	7	.	.	PUNCT
dpc-4075	284	1	pmid	pmid	NOUN
dpc-4075	284	2	:	:	PUNCT
dpc-4075	284	3	20922528	20922528	NUM
dpc-4075	284	4	.	.	PUNCT
dpc-4075	285	1	52	52	NUM
dpc-4075	285	2	.	.	PUNCT
dpc-4075	286	1	mounié	mounié	PROPN
dpc-4075	286	2	m	m	PROPN
dpc-4075	286	3	,	,	PUNCT
dpc-4075	286	4	costa	costa	PROPN
dpc-4075	286	5	n	n	CCONJ
dpc-4075	286	6	,	,	PUNCT
dpc-4075	286	7	conte	conte	PROPN
dpc-4075	286	8	c	c	NOUN
dpc-4075	286	9	,	,	PUNCT
dpc-4075	286	10	et	et	PROPN
dpc-4075	286	11	al	al	PROPN
dpc-4075	286	12	.	.	PUNCT
dpc-4075	287	1	real	real	ADJ
dpc-4075	287	2	-	-	PUNCT
dpc-4075	287	3	world	world	NOUN
dpc-4075	287	4	costs	cost	NOUN
dpc-4075	287	5	of	of	ADP
dpc-4075	287	6	illness	illness	NOUN
dpc-4075	287	7	of	of	ADP
dpc-4075	287	8	hodgkin	hodgkin	PROPN
dpc-4075	287	9	and	and	CCONJ
dpc-4075	287	10	the	the	DET
dpc-4075	287	11	main	main	ADJ
dpc-4075	287	12	b	b	NOUN
dpc-4075	287	13	-	-	PUNCT
dpc-4075	287	14	cell	cell	NOUN
dpc-4075	287	15	non	non	ADJ
dpc-4075	287	16	-	-	ADJ
dpc-4075	287	17	hodgkin	hodgkin	ADJ
dpc-4075	287	18	lymphomas	lymphoma	NOUN
dpc-4075	287	19	in	in	ADP
dpc-4075	287	20	france	france	PROPN
dpc-4075	287	21	.	.	PUNCT
dpc-4075	288	1	j	j	PROPN
dpc-4075	288	2	med	med	PROPN
dpc-4075	288	3	econ	econ	PROPN
dpc-4075	288	4	.	.	PUNCT
dpc-4075	289	1	2020	2020	NUM
dpc-4075	289	2	mar	mar	PROPN
dpc-4075	289	3	;	;	PUNCT
dpc-4075	289	4	23(3):235	23(3):235	NUM
dpc-4075	289	5	-	-	SYM
dpc-4075	289	6	242	242	NUM
dpc-4075	289	7	.	.	PUNCT
dpc-4075	290	1	epub	epub	NOUN
dpc-4075	290	2	2019	2019	NUM
dpc-4075	290	3	dec	dec	PROPN
dpc-4075	290	4	26	26	NUM
dpc-4075	290	5	.	.	PUNCT
dpc-4075	291	1	pmid	pmid	NOUN
dpc-4075	291	2	:	:	PUNCT
dpc-4075	291	3	31876205	31876205	NUM
dpc-4075	291	4	.	.	PUNCT
dpc-4075	292	1	53	53	NUM
dpc-4075	292	2	.	.	PUNCT
dpc-4075	293	1	principi	principi	PROPN
dpc-4075	293	2	m	m	PROPN
dpc-4075	293	3	,	,	PUNCT
dpc-4075	293	4	labarile	labarile	NOUN
dpc-4075	293	5	n	n	CCONJ
dpc-4075	293	6	,	,	PUNCT
dpc-4075	293	7	bianchi	bianchi	PROPN
dpc-4075	293	8	fp	fp	PROPN
dpc-4075	293	9	,	,	PUNCT
dpc-4075	293	10	et	et	PROPN
dpc-4075	293	11	al	al	PROPN
dpc-4075	293	12	.	.	PUNCT
dpc-4075	294	1	the	the	DET
dpc-4075	294	2	cost	cost	NOUN
dpc-4075	294	3	of	of	ADP
dpc-4075	294	4	inflammatory	inflammatory	ADJ
dpc-4075	294	5	bowel	bowel	NOUN
dpc-4075	294	6	disease	disease	NOUN
dpc-4075	294	7	management	management	NOUN
dpc-4075	294	8	matches	match	VERB
dpc-4075	294	9	with	with	ADP
dpc-4075	294	10	clinical	clinical	ADJ
dpc-4075	294	11	course	course	NOUN
dpc-4075	294	12	:	:	PUNCT
dpc-4075	294	13	a	a	DET
dpc-4075	294	14	single	single	ADJ
dpc-4075	294	15	outpatient	outpatient	NOUN
dpc-4075	294	16	centre	centre	NOUN
dpc-4075	294	17	analysis	analysis	NOUN
dpc-4075	294	18	.	.	PUNCT
dpc-4075	295	1	int	int	PROPN
dpc-4075	296	1	j	j	PROPN
dpc-4075	296	2	environ	environ	PROPN
dpc-4075	296	3	res	re	VERB
dpc-4075	296	4	public	public	ADJ
dpc-4075	296	5	health	health	NOUN
dpc-4075	296	6	.	.	PUNCT
dpc-4075	297	1	2020	2020	NUM
dpc-4075	297	2	jun	jun	PROPN
dpc-4075	297	3	24	24	NUM
dpc-4075	297	4	;	;	PUNCT
dpc-4075	297	5	pmcid	pmcid	ADJ
dpc-4075	297	6	:	:	PUNCT
dpc-4075	297	7	pmc7344991	pmc7344991	ADJ
dpc-4075	297	8	.	.	PUNCT
dpc-4075	298	1	54	54	NUM
dpc-4075	298	2	.	.	X
dpc-4075	298	3	de	de	X
dpc-4075	298	4	girolamo	girolamo	PROPN
dpc-4075	298	5	g	g	PROPN
dpc-4075	298	6	,	,	PUNCT
dpc-4075	298	7	polidori	polidori	NOUN
dpc-4075	298	8	g	g	PROPN
dpc-4075	298	9	,	,	PUNCT
dpc-4075	298	10	morosini	morosini	PROPN
dpc-4075	298	11	p	p	NOUN
dpc-4075	298	12	,	,	PUNCT
dpc-4075	298	13	et	et	PROPN
dpc-4075	298	14	al	al	PROPN
dpc-4075	298	15	.	.	PUNCT
dpc-4075	299	1	prevalence	prevalence	NOUN
dpc-4075	299	2	of	of	ADP
dpc-4075	299	3	common	common	ADJ
dpc-4075	299	4	mental	mental	ADJ
dpc-4075	299	5	disorders	disorder	NOUN
dpc-4075	299	6	in	in	ADP
dpc-4075	299	7	italy	italy	PROPN
dpc-4075	299	8	:	:	PUNCT
dpc-4075	299	9	results	result	VERB
dpc-4075	299	10	from	from	ADP
dpc-4075	299	11	the	the	DET
dpc-4075	299	12	european	european	ADJ
dpc-4075	299	13	study	study	NOUN
dpc-4075	299	14	of	of	ADP
dpc-4075	299	15	the	the	DET
dpc-4075	299	16	epidemiology	epidemiology	NOUN
dpc-4075	299	17	of	of	ADP
dpc-4075	299	18	mental	mental	ADJ
dpc-4075	299	19	disorders	disorder	NOUN
dpc-4075	299	20	(	(	PUNCT
dpc-4075	299	21	esemed	eseme	VERB
dpc-4075	299	22	)	)	PUNCT
dpc-4075	299	23	.	.	PUNCT
dpc-4075	300	1	soc	soc	PROPN
dpc-4075	300	2	psychiatry	psychiatry	NOUN
dpc-4075	300	3	psychiatr	psychiatr	ADJ
dpc-4075	300	4	epidemiol	epidemiol	PROPN
dpc-4075	300	5	.	.	PUNCT
dpc-4075	301	1	2006	2006	NUM
dpc-4075	301	2	nov	nov	NOUN
dpc-4075	301	3	;	;	PUNCT
dpc-4075	301	4	epub	epub	PROPN
dpc-4075	301	5	2006	2006	NUM
dpc-4075	301	6	aug	aug	PROPN
dpc-4075	301	7	16	16	NUM
dpc-4075	301	8	.	.	PUNCT
dpc-4075	302	1	pmid	pmid	NOUN
dpc-4075	302	2	:	:	PUNCT
dpc-4075	302	3	16915360	16915360	NUM
dpc-4075	302	4	.	.	PUNCT
dpc-4075	303	1	55	55	NUM
dpc-4075	303	2	.	.	PUNCT
dpc-4075	304	1	perrone	perrone	PROPN
dpc-4075	304	2	v	v	PROPN
dpc-4075	304	3	,	,	PUNCT
dpc-4075	304	4	sangiorgi	sangiorgi	PROPN
dpc-4075	304	5	d	d	PROPN
dpc-4075	304	6	,	,	PUNCT
dpc-4075	304	7	andretta	andretta	PROPN
dpc-4075	304	8	m	m	PROPN
dpc-4075	304	9	,	,	PUNCT
dpc-4075	304	10	et	et	PROPN
dpc-4075	304	11	al	al	PROPN
dpc-4075	304	12	.	.	PUNCT
dpc-4075	305	1	healthcare	healthcare	PROPN
dpc-4075	305	2	resource	resource	NOUN
dpc-4075	305	3	consumption	consumption	NOUN
dpc-4075	305	4	and	and	CCONJ
dpc-4075	305	5	related	related	ADJ
dpc-4075	305	6	costs	cost	NOUN
dpc-4075	305	7	of	of	ADP
dpc-4075	305	8	patients	patient	NOUN
dpc-4075	305	9	estimated	estimate	VERB
dpc-4075	305	10	with	with	ADP
dpc-4075	305	11	treatment	treatment	NOUN
dpc-4075	305	12	-	-	PUNCT
dpc-4075	305	13	resistant	resistant	ADJ
dpc-4075	305	14	depression	depression	NOUN
dpc-4075	305	15	in	in	ADP
dpc-4075	305	16	italy	italy	PROPN
dpc-4075	305	17	.	.	PUNCT
dpc-4075	306	1	clinicoecon	clinicoecon	PROPN
dpc-4075	306	2	outcomes	outcome	NOUN
dpc-4075	306	3	res	re	NOUN
dpc-4075	306	4	.	.	PUNCT
dpc-4075	306	5	2021	2021	NUM
dpc-4075	306	6	jul	jul	PROPN
dpc-4075	306	7	5	5	NUM
dpc-4075	306	8	;	;	PUNCT
dpc-4075	306	9	pmcid	pmcid	ADJ
dpc-4075	306	10	:	:	PUNCT
dpc-4075	306	11	pmc8275098	pmc8275098	NOUN
dpc-4075	306	12	.	.	PUNCT
dpc-4075	307	1	56	56	NUM
dpc-4075	307	2	.	.	PUNCT
dpc-4075	308	1	ruggeri	ruggeri	PROPN
dpc-4075	308	2	m	m	PROPN
dpc-4075	308	3	,	,	PUNCT
dpc-4075	308	4	drago	drago	PROPN
dpc-4075	308	5	c	c	NOUN
dpc-4075	308	6	,	,	PUNCT
dpc-4075	308	7	mandolini	mandolini	PROPN
dpc-4075	308	8	d	d	PROPN
dpc-4075	308	9	,	,	PUNCT
dpc-4075	308	10	francesa	francesa	NOUN
dpc-4075	308	11	morel	morel	PROPN
dpc-4075	308	12	p	p	NOUN
dpc-4075	308	13	,	,	PUNCT
dpc-4075	308	14	mencacci	mencacci	NOUN
dpc-4075	308	15	c	c	NOUN
dpc-4075	308	16	,	,	PUNCT
dpc-4075	308	17	starace	starace	PROPN
dpc-4075	308	18	f.	f.	PROPN
dpc-4075	308	19	the	the	DET
dpc-4075	308	20	costs	cost	NOUN
dpc-4075	308	21	of	of	ADP
dpc-4075	308	22	treatment	treatment	NOUN
dpc-4075	308	23	resistant	resistant	ADJ
dpc-4075	308	24	depression	depression	NOUN
dpc-4075	308	25	:	:	PUNCT
dpc-4075	308	26	evidence	evidence	NOUN
dpc-4075	308	27	from	from	ADP
dpc-4075	308	28	a	a	DET
dpc-4075	308	29	survey	survey	NOUN
dpc-4075	308	30	among	among	ADP
dpc-4075	308	31	italian	italian	ADJ
dpc-4075	308	32	patients	patient	NOUN
dpc-4075	308	33	.	.	PUNCT
dpc-4075	309	1	expert	expert	NOUN
dpc-4075	309	2	review	review	NOUN
dpc-4075	309	3	of	of	ADP
dpc-4075	309	4	pharmacoeconomics	pharmacoeconomic	NOUN
dpc-4075	309	5	&	&	CCONJ
dpc-4075	309	6	outcomes	outcome	NOUN
dpc-4075	309	7	research	research	NOUN
dpc-4075	309	8	.	.	PUNCT
dpc-4075	310	1	2022	2022	NUM
dpc-4075	310	2	;	;	PUNCT
dpc-4075	310	3	437	437	NUM
dpc-4075	310	4	-	-	SYM
dpc-4075	310	5	444	444	NUM
dpc-4075	310	6	.	.	NOUN
dpc-4075	311	1	57	57	NUM
dpc-4075	311	2	.	.	PUNCT
dpc-4075	312	1	pugliatti	pugliatti	PROPN
dpc-4075	312	2	m	m	PROPN
dpc-4075	312	3	,	,	PUNCT
dpc-4075	312	4	sobocki	sobocki	PROPN
dpc-4075	312	5	p	p	PROPN
dpc-4075	312	6	,	,	PUNCT
dpc-4075	312	7	beghi	beghi	PROPN
dpc-4075	312	8	e	e	PROPN
dpc-4075	312	9	,	,	PUNCT
dpc-4075	312	10	et	et	PROPN
dpc-4075	312	11	al	al	PROPN
dpc-4075	312	12	.	.	PUNCT
dpc-4075	312	13	cost	cost	NOUN
dpc-4075	312	14	of	of	ADP
dpc-4075	312	15	disorders	disorder	NOUN
dpc-4075	312	16	of	of	ADP
dpc-4075	312	17	the	the	DET
dpc-4075	312	18	brain	brain	NOUN
dpc-4075	312	19	in	in	ADP
dpc-4075	312	20	europe	europe	PROPN
dpc-4075	312	21	”	"	PUNCT
dpc-4075	312	22	study	study	NOUN
dpc-4075	312	23	group	group	NOUN
dpc-4075	312	24	.	.	PUNCT
dpc-4075	313	1	cost	cost	NOUN
dpc-4075	313	2	of	of	ADP
dpc-4075	313	3	disorders	disorder	NOUN
dpc-4075	313	4	of	of	ADP
dpc-4075	313	5	the	the	DET
dpc-4075	313	6	brain	brain	NOUN
dpc-4075	313	7	in	in	ADP
dpc-4075	313	8	italy	italy	PROPN
dpc-4075	313	9	.	.	PUNCT
dpc-4075	314	1	neurol	neurol	PROPN
dpc-4075	314	2	sci	sci	PROPN
dpc-4075	314	3	.	.	PROPN
dpc-4075	314	4	2008	2008	NUM
dpc-4075	314	5	apr	apr	NOUN
dpc-4075	314	6	;	;	PUNCT
dpc-4075	314	7	epub	epub	PROPN
dpc-4075	314	8	2008	2008	NUM
dpc-4075	314	9	may	may	PROPN
dpc-4075	314	10	16	16	NUM
dpc-4075	314	11	;	;	PUNCT
dpc-4075	314	12	pmid	pmid	PROPN
dpc-4075	314	13	:	:	PUNCT
dpc-4075	314	14	18483707	18483707	NUM
dpc-4075	314	15	.	.	PUNCT
dpc-4075	315	1	58	58	NUM
dpc-4075	315	2	.	.	PUNCT
dpc-4075	316	1	adnkronos	adnkronos	PROPN
dpc-4075	316	2	sanità	sanità	PROPN
dpc-4075	316	3	,	,	PUNCT
dpc-4075	316	4	2019	2019	NUM
dpc-4075	316	5	59	59	NUM
dpc-4075	316	6	.	.	PUNCT
dpc-4075	317	1	kirch	kirch	PROPN
dpc-4075	317	2	,	,	PUNCT
dpc-4075	317	3	w	w	PROPN
dpc-4075	317	4	encyclopedia	encyclopedia	NOUN
dpc-4075	317	5	of	of	ADP
dpc-4075	317	6	public	public	ADJ
dpc-4075	317	7	health	health	NOUN
dpc-4075	317	8	:	:	PUNCT
dpc-4075	317	9	volume	volume	NOUN
dpc-4075	317	10	1	1	NUM
dpc-4075	317	11	:	:	PUNCT
dpc-4075	317	12	a	a	DET
dpc-4075	317	13	-	-	PUNCT
dpc-4075	317	14	h	h	NOUN
dpc-4075	317	15	volume	volume	NOUN
dpc-4075	317	16	2	2	NUM
dpc-4075	317	17	:	:	PUNCT
dpc-4075	317	18	i	i	PROPN
dpc-4075	317	19	-	-	PUNCT
dpc-4075	317	20	z.	z.	PROPN
dpc-4075	317	21	springer	springer	PROPN
dpc-4075	317	22	science	science	PROPN
dpc-4075	317	23	&	&	CCONJ
dpc-4075	317	24	business	business	NOUN
dpc-4075	317	25	media	medium	NOUN
dpc-4075	317	26	.	.	PUNCT
dpc-4075	318	1	2008	2008	NUM
dpc-4075	318	2	60	60	NUM
dpc-4075	318	3	.	.	PUNCT
dpc-4075	319	1	garattini	garattini	PROPN
dpc-4075	319	2	l	l	NOUN
dpc-4075	319	3	,	,	PUNCT
dpc-4075	319	4	ghislandi	ghislandi	X
dpc-4075	319	5	s	s	PROPN
dpc-4075	319	6	,	,	PUNCT
dpc-4075	319	7	tediosi	tediosi	PROPN
dpc-4075	319	8	f.	f.	PROPN
dpc-4075	319	9	l’inclusione	l’inclusione	PROPN
dpc-4075	319	10	dei	dei	PROPN
dpc-4075	319	11	costi	costi	PROPN
dpc-4075	319	12	indiretti	indiretti	VERB
dpc-4075	319	13	nelle	nelle	PROPN
dpc-4075	319	14	valutazioni	valutazioni	PROPN
dpc-4075	319	15	economiche	economiche	PROPN
dpc-4075	319	16	:	:	PUNCT
dpc-4075	319	17	la	la	PROPN
dpc-4075	319	18	situazione	situazione	PROPN
dpc-4075	319	19	italiana	italiana	PROPN
dpc-4075	319	20	.	.	PROPN
dpc-4075	319	21	cesav	cesav	PROPN
dpc-4075	319	22	.	.	PUNCT
dpc-4075	320	1	2000	2000	NUM
dpc-4075	320	2	.	.	PUNCT
dpc-4075	321	1	61	61	NUM
dpc-4075	321	2	.	.	PUNCT
dpc-4075	321	3	nuova	nuova	PROPN
dpc-4075	321	4	assicurazione	assicurazione	PROPN
dpc-4075	321	5	sociale	sociale	PROPN
dpc-4075	321	6	per	per	ADP
dpc-4075	321	7	l’impiego	l’impiego	PROPN
dpc-4075	321	8	(	(	PUNCT
dpc-4075	321	9	naspi	naspi	NOUN
dpc-4075	321	10	)	)	PUNCT
dpc-4075	321	11	,	,	PUNCT
dpc-4075	321	12	istat	istat	PROPN
dpc-4075	321	13	website	website	NOUN
dpc-4075	321	14	62	62	NUM
dpc-4075	321	15	.	.	PUNCT
dpc-4075	322	1	verbooy	verbooy	PROPN
dpc-4075	322	2	k	k	PROPN
dpc-4075	322	3	,	,	PUNCT
dpc-4075	322	4	hoefman	hoefman	PROPN
dpc-4075	322	5	r	r	PROPN
dpc-4075	322	6	,	,	PUNCT
dpc-4075	322	7	van	van	PROPN
dpc-4075	322	8	exel	exel	PROPN
dpc-4075	322	9	j	j	PROPN
dpc-4075	322	10	,	,	PUNCT
dpc-4075	322	11	brouwer	brouwer	PROPN
dpc-4075	322	12	w.	w.	PROPN
dpc-4075	322	13	time	time	PROPN
dpc-4075	322	14	is	be	AUX
dpc-4075	322	15	money	money	NOUN
dpc-4075	322	16	:	:	PUNCT
dpc-4075	322	17	investigating	investigate	VERB
dpc-4075	322	18	the	the	DET
dpc-4075	322	19	value	value	NOUN
dpc-4075	322	20	of	of	ADP
dpc-4075	322	21	leisure	leisure	NOUN
dpc-4075	322	22	time	time	NOUN
dpc-4075	322	23	and	and	CCONJ
dpc-4075	322	24	unpaid	unpaid	ADJ
dpc-4075	322	25	work	work	NOUN
dpc-4075	322	26	.	.	PUNCT
dpc-4075	323	1	value	value	NOUN
dpc-4075	323	2	health	health	NOUN
dpc-4075	323	3	.	.	PUNCT
dpc-4075	324	1	2018	2018	NUM
dpc-4075	324	2	dec	dec	PROPN
dpc-4075	324	3	;	;	PUNCT
dpc-4075	324	4	epub	epub	PROPN
dpc-4075	324	5	2018	2018	NUM
dpc-4075	324	6	jul	jul	PROPN
dpc-4075	324	7	14	14	NUM
dpc-4075	324	8	.	.	PUNCT
dpc-4075	325	1	pmid	pmid	NOUN
dpc-4075	325	2	:	:	PUNCT
dpc-4075	325	3	30502787	30502787	NUM
dpc-4075	325	4	.	.	PUNCT
dpc-4075	326	1	37	37	NUM
dpc-4075	326	2	.	.	X
dpc-4075	326	3	hann	hann	PROPN
dpc-4075	326	4	sk	sk	PROPN
dpc-4075	326	5	,	,	PUNCT
dpc-4075	326	6	lee	lee	PROPN
dpc-4075	326	7	hj	hj	PROPN
dpc-4075	326	8	.	.	PUNCT
dpc-4075	327	1	segmental	segmental	PROPN
dpc-4075	327	2	vitiligo	vitiligo	PROPN
dpc-4075	327	3	:	:	PUNCT
dpc-4075	327	4	clinical	clinical	ADJ
dpc-4075	327	5	findings	finding	NOUN
dpc-4075	327	6	in	in	ADP
dpc-4075	327	7	208	208	NUM
dpc-4075	327	8	patients	patient	NOUN
dpc-4075	327	9	.	.	PUNCT
dpc-4075	328	1	journal	journal	NOUN
dpc-4075	328	2	of	of	ADP
dpc-4075	328	3	the	the	DET
dpc-4075	328	4	american	american	PROPN
dpc-4075	328	5	academy	academy	PROPN
dpc-4075	328	6	of	of	ADP
dpc-4075	328	7	dermatology	dermatology	NOUN
dpc-4075	328	8	.	.	PUNCT
dpc-4075	329	1	1996	1996	NUM
dpc-4075	329	2	;	;	PUNCT
dpc-4075	329	3	35(5	35(5	NUM
dpc-4075	329	4	)	)	PUNCT
dpc-4075	329	5	,	,	PUNCT
dpc-4075	329	6	671	671	NUM
dpc-4075	329	7	-	-	SYM
dpc-4075	329	8	674	674	NUM
dpc-4075	329	9	.	.	PUNCT
dpc-4075	330	1	38	38	NUM
dpc-4075	330	2	.	.	PUNCT
dpc-4075	331	1	silverberg	silverberg	PROPN
dpc-4075	331	2	ji	ji	PROPN
dpc-4075	331	3	,	,	PUNCT
dpc-4075	331	4	silverberg	silverberg	PROPN
dpc-4075	331	5	ai	ai	VERB
dpc-4075	331	6	,	,	PUNCT
dpc-4075	331	7	malka	malka	PROPN
dpc-4075	331	8	e	e	PROPN
dpc-4075	331	9	,	,	PUNCT
dpc-4075	331	10	silverberg	silverberg	PROPN
dpc-4075	331	11	nb	nb	PROPN
dpc-4075	331	12	.	.	PUNCT
dpc-4075	332	1	a	a	DET
dpc-4075	332	2	pilot	pilot	NOUN
dpc-4075	332	3	study	study	NOUN
dpc-4075	332	4	assessing	assess	VERB
dpc-4075	332	5	the	the	DET
dpc-4075	332	6	role	role	NOUN
dpc-4075	332	7	of	of	ADP
dpc-4075	332	8	25	25	NUM
dpc-4075	332	9	hydroxy	hydroxy	ADJ
dpc-4075	332	10	vitamin	vitamin	NOUN
dpc-4075	332	11	d	d	NOUN
dpc-4075	332	12	levels	level	NOUN
dpc-4075	332	13	in	in	ADP
dpc-4075	332	14	patients	patient	NOUN
dpc-4075	332	15	with	with	ADP
dpc-4075	332	16	vitiligo	vitiligo	NOUN
dpc-4075	332	17	vulgaris	vulgaris	NOUN
dpc-4075	332	18	.	.	PUNCT
dpc-4075	333	1	journal	journal	PROPN
dpc-4075	333	2	of	of	ADP
dpc-4075	333	3	the	the	DET
dpc-4075	333	4	american	american	PROPN
dpc-4075	333	5	academy	academy	PROPN
dpc-4075	333	6	of	of	ADP
dpc-4075	333	7	dermatology	dermatology	NOUN
dpc-4075	333	8	.	.	PUNCT
dpc-4075	334	1	2010	2010	NUM
dpc-4075	334	2	;	;	PUNCT
dpc-4075	334	3	62(6	62(6	NOUN
dpc-4075	334	4	)	)	PUNCT
dpc-4075	334	5	,	,	PUNCT
dpc-4075	334	6	937	937	NUM
dpc-4075	334	7	-	-	SYM
dpc-4075	334	8	941	941	NUM
dpc-4075	334	9	.	.	NOUN
dpc-4075	335	1	39	39	NUM
dpc-4075	335	2	.	.	PUNCT
dpc-4075	336	1	lin	lin	PROPN
dpc-4075	336	2	z	z	PROPN
dpc-4075	336	3	,	,	PUNCT
dpc-4075	336	4	tian	tian	PROPN
dpc-4075	336	5	y	y	PROPN
dpc-4075	336	6	,	,	PUNCT
dpc-4075	336	7	bai	bai	PROPN
dpc-4075	336	8	b	b	PROPN
dpc-4075	336	9	,	,	PUNCT
dpc-4075	336	10	et	et	PROPN
dpc-4075	336	11	al	al	PROPN
dpc-4075	336	12	..	..	PROPN
dpc-4075	336	13	comprehensive	comprehensive	ADJ
dpc-4075	336	14	survey	survey	NOUN
dpc-4075	336	15	of	of	ADP
dpc-4075	336	16	vitiligo	vitiligo	ADJ
dpc-4075	336	17	patients	patient	NOUN
dpc-4075	336	18	in	in	ADP
dpc-4075	336	19	the	the	DET
dpc-4075	336	20	northeast	northeast	NOUN
dpc-4075	336	21	of	of	ADP
dpc-4075	336	22	china	china	PROPN
dpc-4075	336	23	using	use	VERB
dpc-4075	336	24	a	a	DET
dpc-4075	336	25	predesigned	predesigned	ADJ
dpc-4075	336	26	questionnaire	questionnaire	NOUN
dpc-4075	336	27	.	.	PUNCT
dpc-4075	337	1	the	the	DET
dpc-4075	337	2	journal	journal	NOUN
dpc-4075	337	3	of	of	ADP
dpc-4075	337	4	dermatology	dermatology	NOUN
dpc-4075	337	5	.	.	PUNCT
dpc-4075	337	6	2018	2018	NUM
dpc-4075	337	7	;	;	PUNCT
dpc-4075	337	8	45(1	45(1	NOUN
dpc-4075	337	9	)	)	PUNCT
dpc-4075	337	10	,	,	PUNCT
dpc-4075	337	11	39	39	NUM
dpc-4075	337	12	-	-	SYM
dpc-4075	337	13	45	45	NUM
dpc-4075	337	14	.	.	NOUN
dpc-4075	337	15	40	40	NUM
dpc-4075	337	16	.	.	PUNCT
dpc-4075	338	1	lotti	lotti	PROPN
dpc-4075	338	2	t	t	PROPN
dpc-4075	338	3	,	,	PUNCT
dpc-4075	338	4	et	et	PROPN
dpc-4075	338	5	al	al	PROPN
dpc-4075	338	6	.	.	PROPN
dpc-4075	339	1	linee	linee	PROPN
dpc-4075	339	2	guida	guida	PROPN
dpc-4075	339	3	e	e	PROPN
dpc-4075	339	4	raccomandazioni	raccomandazioni	PROPN
dpc-4075	339	5	sidemast	sidemast	NOUN
dpc-4075	339	6	:	:	PUNCT
dpc-4075	339	7	vitiligine	vitiligine	NOUN
dpc-4075	339	8	.	.	PUNCT
dpc-4075	340	1	2022	2022	NUM
dpc-4075	340	2	.	.	PUNCT
dpc-4075	341	1	41	41	NUM
dpc-4075	341	2	.	.	PUNCT
dpc-4075	342	1	van	van	PROPN
dpc-4075	342	2	geel	geel	PROPN
dpc-4075	342	3	n	n	CCONJ
dpc-4075	342	4	,	,	PUNCT
dpc-4075	342	5	uitentuis	uitentuis	PROPN
dpc-4075	342	6	se	se	X
dpc-4075	342	7	,	,	PUNCT
dpc-4075	342	8	zuidgeest	zuidge	ADJ
dpc-4075	342	9	m	m	PROPN
dpc-4075	342	10	,	,	PUNCT
dpc-4075	342	11	et	et	PROPN
dpc-4075	342	12	al	al	PROPN
dpc-4075	342	13	.	.	PUNCT
dpc-4075	342	14	validation	validation	NOUN
dpc-4075	342	15	of	of	ADP
dpc-4075	342	16	a	a	DET
dpc-4075	342	17	patient	patient	ADJ
dpc-4075	342	18	global	global	ADJ
dpc-4075	342	19	assessment	assessment	NOUN
dpc-4075	342	20	for	for	ADP
dpc-4075	342	21	extent	extent	NOUN
dpc-4075	342	22	,	,	PUNCT
dpc-4075	342	23	severity	severity	NOUN
dpc-4075	342	24	and	and	CCONJ
dpc-4075	342	25	impact	impact	NOUN
dpc-4075	342	26	to	to	PART
dpc-4075	342	27	define	define	VERB
dpc-4075	342	28	the	the	DET
dpc-4075	342	29	severity	severity	NOUN
dpc-4075	342	30	strata	strata	NOUN
dpc-4075	342	31	for	for	ADP
dpc-4075	342	32	the	the	DET
dpc-4075	342	33	self	self	NOUN
dpc-4075	342	34	assessment	assessment	NOUN
dpc-4075	342	35	vitiligo	vitiligo	NOUN
dpc-4075	342	36	extent	extent	NOUN
dpc-4075	342	37	score	score	NOUN
dpc-4075	342	38	(	(	PUNCT
dpc-4075	342	39	sa‐ves	sa‐ve	NOUN
dpc-4075	342	40	)	)	PUNCT
dpc-4075	342	41	.	.	PUNCT
dpc-4075	343	1	journal	journal	NOUN
dpc-4075	343	2	of	of	ADP
dpc-4075	343	3	the	the	DET
dpc-4075	343	4	european	european	PROPN
dpc-4075	343	5	academy	academy	PROPN
dpc-4075	343	6	of	of	ADP
dpc-4075	343	7	dermatology	dermatology	NOUN
dpc-4075	343	8	and	and	CCONJ
dpc-4075	343	9	venereology	venereology	NOUN
dpc-4075	343	10	.	.	PUNCT
dpc-4075	344	1	2021	2021	NUM
dpc-4075	344	2	;	;	PUNCT
dpc-4075	344	3	35(1	35(1	NUM
dpc-4075	344	4	)	)	PUNCT
dpc-4075	344	5	,	,	PUNCT
dpc-4075	344	6	216	216	NUM
dpc-4075	344	7	-	-	SYM
dpc-4075	344	8	221	221	NUM
dpc-4075	344	9	.	.	PUNCT
dpc-4075	345	1	42	42	NUM
dpc-4075	345	2	.	.	PUNCT
dpc-4075	346	1	sobocki	sobocki	PROPN
dpc-4075	346	2	p	p	PROPN
dpc-4075	346	3	,	,	PUNCT
dpc-4075	346	4	pugliatti	pugliatti	PROPN
dpc-4075	346	5	m	m	PROPN
dpc-4075	346	6	,	,	PUNCT
dpc-4075	346	7	lauer	lauer	PROPN
dpc-4075	346	8	k	k	PROPN
dpc-4075	346	9	,	,	PUNCT
dpc-4075	346	10	kobelt	kobelt	PROPN
dpc-4075	346	11	g.	g.	PROPN
dpc-4075	346	12	estimation	estimation	NOUN
dpc-4075	346	13	of	of	ADP
dpc-4075	346	14	the	the	DET
dpc-4075	346	15	cost	cost	NOUN
dpc-4075	346	16	of	of	ADP
dpc-4075	346	17	ms	ms	PROPN
dpc-4075	346	18	in	in	ADP
dpc-4075	346	19	europe	europe	PROPN
dpc-4075	346	20	:	:	PUNCT
dpc-4075	346	21	extrapolations	extrapolation	NOUN
dpc-4075	346	22	from	from	ADP
dpc-4075	346	23	a	a	DET
dpc-4075	346	24	multinational	multinational	ADJ
dpc-4075	346	25	cost	cost	NOUN
dpc-4075	346	26	study	study	NOUN
dpc-4075	346	27	.	.	PUNCT
dpc-4075	347	1	2007	2007	NUM
dpc-4075	347	2	43	43	NUM
dpc-4075	347	3	.	.	PUNCT
dpc-4075	348	1	doria	doria	PROPN
dpc-4075	348	2	a	a	PRON
dpc-4075	348	3	,	,	PUNCT
dpc-4075	348	4	amoura	amoura	NOUN
dpc-4075	348	5	z	z	NOUN
dpc-4075	348	6	,	,	PUNCT
dpc-4075	348	7	cervera	cervera	NOUN
dpc-4075	348	8	r	r	NOUN
dpc-4075	348	9	,	,	PUNCT
dpc-4075	348	10	et	et	PROPN
dpc-4075	348	11	al	al	PROPN
dpc-4075	348	12	.	.	PROPN
dpc-4075	349	1	annual	annual	ADJ
dpc-4075	349	2	direct	direct	ADJ
dpc-4075	349	3	medical	medical	ADJ
dpc-4075	349	4	cost	cost	NOUN
dpc-4075	349	5	of	of	ADP
dpc-4075	349	6	active	active	ADJ
dpc-4075	349	7	systemic	systemic	ADJ
dpc-4075	349	8	lupus	lupus	NOUN
dpc-4075	349	9	erythematosus	erythematosus	NOUN
dpc-4075	349	10	in	in	ADP
dpc-4075	349	11	five	five	NUM
dpc-4075	349	12	european	european	ADJ
dpc-4075	349	13	countries	country	NOUN
dpc-4075	349	14	.	.	PUNCT
dpc-4075	350	1	annals	annal	NOUN
dpc-4075	350	2	of	of	ADP
dpc-4075	350	3	the	the	DET
dpc-4075	350	4	rheumatic	rheumatic	ADJ
dpc-4075	350	5	diseases	disease	NOUN
dpc-4075	350	6	.	.	PUNCT
dpc-4075	351	1	2014	2014	NUM
dpc-4075	351	2	;	;	PUNCT
dpc-4075	351	3	73(1	73(1	X
dpc-4075	351	4	)	)	PUNCT
dpc-4075	351	5	,	,	PUNCT
dpc-4075	351	6	154	154	NUM
dpc-4075	351	7	-	-	SYM
dpc-4075	351	8	160	160	NUM
dpc-4075	351	9	.	.	NOUN
dpc-4075	351	10	44	44	NUM
dpc-4075	351	11	.	.	PUNCT
dpc-4075	352	1	jönsen	jönsen	NOUN
dpc-4075	352	2	a.	a.	PROPN
dpc-4075	352	3	et	et	PROPN
dpc-4075	352	4	al	al	PROPN
dpc-4075	352	5	.	.	PROPN
dpc-4075	353	1	direct	direct	ADJ
dpc-4075	353	2	and	and	CCONJ
dpc-4075	353	3	indirect	indirect	ADJ
dpc-4075	353	4	costs	cost	NOUN
dpc-4075	353	5	for	for	ADP
dpc-4075	353	6	systemic	systemic	ADJ
dpc-4075	353	7	lupus	lupus	NOUN
dpc-4075	353	8	erythematosus	erythematosus	NOUN
dpc-4075	353	9	in	in	ADP
dpc-4075	353	10	sweden	sweden	PROPN
dpc-4075	353	11	.	.	PUNCT
dpc-4075	354	1	a	a	DET
dpc-4075	354	2	nationwide	nationwide	ADJ
dpc-4075	354	3	health	health	NOUN
dpc-4075	354	4	economic	economic	ADJ
dpc-4075	354	5	study	study	NOUN
dpc-4075	354	6	based	base	VERB
dpc-4075	354	7	on	on	ADP
dpc-4075	354	8	five	five	NUM
dpc-4075	354	9	defined	define	VERB
dpc-4075	354	10	cohorts	cohort	NOUN
dpc-4075	354	11	.	.	PUNCT
dpc-4075	355	1	2015	2015	NUM
dpc-4075	355	2	45	45	NUM
dpc-4075	355	3	.	.	PUNCT
dpc-4075	356	1	møllehave	møllehave	NOUN
dpc-4075	356	2	lt	lt	PROPN
dpc-4075	356	3	,	,	PUNCT
dpc-4075	356	4	linneberg	linneberg	PROPN
dpc-4075	356	5	a	a	PRON
dpc-4075	356	6	,	,	PUNCT
dpc-4075	356	7	skaaby	skaaby	NOUN
dpc-4075	356	8	t	t	PROPN
dpc-4075	356	9	,	,	PUNCT
dpc-4075	356	10	et	et	PROPN
dpc-4075	356	11	al	al	PROPN
dpc-4075	356	12	.	.	PUNCT
dpc-4075	356	13	trends	trend	NOUN
dpc-4075	356	14	in	in	ADP
dpc-4075	356	15	costs	cost	NOUN
dpc-4075	356	16	of	of	ADP
dpc-4075	356	17	thyroid	thyroid	NOUN
dpc-4075	356	18	disease	disease	NOUN
dpc-4075	356	19	treatment	treatment	NOUN
dpc-4075	356	20	in	in	ADP
dpc-4075	356	21	denmark	denmark	NOUN
dpc-4075	356	22	during	during	ADP
dpc-4075	356	23	1995	1995	NUM
dpc-4075	356	24	-	-	SYM
dpc-4075	356	25	2015	2015	NUM
dpc-4075	356	26	.	.	PUNCT
dpc-4075	357	1	european	european	PROPN
dpc-4075	357	2	thyroid	thyroid	PROPN
dpc-4075	357	3	journal	journal	NOUN
dpc-4075	357	4	.	.	PUNCT
dpc-4075	358	1	2018	2018	NUM
dpc-4075	358	2	;	;	PUNCT
dpc-4075	358	3	7(2	7(2	NUM
dpc-4075	358	4	)	)	PUNCT
dpc-4075	358	5	,	,	PUNCT
dpc-4075	358	6	75	75	NUM
dpc-4075	358	7	-	-	SYM
dpc-4075	358	8	83	83	NUM
dpc-4075	358	9	.	.	PUNCT
dpc-4075	359	1	46	46	NUM
dpc-4075	359	2	.	.	PUNCT
dpc-4075	360	1	vadziuk	vadziuk	PROPN
dpc-4075	360	2	i	i	PROPN
dpc-4075	360	3	,	,	PUNCT
dpc-4075	360	4	klishch	klishch	PROPN
dpc-4075	360	5	i	i	PRON
dpc-4075	360	6	,	,	PUNCT
dpc-4075	360	7	markiv	markiv	PROPN
dpc-4075	360	8	i.	i.	PROPN
dpc-4075	360	9	12	12	NUM
dpc-4075	360	10	-	-	PUNCT
dpc-4075	360	11	month	month	NOUN
dpc-4075	360	12	cost	cost	NOUN
dpc-4075	360	13	of	of	ADP
dpc-4075	360	14	illness	illness	NOUN
dpc-4075	360	15	analysis	analysis	NOUN
dpc-4075	360	16	of	of	ADP
dpc-4075	360	17	the	the	DET
dpc-4075	360	18	thyroid	thyroid	NOUN
dpc-4075	360	19	disease	disease	NOUN
dpc-4075	360	20	in	in	ADP
dpc-4075	360	21	ukraine	ukraine	PROPN
dpc-4075	360	22	.	.	PUNCT
dpc-4075	361	1	pubmed	pubmed	PROPN
dpc-4075	361	2	2013	2013	NUM
dpc-4075	361	3	47	47	NUM
dpc-4075	361	4	.	.	PUNCT
dpc-4075	362	1	benucci	benucci	PROPN
dpc-4075	362	2	m	m	PROPN
dpc-4075	362	3	,	,	PUNCT
dpc-4075	362	4	rogai	rogai	ADJ
dpc-4075	362	5	v	v	NOUN
dpc-4075	362	6	,	,	PUNCT
dpc-4075	362	7	atzeni	atzeni	ADJ
dpc-4075	362	8	f	f	NOUN
dpc-4075	362	9	,	,	PUNCT
dpc-4075	362	10	hammen	hamman	NOUN
dpc-4075	362	11	v	v	NOUN
dpc-4075	362	12	,	,	PUNCT
dpc-4075	362	13	sarzti	sarzti	PROPN
dpc-4075	362	14	-	-	PUNCT
dpc-4075	362	15	puttini	puttini	NOUN
dpc-4075	362	16	p	p	NOUN
dpc-4075	362	17	,	,	PUNCT
dpc-4075	362	18	migliore	migliore	PROPN
dpc-4075	362	19	a.	a.	NOUN
dpc-4075	362	20	costs	cost	NOUN
dpc-4075	362	21	associated	associate	VERB
dpc-4075	362	22	with	with	ADP
dpc-4075	362	23	rheumatoid	rheumatoid	NOUN
dpc-4075	362	24	arthritis	arthritis	NOUN
dpc-4075	362	25	in	in	ADP
dpc-4075	362	26	italy	italy	PROPN
dpc-4075	362	27	:	:	PUNCT
dpc-4075	362	28	past	past	ADJ
dpc-4075	362	29	,	,	PUNCT
dpc-4075	362	30	present	present	ADJ
dpc-4075	362	31	,	,	PUNCT
dpc-4075	362	32	and	and	CCONJ
dpc-4075	362	33	future	future	NOUN
dpc-4075	362	34	.	.	PUNCT
dpc-4075	363	1	clinicoeconomics	clinicoeconomic	NOUN
dpc-4075	363	2	and	and	CCONJ
dpc-4075	363	3	outcomes	outcome	NOUN
dpc-4075	363	4	research	research	NOUN
dpc-4075	363	5	.	.	PUNCT
dpc-4075	364	1	2016	2016	NUM
dpc-4075	364	2	;	;	PUNCT
dpc-4075	364	3	33	33	NUM
dpc-4075	364	4	-	-	SYM
dpc-4075	364	5	41	41	NUM
dpc-4075	364	6	.	.	PUNCT
dpc-4075	365	1	48	48	NUM
dpc-4075	365	2	.	.	PUNCT
dpc-4075	366	1	landfeldt	landfeldt	PROPN
dpc-4075	366	2	e	e	NOUN
dpc-4075	366	3	,	,	PUNCT
dpc-4075	366	4	pogoryelova	pogoryelova	NOUN
dpc-4075	366	5	o	o	NOUN
dpc-4075	366	6	,	,	PUNCT
dpc-4075	366	7	sejersen	sejersen	PROPN
dpc-4075	366	8	t	t	PROPN
dpc-4075	366	9	,	,	PUNCT
dpc-4075	366	10	zethraeus	zethraeus	PROPN
dpc-4075	366	11	n	n	CCONJ
dpc-4075	366	12	,	,	PUNCT
dpc-4075	366	13	breiner	breiner	NOUN
dpc-4075	366	14	a	a	DET
dpc-4075	366	15	,	,	PUNCT
dpc-4075	366	16	lochmüller	lochmüll	ADJ
dpc-4075	366	17	h.	h.	PROPN
dpc-4075	366	18	economic	economic	ADJ
dpc-4075	366	19	costs	cost	NOUN
dpc-4075	366	20	of	of	ADP
dpc-4075	366	21	myasthenia	myasthenia	NOUN
dpc-4075	366	22	gravis	gravis	NOUN
dpc-4075	366	23	:	:	PUNCT
dpc-4075	366	24	a	a	DET
dpc-4075	366	25	systematic	systematic	ADJ
dpc-4075	366	26	review	review	NOUN
dpc-4075	366	27	.	.	PUNCT
dpc-4075	367	1	pharmacoeconomics	pharmacoeconomic	NOUN
dpc-4075	367	2	.	.	PUNCT
dpc-4075	368	1	2020	2020	NUM
dpc-4075	368	2	;	;	PUNCT
dpc-4075	368	3	38	38	NUM
dpc-4075	368	4	,	,	PUNCT
dpc-4075	368	5	715	715	NUM
dpc-4075	368	6	-	-	SYM
dpc-4075	368	7	728	728	NUM
dpc-4075	368	8	.	.	PUNCT
dpc-4075	368	9	49	49	NUM
dpc-4075	368	10	.	.	PUNCT
dpc-4075	369	1	schepelmann	schepelmann	PROPN
dpc-4075	369	2	k	k	PROPN
dpc-4075	369	3	,	,	PUNCT
dpc-4075	369	4	winter	winter	PROPN
dpc-4075	369	5	y	y	PROPN
dpc-4075	369	6	,	,	PUNCT
dpc-4075	369	7	spottke	spottke	VERB
dpc-4075	369	8	ae	ae	PROPN
dpc-4075	369	9	,	,	PUNCT
dpc-4075	369	10	et	et	PROPN
dpc-4075	369	11	al	al	PROPN
dpc-4075	369	12	.	.	PUNCT
dpc-4075	370	1	socioeconomic	socioeconomic	ADJ
dpc-4075	370	2	burden	burden	NOUN
dpc-4075	370	3	of	of	ADP
dpc-4075	370	4	amyotrophic	amyotrophic	ADJ
dpc-4075	370	5	lateral	lateral	ADJ
dpc-4075	370	6	sclerosis	sclerosis	NOUN
dpc-4075	370	7	,	,	PUNCT
dpc-4075	370	8	myasthenia	myasthenia	NOUN
dpc-4075	370	9	gravis	gravis	NOUN
dpc-4075	370	10	and	and	CCONJ
dpc-4075	370	11	facioscapulohumeral	facioscapulohumeral	ADJ
dpc-4075	370	12	muscular	muscular	ADJ
dpc-4075	370	13	dystrophy	dystrophy	NOUN
dpc-4075	370	14	.	.	PUNCT
dpc-4075	371	1	journal	journal	PROPN
dpc-4075	371	2	of	of	ADP
dpc-4075	371	3	neurology	neurology	NOUN
dpc-4075	371	4	.	.	PUNCT
dpc-4075	372	1	2010	2010	NUM
dpc-4075	372	2	;	;	PUNCT
dpc-4075	372	3	257	257	NUM
dpc-4075	372	4	,	,	PUNCT
dpc-4075	372	5	15	15	NUM
dpc-4075	372	6	-	-	SYM
dpc-4075	372	7	23	23	NUM
dpc-4075	372	8	.	.	PUNCT